<SEC-DOCUMENT>0001140361-25-000113.txt : 20250103
<SEC-HEADER>0001140361-25-000113.hdr.sgml : 20250103
<ACCEPTANCE-DATETIME>20250103060101
ACCESSION NUMBER:		0001140361-25-000113
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250102
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250103
DATE AS OF CHANGE:		20250103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES, INC.
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12421
		FILM NUMBER:		25503642

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-1000

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ENTERPRISES INC
		DATE OF NAME CHANGE:	19980909

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20041017_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:nus="http://nuskin.com/20250102" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_1810df1c96af46559905d5f3515db7b4" contextRef="c20250102to20250102" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_0caa692cb4c747929457a618dd3a8c95" contextRef="c20250102to20250102">0001021561</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="nus-20250102.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250102to20250102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001021561</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-02</xbrli:startDate><xbrli:endDate>2025-01-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_0b8fd64ba47449c597a6e69b0675b569" contextRef="c20250102to20250102">8-K</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">
                <div><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_a549a580a03c4c44b1e87338fdeb46fd" contextRef="c20250102to20250102" format="ixt:date-monthname-day-year-en">January 2, 2025</ix:nonNumeric><br/>
                </div>
              </div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date of Report (Date of earliest event reported)</div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>


</table>
      <div><span style="font-size: 10pt;"><br/>
        </span> </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 24pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_c254e99801e243e18dc6a8cda7836358" contextRef="c20250102to20250102">NU SKIN ENTERPRISES, INC.</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: top;">
              <div style="text-align: center;">(Exact name of registrant as specified in its charter)<span style="font-size: 10pt;"> <br/>
                </span></div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>


</table>
      <div><span style="font-size: 10pt;"><br/>
        </span> </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_307f90c0bf7845f3b0a9e35176d24278" contextRef="c20250102to20250102" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_c89dcc002a864412a6d4556c2e737653" contextRef="c20250102to20250102">001-12421</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_14e4e15c041a469babea233ccbc53803" contextRef="c20250102to20250102">87-0565309</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center;">(Commission File Number) <br/>
              </div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div><span style="font-size: 10pt;"><br/>
        </span> </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: middle; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_88064ad6030843579a84c6eef6872943" contextRef="c20250102to20250102">75 West Center Street</ix:nonNumeric><br/>
              </div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_d68ae28ecd4647718cdbaf2f91723395" contextRef="c20250102to20250102">Provo</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_f5265a4e9aeb4cb6ba45069d1f4d9a48" contextRef="c20250102to20250102" format="ixt-sec:stateprovnameen">Utah</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_76da7dcacbec4f3a87be86ab724d0e68" contextRef="c20250102to20250102">84601</ix:nonNumeric></div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center;">(Address of principal executive offices and zip code) <br/>
              </div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>


</table>
      <div><span style="font-size: 10pt;"><br/>
        </span> </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_8f9a3838b7784264ac3efeb94c87a220" contextRef="c20250102to20250102">801</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_62c7500726464b7c955767bcb83b96b4" contextRef="c20250102to20250102">345-1000</ix:nonNumeric></div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center;">(Registrant&#8217;s telephone number, including area code) <br/>
              </div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>


</table>
      <div><span style="font-size: 10pt;"><br/>
        </span> </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">N/A</div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 23.23%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 53.54%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Former name or former address, if changed since last report)</div>
            </td>

    <td style="width: 23.24%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions:</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 27pt; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_0fe86df9f77140e6b4ac3c8d21430bc6" contextRef="c20250102to20250102" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 27pt; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_f1e93f8f1cf847ebb655233a4b0adbbd" contextRef="c20250102to20250102" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;">&#160;</div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 27pt; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_f33c44402eee4649990f03900f3a2f0e" contextRef="c20250102to20250102" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
              </td>

  </tr>


</table>
        <div> <span style="font-size: 10pt;"><br/>
          </span></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 27pt; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_6455ccda734a45ff9c4ceb9c4fecd99e" contextRef="c20250102to20250102" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto; font-size: 10pt;">
                <div style="text-align: left;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 30%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of each class</div>
            </td>

    <td style="width: 35.16%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Trading Symbol(s)</div>
            </td>

    <td style="width: 35%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name of each exchange on which</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_b321ec4a195549c585e954889de768d8" contextRef="c20250102to20250102">Class A Common Stock, $.001 par value</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 35.16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_9c29162cf7084223a8724086eb0bf17c" contextRef="c20250102to20250102">NUS</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 35%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_0680ae7b05714700ab048a1bb872eae9" contextRef="c20250102to20250102" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_2d4db45d7e554cf987899529f050f1fa" contextRef="c20250102to20250102" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt; white-space: nowrap;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 1.01</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Entry into a Material Definitive Agreement.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 2, 2025, <span style="font-family: 'Times New Roman';">Mavely Seller LLC (&#8220;<span style="text-decoration: underline;">Seller</span>&#8221;), a Delaware limited liability company and
          subsidiary of </span>Nu Skin Enterprises, Inc. (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Company</span></span>&#8221;),<span style="font-family: 'Times New Roman';"> entered into a Unit Purchase Agreement (the &#8220;<span style="text-decoration: underline;">Purchase Agreement</span>&#8221;)
          with Clout.io Holdings, Inc., a Delaware corporation (&#8220;<span style="text-decoration: underline;">Purchaser</span>&#8221;), Mavrck LLC, a Delaware limited liability company and direct wholly-owned subsidiary of Purchaser (&#8220;<span style="text-decoration: underline;">Mavrck</span>&#8221;), and Mavely LLC, a Delaware limited liability company (&#8220;<span style="text-decoration: underline;">Mavely</span>&#8221;),</span>&#160;<span style="font-family: 'Times New Roman';">pursuant to which, among other things, Purchaser purchased all of Seller&#8217;s equity in Mavely for total consideration consisting of $230 million in cash, subject to certain adjustments as set forth in the
          Purchase Agreement, including post-closing determination of net working capital and other elements of the purchase price, and a number of shares of Purchaser&#8217;s common stock valued by the parties at $20 million (such equity purchase and related
          transactions, collectively, the &#8220;<span style="text-decoration: underline;">Mavely Transaction</span>&#8221;). </span>A portion of the aggregate cash purchase price will be held in escrow to secure certain purchase price reconciliation processes.<span style="font-family: 'Times New Roman';">&#160;
          Following the completion of certain payments to other equity holders in Seller to be made at and following the closing of the Mavely Transaction, the Company and its subsidiaries expect to retain approximately $207 </span>million of cash,
        subject to certain adjustments as set forth in the Purchase Agreement, and a number of shares of Purchaser&#8217;s common stock valued at $10 million.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Purchase Agreement includes customary representations, warranties, covenants and
          releases by Purchaser, Mavely and Seller. </span><span style="font-size: 10pt;">The Purchase Agreement also includes certain post-closing indemnification provisions in favor of Purchaser.</span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the Mavely Transaction, Mavely is expected to continue to provide certain technology and social commerce capabilities to support the
        Company&#8217;s affiliate marketing business.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description has been included to provide investors with information regarding the terms of the transactions described above, and is not
        intended to provide any factual information about the parties or the Company&#8217;s business.&#160; The Purchase Agreement contains representations and warranties that the parties made solely for the benefit of each other.&#160; These representations and
        warranties (a) may be intended not as statements of fact, but rather as a way of allocating risk to one of the parties if those statements prove to be inaccurate, (b) may apply materiality standards different from what may be viewed as material to
        investors and shareholders and (c) are made only as of the date of the Purchase Agreement, and/or as of such other date or dates as may be specified in the Purchase Agreement.&#160; Moreover, information concerning the subject matter of such
        representations and warranties may change after the date of the Purchase Agreement, which information may or may not be fully reflected in the Company&#8217;s public disclosures.&#160; Investors and shareholders are urged not to rely on such representations
        and warranties as characterizations of the actual state of facts or circumstances regarding the Company at this time or any other time.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Purchase Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the
        full text of the Purchase Agreement. A copy of the Purchase Agreement is attached as Exhibit 2.1 to this Current Report on Form 8-K and incorporated herein by reference.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt; white-space: nowrap;">
                <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Item 2.01</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold;">Completion of Acquisition or Disposition of Assets.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The information contained in Item 1.01 above is incorporated by reference into this Item 2.01.&#160; The Mavely Transaction closed on January <span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">2, 2025.</span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company is also filing herewith certain pro forma financial information related to the <span style="font-family: 'Times New Roman';">Mavely
          Transaction</span>, which is attached hereto as Exhibit 99.2.</div>

      <div>
        <div style="font-size: 10pt;"><br/>
        </div>

        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt; white-space: nowrap;">
                  <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Item 7.01</span></div>
                </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Regulation FD Disclosure.</span></span></div>
                </td>

  </tr>


</table>
        </div>

        <div style="font-size: 10pt;"><br/>
        </div>

      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 3, 2025, the Company issued a press release announcing the Mavely Transaction. The full text of the press release is attached hereto as
        Exhibit 99.1 and is incorporated herein by reference.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information furnished pursuant to this Item 7.01 and Exhibit 99.1 hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities
        Exchange Act of 1934, as amended (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Exchange Act</span></span>&#8221;), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange
        Act except as shall be expressly set forth by specific reference in such filing.</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 54pt; white-space: nowrap;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 9.01</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Financial Statements and Exhibits.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(b) <span style="font-family: 'Times New Roman'; font-style: italic;">Pro Forma Financial Information</span>.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The unaudited pro forma condensed consolidated financial information of the Company giving effect to the Mavely Transaction as required by Item 9.01(b) is
        filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-style: italic;">Exhibits.</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Exhibit No.</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 87%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 11%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20041017_ex2-1.htm">2.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Unit Purchase Agreement, dated as of January 2, 2025, by and among <span style="font-family: 'Times New Roman';">Mavely </span>Seller<span style="font-family: 'Times New Roman';"> LLC, Mavely LLC, Clout.io Holdings, Inc. </span>and Mavrck LLC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 11%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20041017_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release, dated as of January 3, 2025.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 11%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20041017_ex99-2.htm">99.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Unaudited Pro Forma Condensed Consolidated Financial Information.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 11%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (formatted as Inline XBRL).</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
        Exchange Act that represent the Company&#8217;s current expectations and beliefs. All statements other than statements of historical fact are &#8220;forward-looking statements&#8221; for purposes of federal and state securities laws and include, but are not limited
        to, statements regarding the consideration to be retained by the Company and its subsidiaries relating to the Mavely Transaction, management&#8217;s expectations regarding achievement of the Company&#8217;s vision, the future performance and capabilities of
        the ongoing Mavely business, the benefits of the continuing commercial services arrangement with Mavely, and planned uses of cash received in connection with the Mavely Transaction. In some cases, you can identify these statements by
        forward-looking words such as &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;achieve,&#8221; &#8220;expect,&#8221; and &#8220;anticipate,&#8221; the negative of these words and other similar words.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any
        forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the net proceeds to be retained by the Company and its subsidiaries in connection with the closing of the Mavely Transaction are subject to <span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">adjustments as set forth in the Purchase Agreement, including post-closing determination of working capital and other elements of the purchase price</span>, which may reduce the amount of consideration to be retained by the
                Company and its subsidiaries;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">risk that the Purchaser, Mavrck, and Mavely companies may encounter difficulties integrating their businesses or achieving the synergies that are anticipated from the transaction, or risks
                associated with not providing services to the company as currently anticipated;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">any failure of current or planned initiatives or products to generate interest among the Company&#8217;s sales force and customers and generate sponsoring and selling activities on a sustained basis;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">risk that direct selling laws and regulations in any of the Company&#8217;s markets, including the United States and Mainland China, may be modified, interpreted or enforced in a manner that results in
                negative changes to the Company&#8217;s business model or negatively impacts its revenue, sales force or business, including through the interruption of sales activities, loss of licenses, increased scrutiny of sales force actions, imposition of
                fines, or any other adverse actions or events;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">economic conditions and events globally;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">competitive pressures in the Company&#8217;s markets;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">risk that epidemics, including COVID-19 and related disruptions, or other crises could negatively impact our business;</div>
            </td>

  </tr>


</table>
      <div> <br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">adverse publicity related to the Company&#8217;s business, products, industry or any legal actions or complaints by the Company&#8217;s sales force or others;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">political, legal, tax and regulatory uncertainties, including trade policies, associated with operating in Mainland China and other international markets;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">uncertainty regarding meeting restrictions and other government scrutiny in Mainland China, as well as negative media and consumer sentiment in Mainland China on our business operations and
                results;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">risk of foreign-currency fluctuations and the currency translation impact on the Company&#8217;s business associated with these fluctuations;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">uncertainties regarding the future financial performance of the businesses the Company has acquired;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support planned initiatives or launch strategies, and increased risk of inventory write-offs
                if the Company over-forecasts demand for a product or changes its planned initiatives or launch strategies;</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">regulatory risks associated with the Company&#8217;s products, which could require the Company to modify its claims or inhibit its ability to import or continue selling a product in a market if the
                product is determined to be a medical device or if the Company is unable to register the product in a timely manner under applicable regulatory requirements; and</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Company&#8217;s future tax-planning initiatives, any prospective or retrospective increases in duties or tariffs on the Company&#8217;s products imported into the Company&#8217;s markets outside of the United
                States, and any adverse results of tax audits or unfavorable changes to tax laws in the Company&#8217;s various markets.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the
        Company with the SEC. The forward-looking statements set forth the Company&#8217;s beliefs as of the date that such information was first provided, and the Company assumes no duty to update the forward-looking statements contained in this release to
        reflect any change except as required by law.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; text-indent: -72pt; margin-left: 72pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Registrant)</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br/>
            </td>

    <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">/s/&#160; James D. Thomas</span><br/>
              </div>
            </td>

    <td style="width: 25%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">James D. Thomas</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br/>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date:&#160; January 3, 2025</div>
            </td>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="2"><br/>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ef20041017_ex2-1.htm
<DESCRIPTION>UNIT PURCHASE AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 2.1</font><font style="font-size: 10pt;"><br>
    </font></div>
  <div style="text-align: left;"><br>
    <div style="font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">UNIT PURCHASE AGREEMENT</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">BY AND AMONG</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">MAVELY SELLER LLC,</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">MAVELY LLC,</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CLOUT.IO HOLDINGS, INC.,</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">and</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">MAVRCK LLC</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Dated as of January 2, 2025</div>
      <div style="font-size: 10pt;">&#160;
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%-%-%-->
    <div style="text-align: center; margin-left: 5.4pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>TABLE OF CONTENTS</u></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z12fa7ae24b2345aa97a534b7160520df" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 85%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: center;"><u>Page</u></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="3">
            <div>Article I CERTAIN DEFINITIONS</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">2<br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>1.1</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Definitions</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">2<br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="3">
            <div>Article II UNIT purchase</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">21</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>2.1</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Unit Purchase</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">21</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>2.2</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Closing</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">21</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>2.3</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Closing Payments by Purchaser</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">22</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>2.4</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Certain Indebtedness and Liens</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">23</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>2.5</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Post-Closing Determination of Additional Cash Purchase Price</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">23</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>2.6</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Withholding Taxes</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">26</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>2.7</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Changes in Purchaser Common Stock</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>2.8</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Profits Interest Units Payroll Mechanics</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">27</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="3">
            <div>Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.1</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Organization, Standing and Power</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.2</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Authorization</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.3</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Noncontravention</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.4</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Governmental Approvals</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.5</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Capitalization</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.6</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Subsidiaries</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.7</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Financial Statements; Undisclosed Liabilities</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.8</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Absence of Certain Changes</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">30</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.9</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Legal Proceedings</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">31</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.10</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Compliance With Laws; Permits</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">31</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.11</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Material Contracts</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">33</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.12</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Intellectual Property; Privacy and Security.</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">35</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.13</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Employee Benefits Matters</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">38</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.14</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Labor</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.15</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Tax Matters</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">40</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.16</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Real Property</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">43</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.17</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Insurance</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">43</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.18</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Environmental Matters</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">44</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.19</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Interested Party Transactions</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">44</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>3.20</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Brokers and Other Advisors</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">44</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>3.21</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Title to Assets; Sufficiency of Assets</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">44</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-i-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z38b50bdf226946ec817cf67f8793a990" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="3">
            <div>Article IV REPRESENTATIONS AND WARRANTIES OF SELLER</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>4.1</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Organization, Standing and Power; Capacity</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>4.2</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Authorization</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>4.3</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Noncontravention</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>4.4</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Governmental Approvals</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>4.5</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Ownership</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>4.6</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Legal Proceedings</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">45</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>4.7</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Brokers and Other Advisors</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>4.8</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>IP Assignment Agreement</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">46</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="3">
            <div>Article V REPRESENTATIONS AND WARRANTIES OF Purchaser</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.1</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Organization, Standing and Power</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>5.2</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Authorization</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.3</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Noncontravention</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>5.4</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Governmental Approvals</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.5</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Capitalization</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>5.6</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Legal Proceedings</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">48</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.7</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Compliance With Laws</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">48</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>5.8</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Purchaser Financial Statements; No Undisclosed Liabilities</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">49</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.9</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Solvency</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">49</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>5.10</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Investment Representation</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">49</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.11</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Brokers and Other Advisors</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">50</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>5.12</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>No Prior Agreements</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">50</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>5.13</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>No Other Representations</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">50</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="3">
            <div>Article VI COVENANTS</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">50</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.1</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Indemnification, Exculpation and Insurance</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">50</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.2</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Preservation of Records</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">52</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.3</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Publicity; Confidentiality</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">52</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.4</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Insurance Matters</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">53</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.1</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Employee Benefits</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">53</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.2</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>R&amp;W Insurance Policy</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">53</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.3</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Intercompany Agreements and Arrangements</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">53</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.4</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Use of Seller Names/Transferred IP</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">54</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.5</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Transition Services Agreement</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">54</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.6</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Section 280G</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">54</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.7</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Wrong Pockets</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">54</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.8</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Tax Matters</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">55</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-ii-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z9dce1253ce3b4878b3d87c9129b26a18" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>6.9</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Company Valuation.</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">57</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>6.10</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Tax Contests.</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">57</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="3">
            <div>Article VII No Survival</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">58</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>7.1</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>No Survival</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">58</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>7.2</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Indemnification by Sellers</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">58</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>7.3</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Notice and Opportunity to Defend.</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">60</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>7.4</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Manner of Payment.</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">61</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>7.5</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Exclusive Remedy.</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">61</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="3">
            <div>Article VIII ADDITIONAL AGREEMENTS</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">62</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>8.1</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>No Other Representations</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">62</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="3">
            <div>Article IX MISCELLANEOUS</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">62</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>9.1</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Remedies</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">62</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>9.2</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Expenses</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">62</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>9.3</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Entire Agreement; Amendments and Waivers</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">63</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>9.4</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Governing Law</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">63</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>9.5</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Waiver of Jury Trial</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">63</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>9.6</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Notices</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">64</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>9.7</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Severability</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">65</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>9.8</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Binding Effect; Assignment</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">65</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>9.9</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Non-Recourse</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">65</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>9.10</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Provision Respecting Legal Representation</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">66</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div>9.11</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Release</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: right;">66</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>9.12</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Counterparts</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">67</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>EXHIBITS</u></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z657bb3afe8d148fbbcca381e28c2a7f5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit A</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Restrictive Covenant Agreement</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div>Exhibit B</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Net Working Capital and Accounting Principles</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit C</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Intellectual Property Assignment Agreement</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div>Exhibit D</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Form of Transition Services Agreement</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit E</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Officer&#8217;s Certificate</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div>Exhibit F</div>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Form of Intercompany Agreement Termination Letter</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit G</div>
          </td>
          <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>&#8211;</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Termination of Employee Covenants Agreement</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">-iii-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNIT PURCHASE AGREEMENT</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">This UNIT PURCHASE AGREEMENT, dated as of January 2, 2025 (this &#8220;<u>Agreement</u>&#8221;), by and among Clout.io Holdings, Inc., a Delaware corporation (&#8220;<u>Purchaser</u>&#8221;),





      Mavrck LLC, a Delaware limited liability company and directly wholly-owned subsidiary of Purchaser (&#8220;<u>Mavrck</u>&#8221;), Mavely LLC, a Delaware limited liability company (the &#8220;<u>Company</u>&#8221;) and Mavely Seller LLC, a Delaware limited liability company
      (&#8220;<u>Seller</u>&#8221;).&#160; Each of Purchaser, the Company and Seller are herein referred to individually as a &#8220;<u>party</u>&#8221; and collectively as the &#8220;<u>parties</u>&#8221;.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">WITNESSETH:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, prior to the execution of this Agreement, the Seller Equityholders (as defined herein) (i) formed Seller and (ii) contributed 100% of the
      issued and outstanding Company Units (as defined herein) to Seller in exchange for units of Seller (collectively, the &#8220;<u>Restructuring</u>&#8221;);</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, following the Restructuring, Seller owns 100% of the issued and outstanding Company Units (as defined herein), which represents all of the
      issued and outstanding equity interests of the Company;</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, Seller desires to sell the Company Units to Purchaser, and Purchaser desires to purchase from Seller the Company Units, upon the terms and
      subject to the conditions hereinafter set forth;</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, concurrently with the execution of this Agreement and as a material inducement to the willingness of Purchaser to enter into this Agreement,
      the individuals set forth on <u>Schedule 1.1(a)-1</u> (the &#8220;<u>Key Employees</u>&#8221;) are executing employee offer letters with Purchaser or an Affiliate thereof (each an &#8220;<u>Offer Letter</u>&#8221;) together with a confidentiality and ownership of
      inventions agreement (each a &#8220;<u>CIAA</u>&#8221;) and a non-competition and non-solicitation agreement (collectively with the Offer Letters and the CIAAs, the &#8220;<u>Key Employee Onboarding Documents</u>&#8221;);</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, concurrently with the execution of this Agreement and as a material inducement to the willingness of Purchaser to enter into this Agreement,
      each of the individuals set forth on <u>Schedule 1.1(a)-2</u> are executing a restrictive covenant agreement in substantially the form attached hereto as <u>Exhibit A</u> (each a &#8220;<u>Restrictive Covenant Agreement</u>&#8221;);</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, as a material inducement to the willingness of Purchaser to enter into this Agreement, Nu Skin Enterprises, Inc. (i) has executed that
      certain Intellectual Property Assignment, dated as of December 23, 2024, by and between Nu Skin Enterprises, Inc. (together with Nu Skin Enterprises de Venezuela, C.A.) and MyFavoriteThings, Inc. (&#8220;<u>MFT</u>&#8221;), (ii) is executing, concurrently with
      the execution of this Agreement, that certain Intellectual Property Assignment, by and between Nu Skin Enterprises, Inc. (together with each Affiliate of NuSkin Enterprises, Inc. as of the date hereof (other than Nu Skin El Salvador, S.A. DE C.V., Nu
      Skin Honduras, S.A., Nu Skin Enterprises de Venezuela, C.A. and MyFavoriteThings, Inc.), &#8220;<u>Nu Skin</u>&#8221;) and MFT (collectively, the &#8220;<u>IP Assignment Agreements</u>&#8221;), and (iii) is executing, concurrently with the execution of this Agreement, that
      certain Termination Acknowledgement and Agreement, by Nu Skin Enterprises, Inc., on behalf of itself and its affiliated companies;</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the parties desire to make certain representations, warranties, covenants and agreements in connection with the transactions contemplated by
      this Agreement and also to prescribe various conditions thereto.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%-%-%-->
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained in this Agreement, the parties hereto agree as
      follows:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE I</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>CERTAIN DEFINITIONS</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">1.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u><u>. </u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">For purposes of
          this <u>Agreement</u>, the following terms shall have the meanings specified in this <u>Section 1.1(a)</u>:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>280G Stockholder Approval</u>&#8221; has the meaning specified in <u>Section 6.6</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Accounting Advisor</u>&#8221; has the meaning specified in <u>Section 2.5(h)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Accredited Investor</u>&#8221; means a Person that is an &#8220;accredited investor&#8221; within the meaning of Rule 501 of the Securities Act.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Accrued Income Taxes</u>&#8221; means an amount (which shall not be less than zero in any jurisdiction or for any taxpayer) equal to
      the aggregate accrued but unpaid income Tax liabilities of the Company and its Subsidiaries attributable to a Pre-Closing Tax Period; <u>provided</u>, that for purposes of computing the amount of Accrued Income Taxes; (i) any Tax liabilities
      attributable to transactions incurred outside the ordinary course of business on the Closing Date after the Closing and not otherwise contemplated by this Agreement shall be excluded, (ii) any Transaction Tax Deductions that are deductible in a
      Pre-Closing Tax Period at &#8220;more likely than not&#8221; (or higher) level of confidence shall be taken into account in a Pre-Closing Tax Period, (iii) any contingent Taxes or liabilities for accruals or reserves established or required to be established
      under GAAP methodologies that require the accrual for contingent Taxes or with respect to uncertain or speculative Tax positions shall be excluded, (iv) any Tax liabilities shall be calculated in accordance with the past practice (including reporting
      positions, elections, and accounting periods) of the Company and its Subsidiaries in preparing Tax Returns, (v) any estimated (or other prepaid) income Tax payments made on or prior to the Closing Date shall be taken into account to the extent paid
      to the applicable Taxing Authority and not already used to offset Taxes in any taxable period, and (vi) items with respect to a Straddle Period shall be allocated in accordance with <u>Section 6.8(e)</u>, and for the avoidance of doubt such Accrued
      Income Taxes shall be calculated as of the end of the Closing Date and by taking into account the transactions contemplated by this Agreement.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Action</u>&#8221; <font style="color: rgb(0, 0, 0);">any governmental investigation, inquiry or audit, or private or governmental
        action, claim, counterclaim, charge, complaint, proceeding, arbitration, mediation, suit, hearing or litigation, in each case whether civil, criminal, administrative, judicial or any appeal therefrom</font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Additional Cash Purchase Price</u>&#8221; means the aggregate amount of all funds (if any) distributed pursuant to and in accordance
      with <u>Section 2.5(f)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Adjustment Escrow Account</u>&#8221; means the escrow account established pursuant to the Escrow Agreement in respect of the
      Adjustment Escrow Amount.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Adjustment Escrow Amount</u>&#8221; means $1,725,000.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-2-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Affordable Care Act</u>&#8221; means the Patient Protection and Affordable Care Act (Pub. L. 111&#8722;148), as amended by the Health Care
      and Education Reconciliation Act of 2010 (Pub. L. 111&#8722;152), and the regulations promulgated pursuant to each of the foregoing Laws.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">&#8220;</font><u>Affiliate</u><font style="color: rgb(0, 0, 0);">&#8221;</font> means, with respect to any
      Person, any other Person that, directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person, and the term <font style="color: rgb(0, 0, 0);">&#8220;</font><u>control</u><font style="color: rgb(0, 0, 0);">&#8221;</font> (including the terms &#8220;<u>controlled by</u>&#8221; and <font style="color: rgb(0, 0, 0);">&#8220;</font><u>under </u><u>common control with</u><font style="color: rgb(0, 0, 0);">&#8221;</font>) means the possession, directly or
      indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through ownership of voting securities, by contract or otherwise; <u>provided</u>, that, notwithstanding anything to the contrary
      herein, except with respect to the provisions of <u>Section 6.3</u>, <u>Section 9.9</u> and <u>Section 9.11</u> and the definitions used therein, in no event shall Summit Partners, L.P. or any other Equityholder or any other Person directly or
      indirectly controlling, controlled by or under common control with Summit Partners, L.P. or any investment fund or vehicle affiliated with any of them, or any &#8220;portfolio company&#8221; (as such term is customarily understood among institutional private
      equity investors) of any of the foregoing or any of their respective portfolio companies (other than Seller, the Company or the Company&#8217;s Subsidiaries) be deemed, treated or considered to be an &#8220;Affiliate&#8221; of Seller, the Company or any of the
      Company&#8217;s Subsidiaries (or, in each case, vice versa).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Agreement</u>&#8221; has the meaning specified in the <u>Preamble</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Allocation</u>&#8221; has the meaning specified in <u>Section 6.8(d)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Anti-Corruption Laws</u>&#8221; means all applicable Laws, rules or regulations of the United States, EU, or UKconcerning or relating
      to kickbacks, bribery or corruption that are applicable to the Company or any Subsidiary or Affiliate, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder, the U.S. domestic anti-bribery
      statute codified in 18 U.S.C. &#167; 201 and its state analogs, and the UK Bribery Act 2010.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Applicable Expiration Date</u>&#8221; has the meaning specified in <u>Section 7.2</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Balance Sheet Date</u>&#8221; has the meaning specified in <u>Section 3.7(c)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Bankruptcy and Equity Exception</u>&#8221; has the meaning specified in <u>Section 3.2</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Benefit Plan</u>&#8221; means (i) each &#8220;employee benefit plan&#8221; (as defined in Section 3(3) of ERISA), whether or not such plan is
      subject to ERISA, (ii) each employment, change in control, retention, bonus, defined benefit or defined contribution, pension, profit sharing, deferred compensation, stock ownership, stock purchase, stock option, stock appreciation, restricted stock,
      restricted stock unit, phantom stock or other equity-based, retirement, vacation, severance, termination, disability, death benefit, medical, dental, or other employee benefit plan, program, agreement or arrangement not described in clause (i) above,
      and (iii) each other plan or arrangement providing compensation to employee and non-employee directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Business</u>&#8221; means the business of the Company and/or its Subsidiaries and their respective successors and assigns as
      conducted as of the date of this Agreement.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Business Day</u>&#8221; means any day of the year on which national banking institutions in Menlo Park, California, Boston,
      Massachusetts and Provo, Utah are open to the public for conducting business and are not required or authorized to be closed.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-3-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Cash</u>&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>means, with respect to the Company
      and the Company&#8217;s Subsidiaries, the sum of all cash, cash equivalents and marketable securities as of 11:59 p.m. Pacific Time on the day immediately preceding the Closing Date, determined in accordance with GAAP.&#160; For the avoidance of doubt, Cash
      shall (x) be calculated net of uncleared checks, drafts and wires issued by the Company and/or the Company&#8217;s Subsidiaries, (y) include uncleared checks, drafts and wires received or deposited for the account of the Company and/or the Company&#8217;s
      Subsidiaries and (z) exclude all Restricted Cash; <font style="color: rgb(0, 0, 0);"><u>provided</u>, that Cash shall be calculated by reducing amounts held outside the United States (if any) by the costs and Taxes that would be incurred in
        repatriating such amounts to the United States</font>.&#160; Notwithstanding the foregoing, &#8220;Cash&#8221; shall be reduced by any cash, cash equivalents and marketable securities used to pay any Taxes after 11:59 p.m. Pacific Time on the day immediately
      preceding the Closing Date and prior to the Closing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Class A Exit Shares</u>&#8221; means the Class A Exit Preferred Shares of ExchangeCo that are redeemable for cash as stated in
      constating documents of ExchangeCo.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Class B Exit Shares</u>&#8221; means the Class B Exit Preferred Shares of ExchangeCo that are convertible into either cash or shares
      of Purchaser Common Stock as stated in the constating documents of ExchangeCo.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Closing</u>&#8221; has the meaning specified in <u>Section 2.2(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Closing Date</u>&#8221; has the meaning specified in <u>Section 2.2(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Closing Indebtedness</u>&#8221; means the Indebtedness of the Company and the Company&#8217;s Subsidiaries immediately prior to the
      Closing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Closing Statement</u>&#8221; has the meaning specified in <u>Section 2.5(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986, as amended.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Commercial Services Agreement</u>&#8221; means that certain Services Agreement by and between Nu Skin Enterprises, Inc. and
      MyFavoriteThings, Inc., dated as of the date hereof.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company</u>&#8221; has the meaning specified in the <u>Preamble</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Benefit Plan</u>&#8221; means each Benefit Plan that the Company or any of its Subsidiaries sponsors, maintains or, other
      than as a participating employer in a Shared Company Benefit Plan, contributes to, or provides benefits under or through, or has any obligation to contribute to or provide benefits under or through, or if such Benefit Plan is not a Shared Benefit
      Plan and either provides benefits to or otherwise covers any Company Employee or Former Company Employee (or their spouses, dependents, or beneficiaries) or with respect to which the Company or any of its Subsidiaries has or may have any Liability
      (contingent or otherwise, including by reason of being an ERISA Affiliate) other than any statutory benefit plans which the Company or any of the Company&#8217;s Subsidiaries is required to participate in or comply with.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Disclosure Schedule</u>&#8221; has the meaning specified in <u>Article III</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Employee</u>&#8221; means any current employee, manager, director or individual consultant of the Company or any of the
      Company&#8217;s Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-4-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Intellectual Property</u>&#8221; means the Intellectual Property owned, purported to be owned or used or held for use by the
      Company or any of the Company&#8217;s Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Material Adverse Effect</u>&#8221; means an effect, event, change, occurrence or circumstance (each an &#8220;<u>Effect</u>&#8221;) that,
      individually or in the aggregate, (i) has or would reasonably be expected to have a material adverse effect on the business, properties, assets, operations, results of operations, or financial condition of the Company and the Company&#8217;s Subsidiaries,
      taken as a whole; <u>provided</u>, <u>however</u>, that no effect, event, change, occurrence or circumstance arising or resulting from any of the following, either alone or in combination, shall constitute or be taken into account in determining
      whether there has been a Company Material Adverse Effect: (A) operating, business, regulatory or other conditions in the industry in which the Company and the Company&#8217;s Subsidiaries operate; (B) general economic conditions, including changes in the
      credit, debt, financial, currency or capital markets (including changes in interest or exchange rates), in each case, in the United States or anywhere else in the world; (C) any effect, event, change, occurrence or circumstance related to weather,
      meteorological conditions or climate, pandemics, storms, earthquakes, floods, hurricanes, tornadoes, volcanic eruptions, wildfires, natural disasters or other acts of nature; (D) COVID-19 or any Law, directive, pronouncement or guideline issued by a
      Governmental Authority, the Centers for Disease Control and Prevention, the World Health Organization or industry group providing for business closures, changes to business operations, &#8220;sheltering-in-place&#8221; or other restrictions that relate to, or
      arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such Law, directive, pronouncement or guideline or interpretation thereof following the date of this Agreement or the Company&#8217;s or any of its Subsidiaries&#8217;
      compliance therewith; (E) global, national or regional political conditions, including hostilities, acts of war, sabotage or terrorism (including cyberattacks) or military actions or any escalation, worsening or diminution of any such hostilities,
      acts of war, sabotage or terrorism (including cyberattacks) or military actions existing or underway as of the date hereof; (F) the negotiation, execution, announcement, pendency or performance of this Agreement or the consummation of the
      transactions contemplated hereby (including compliance with the covenants set forth herein and any action taken or omitted to be taken by any of Seller, the Company or any of the Company&#8217;s Subsidiaries at the request or with the consent of
      Purchaser), including the impact thereof on relationships, contractual or otherwise with, or actual or potential loss or impairment of, clients, customers, suppliers, distributors, partners, or financing sources and on revenue, profitability and/or
      cash flows; (G) any change in Laws, regulatory policies or GAAP or other applicable accounting rules, or any guidance relating to or the interpretation of the foregoing; (H) Purchaser&#8217;s or its Representatives&#8217; or Affiliates&#8217; announcements of or other
      disclosure of its plans or intentions with respect to the conduct of business (or any portion thereof) of the Company or any of the Company&#8217;s Subsidiaries after Closing; (I) any failure by the Company or any of the Company&#8217;s Subsidiaries or any of
      Purchaser or any of its Affiliates to meet any projections, forecasts or estimates (<u>provided</u>, <u>however</u>, that any Effect that caused or contributed to such failure to meet any projections, forecasts or estimates shall not be excluded
      under this clause (I)); (J) any change in the credit rating of the Company or any of the Company&#8217;s Subsidiaries or any of Purchaser or any if its Affiliates (<u>provided</u>, <u>however</u>, that any Effect that caused or contributed to such change
      in such credit rating shall not be excluded under this clause (J)); (K) actions required to be taken under applicable Laws or Contracts; or (L) any breach of this Agreement by Purchaser; <u>provided</u>, <u>however</u>, that the foregoing clauses
      (A), (B), (C), (D), (E) and (G) shall only be taken into account in determining whether there has been a Company Material Adverse Effect to the extent that such effects, events, changes, occurrences, or circumstances referenced therein have a
      material and disproportionate adverse impact on the Company and the Company&#8217;s Subsidiaries, taken as a whole, relative to the Company&#8217;s and the Company&#8217;s Subsidiaries&#8217; competitors, in which case solely the incremental material and disproportionate
      adverse impact may be taken into account in determining whether there has been a Company Material Adverse Effect.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-5-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Organizational Documents</u>&#8221; means the Amended and Restated Limited Liability Company Agreement of the Company, dated
      as of July 24, 2024, as amended from time to time thereafter.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Company Units</u>&#8221; means the Units and Profits Interest Units, as defined in the Company Organizational Documents.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Confidentiality Agreement</u>&#8221; means the confidentiality agreement between MyFavoriteThings, Inc. and Summit Partners, LP,
      dated as of April 7, 2023 (as amended from time to time).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Contract</u>&#8221; <font style="color: rgb(0, 0, 0);">means any written or oral legally binding contract, agreement, instrument,
        commitment or undertaking of any nature (including leases, subleases, licenses, mortgages, notes, guarantees, sublicenses, subcontracts, letters of intent and purchase orders), and all amendments, waivers or other changes thereto.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Contracting Parties</u>&#8221; has the meaning specified in <u>Section 9.9</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Controlling Company</u>&#8221; has the meaning specified in the definition of &#8220;<u>Subsidiary</u>&#8221;.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Counsel</u>&#8221; has the meaning specified in <u>Section 9.10</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>COVID-19</u>&#8221; means SARS-CoV-2 or COVID-19, and any evolutions thereof or any other epidemics, pandemics or disease outbreaks.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Debt Agreements</u>&#8221; means the Amended and Restated Credit Agreement, dated as of June 14, 2022, among Nu Skin Enterprises,
      Inc., as the borrower, the Company, the other guarantors from time to time party thereto, Bank of America, N.A., as administrative agent, and the lenders from time to time party thereto, as amended, supplemented, or otherwise modified.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Dispute Notice</u>&#8221; has the meaning specified in <u>Section 2.5(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Dispute Resolution Firm</u>&#8221; has the meaning specified in <u>Section 6.8(d)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Disputed Items</u>&#8221; has the meaning specified in <u>Section 2.5(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>DPA</u>&#8221; has the meaning specified in <u>Section 3.13</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Environmental Law</u>&#8221; means any applicable Law (including common law) relating to pollution or the protection of the
      environment.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Equityholders</u>&#8221; means the direct and indirect equityholders of the Company.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>ERISA</u>&#8221; means the Employee Retirement Income Security Act of 1974, as amended.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>ERISA Affiliate</u>&#8221; means any entity, trade or business that is, or at any applicable time was, a member of a group described
      in Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes the Company.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Escrow Amount</u>&#8221; means the Adjustment Escrow Amount plus the Profits Interest Units Escrow Amount.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-6-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Escrow Agent</u>&#8221; means Wilmington Trust, N.A., as escrow agent under the Escrow Agreement, or any successor Person appointed
      in accordance with the terms of the Escrow Agreement.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Escrow Agreement</u>&#8221; means an escrow agreement to be executed as of the Closing Date, by and among Purchaser, Seller and the
      Escrow Agent, providing for the holding and disbursement of certain funds held in escrow in accordance with the terms hereof and thereof.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Cash</u>&#8221; means the Company&#8217;s good faith estimate of Cash, based on the books and records of the Company and its
      Subsidiaries; <u>provided</u>, that, notwithstanding anything herein to the contrary, if such amount is greater than the Minimum Cash Amount, the Estimated Cash shall be deemed to be equal to the Minimum Cash Amount for all purposes herein.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Cash Purchase Price</u>&#8221; means (i) $230,000,000, <u>plus</u> (ii) Estimated Cash, <u>minus</u> (iii) Estimated
      Closing Indebtedness, <u>plus</u> (iv) amount equal to fifty percent (50%) of the Estimated Net Working Capital Adjustment, <u>minus</u> (v) the Estimated Transaction Expenses, <u>minus</u> (vi) the Adjustment Escrow Amount, in each case, as set
      forth in the Estimated Closing Statement.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Cash Purchase Price Elements</u>&#8221; means, collectively, the following: (i) Estimated Cash; (ii) Estimated Closing
      Indebtedness; (iii) Estimated Net Working Capital; and (iv) Estimated Transaction Expenses.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Closing Indebtedness</u>&#8221; means the Company&#8217;s good faith estimate of Closing Indebtedness, based on the books and
      records of the Company and its Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Closing Statement</u>&#8221; has the meaning specified in <u>Section 2.3(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Net Working Capital</u>&#8221; means the Company&#8217;s good faith estimate of Net Working Capital, based on the books and
      records of the Company and its Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Net Working Capital Adjustment</u>&#8221; means an amount (which may be positive or negative) equal to (i) if Estimated Net
      Working Capital is greater than the Net Working Capital Upper Target, (a) Estimated Net Working Capital <u>minus</u> (b) the Net Working Capital Upper Target, (ii) if Estimated Net Working Capital is less than the Net Working Capital Lower Target,
      (x) Estimated Net Working Capital <u>minus</u> (y) the Net Working Capital Lower Target, and (iii) if Estimated Net Working Capital is not greater than the Net Working Capital Upper Target and not less than the Net Working Capital Lower Target, 0.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Estimated Transaction Expenses</u>&#8221; means the Company&#8217;s good faith estimate of Transaction Expenses, based on the books and
      records of the Company and its Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Excess Amount</u>&#8221; has the meaning specified in <u>Section 2.5(f)(i)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Exchange Act</u>&#8221; means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations
      promulgated thereunder.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Exchangeable Shares</u>&#8221; means shares of Clout.io Exchange Inc., a direct wholly-owned subsidiary of Purchaser, that are
      exchangeable for shares of Purchaser Common Stock.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>ExchangeCo</u>&#8221; means Clout.io Exchange Inc., a wholly-owned subsidiary of Purchaser.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-7-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;">&#8220;<u>Existing Policy</u>&#8221; has the meaning specified in <u>Section 6.1(d)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Final Cash Purchase Price</u>&#8221; means (i) $230,000,000, <u>plus</u> (ii) Cash, <u>minus</u> (iii) Closing Indebtedness, <u>plus</u>
      (iv) the amount of the Net Working Capital Adjustment, <u>minus</u> (v) Transaction Expenses, <u>minus</u> (vi) the Adjustment Escrow Amount, in each case, as set forth in the Final Closing Statement.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Final Cash Purchase Price Elements</u>&#8221; means, collectively, the following: (i) Cash; (ii) Closing Indebtedness; (iii) Net
      Working Capital; and (iv) Transaction Expenses.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Final Closing Statement</u>&#8221; has the meaning specified in <u>Section 2.5(e)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Financial Advisor</u>&#8221; has the meaning specified in <u>Section 3.20</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Financial Statements</u>&#8221; has the meaning specified in <u>Section 3.7</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Founder Pro Rata Share</u>&#8221; means, with respect to each Founder, the ratio obtained by dividing (a) the total number of Profits
      Interest Units beneficially owned directly or indirectly by such Founder by (b) the total number of outstanding Profits Interest Units, in each case, as of immediately prior to the Closing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Founders</u>&#8221; means Evan Wray, Sean O&#8217;Brien and Kevin Kenefick.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Former Company Employee</u>&#8221; means an employee, manager, director or individual consultant of the Company or any of the
      Company&#8217;s Subsidiaries, whether salaried or hourly and including individuals on layoff, or medical, educational, personal, long-term, short-term, disability, family or other authorized leave of absence, but who ceased to be employed by the Company or
      its applicable Subsidiary for any reason, including retirement, at any time prior to the Closing Date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Fraud</u>&#8221; means Delaware common law fraud (with the element of scienter) in the making of a specific representation or
      warranty expressly set forth in <u>Article III</u>, <u>Article IV</u> or <u>Article V</u>, as applicable, of this Agreement, committed by the party making such express representation or warranty.&#160; For the avoidance of doubt, in no event shall
      Fraud include negligent or constructive fraud.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>GAAP</u>&#8221; means generally accepted accounting principles in the United States, consistently applied.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Generative AI Tools</u>&#8221; means artificial intelligence systems or models that have the ability to generate content or output,
      including content or output closely resembling or mimicking human-created content or output.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Government Official</u>&#8221;<font style="font-weight: bold;">&#160;</font>means (i) any official or employee of any Governmental
      Authority, including officials and employees who are appointed, elected or hired at any level within the legislative, administrative, executive, judicial or regulatory bodies of a national, regional or local government (<font style="font-style: italic;">e.g.</font>, military personnel, police, judges, inspectors, licensing officers, customs agents); (ii) any director, officer or employee at any level of any company, legal entity or other instrumentality owned or controlled by a
      Governmental Authority; (iii) any director, officer or employee at any level of a public international organization (<font style="font-style: italic;">e.g.</font>, the United Nations, the World Bank, the International Monetary Fund); (iv) any third
      party acting as a representative of or otherwise in an official capacity for or on behalf of a Governmental Authority, an enterprise owned or controlled by a Governmental Authority (<font style="font-style: italic;">e.g.</font>, a third party acting
      under a delegation of authority to conduct government functions) or a public international organization; (v) any political party, any official of a political party or any candidate for political office; or (vi) any member of a royal or ruling family.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-8-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Governmental Authority</u>&#8221; means any government or governmental or regulatory body thereof, or political subdivision thereof,
      whether foreign, European Union, multi-national or other supra-national, national, federal, regional, state, provincial or local or any agency, instrumentality, authority, department, commission, ministry, board or bureau thereof, or any court,
      arbitrator or arbitral body (whether public or private), arbitration panel or similar judicial body.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Hazardous Material</u>&#8221; means any material, substance or waste that is regulated as &#8220;toxic,&#8221; &#8220;hazardous,&#8221; or as a &#8220;pollutant&#8221;
      or &#8220;contaminant&#8221; under any applicable Environmental Laws.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>HSR Act</u>&#8221; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations
      promulgated thereunder.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Indebtedness</u>&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>means, without duplication,
      solely the following, (i) the principal amount of and accrued interest, premiums, penalties, make-whole payments or obligations or other similar costs, fees or expenses (if any) that would be required to be paid by the borrower pursuant to any
      underlying Contract evidencing the applicable obligations or a customary payoff letter, in each case, in respect of (A) any indebtedness of the Company or any of its Subsidiaries for money borrowed and (B) any indebtedness of the Company or any of
      its Subsidiaries evidenced by a note, bond, debenture or other similar instrument or debt security, (ii) all obligations of the type referred to in clause (i) above of other Persons for the payment of which the Company or its Subsidiaries is
      responsible or liable, as obligor, guarantor, surety or otherwise, including any guarantee of such obligations, (iii) all obligations in respect of letters of credit, bankers&#8217; acceptances and similar facilities issued for the account of the Company
      or any of its Subsidiaries (but solely to the extent drawn and not paid), (iv) any lease that is required to be classified as a capital/finance lease in accordance with GAAP (excluding any operating leases for real property, vehicles or equipment
      that may be recorded as a liability), (v) the net obligations, which may be positive or negative, under all interest rate and exchange rate derivatives, swaps or similar agreements of the Company and its Subsidiaries, (vi) all post-retirement health
      and welfare benefit, accrued annual or other bonus obligations, any accrued and unpaid vacation and paid time off, any unpaid severance Liabilities currently being paid or payable in respect of employees and service providers of the Company or any of
      its Subsidiaries who terminated employment or whose services to the Company or any of its Subsidiaries have ceased (as applicable) prior to the Closing and deferred compensation Liabilities of the Company or any of its Subsidiaries, together, in each
      case, with the employer portion of payroll and employment-related Taxes with respect thereto, (vii) <font style="color: rgb(0, 0, 0);">any indebtedness for the deferred purchase price of property, business, equipment, services or assets for which
        the Company or any Subsidiary is liable, contingently or otherwise, as obligor or otherwise (including any earn-out payments or purchase price adjustment payments), in each case calculated assuming the maximum amount payable thereunder, (viii) any
        unfunded or underfunded Liabilities pursuant to any pension or nonqualified deferred compensation plan or arrangement and the employer portion of payroll and employment-related Taxes with respect thereto, (ix) Accrued Income Taxes, (x) annual
        bonuses with respect to calendar year 2024 payable to the employees of the Company and the employer portion of payroll taxes with respect thereto, </font>and (xi) the net obligations, which may be positive or negative, for amounts due to or from
      any member of the Seller Group that are not cancelled, settled and/or extinguished and from which the Company and its Subsidiaries are not released prior to or substantially simultaneously with the Closing.&#160; Notwithstanding anything herein to the
      contrary, Indebtedness shall not include (1) Indebtedness solely among the Company and/or any of the Company&#8217;s Subsidiaries, (2) any intercompany payables and/or receivables due to or from any member of the Seller Group that are cancelled, settled
      and/or extinguished or from which the Company and its Subsidiaries are released prior to or substantially simultaneously with the Closing, (3) deferred revenue, (4) Indebtedness incurred by or on behalf of Purchaser or any of its Affiliates, (5)
      uncleared checks, drafts and wires issued by the Company and/or the Company&#8217;s Subsidiaries and included in the calculation of Cash, (6) Indebtedness that is cancelled, settled and/or extinguished or from which the Company and its Subsidiaries are
      released prior to or substantially simultaneously with the Closing, including any Indebtedness incurred under the Debt Agreements and the Intercompany Loan Agreements, (7) (i) letters of credit, bankers&#8217; acceptances, bank guarantees, performance
      guarantees, bonds and surety obligations issued or provided for the account or benefit of the Company or any of its Subsidiaries and (ii) other similar facilities, obligations or arrangements, in each case, constituting Seller Support Arrangements,
      (8) Indebtedness of the Seller Group, or (9) Liabilities under or with respect to Insurance Policies.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-9-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Indemnified Taxes</u>&#8221; means, without duplication, any U.S. federal or state income Taxes of Seller or any of its Affiliates
      (other than the Company and its Subsidiaries) which are required to be paid by any of the Company and its Subsidiaries pursuant to Treasury Regulations Section 1.1502-6 (or any corresponding state Tax Law) solely by reason of the Company or such
      Subsidiary having been a member of any Seller Consolidated Group on or prior to the Closing Date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Indemnitees</u>&#8221; has the meaning specified in <u>Section 6.1(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Independent Accountant</u>&#8221; means such firm of independent accountants of national standing to which Purchaser and Seller
      mutually agree in writing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Insurance Policies</u>&#8221; has the meaning specified in <u>Section 3.17</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Intellectual Property</u>&#8221; means all worldwide intellectual property and/or industrial rights, including all (i) patents,
      patent applications, provisionals, continuations, divisionals, continuations-in-part, reissues or reexaminations (collectively, &#8220;<u>Patents</u>&#8221;), (ii) registered and unregistered trademarks, service marks, trade dress, logos, corporate names, trade
      names, Internet domain names, rights to social media accounts and mobile media identifiers and other indicators of source, origin or quality, together with all the goodwill associated with any of the foregoing and common-law rights related thereto,
      and all applications, registrations and renewals therefor (collectively, &#8220;<u>Trademarks</u>&#8221;), (iii) copyrights in both published and unpublished works (including without limitation all compilations, databases and computer programs, manuals and other
      documentation and all derivatives, translations, adaptations and combinations of the above), mask work rights and registrations and applications for registration therefor (collectively, &#8220;<u>Copyrights</u>&#8221;), (iv) trade secrets and other proprietary
      information (including know-how, inventions and invention disclosures (whether or not patented or patentable and whether or not reduced to practice), research in progress, process technology, methods and software development methodologies, processes,
      algorithms, technical information, proprietary business information, customer and supplier lists, customer and supplier records, pricing and cost information, reports, plans, drawings, databases, data collections, designs, processes, flow charts,
      models, strategies, prototypes, techniques, source code, source code documentation, testing procedures, testing results and business, financial, sales and marketing plans), and all rights under applicable trade secret Law (collectively, &#8220;<u>Trade
        Secrets</u>&#8221;), and (v) rights of publicity and similar rights.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Intercompany Agreements</u>&#8221; means the Contracts, agreements, arrangements, commitments or understandings, whether or not in
      writing, between or among any member of the Seller Group, on the one hand, and the Company and/or any of its Subsidiaries, on the other hand, that are effective prior to the Closing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-10-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Intercompany Loan Agreements</u>&#8221; means (i) the Loan Agreement, dated as of May 18, 2023, among MyFavoriteThings, Inc., as the
      borrower and Nu Skin Enterprises, Inc., as lender, and any other lenders from time to time party thereto, as amended, supplemented, or otherwise modified, (ii) the Loan Agreement, dated as of February 20, 2024, among MyFavoriteThings, Inc., as the
      borrower and RHYZ, Inc., as lender, and any other lenders from time to time party thereto, as amended, supplemented, or otherwise modified, (iii) the Loan Agreement, dated as of September 26, 2022, among MyFavoriteThings, Inc., as the borrower and Nu
      Skin Enterprises, Inc., as lender, and any other lenders from time to time party thereto, as amended, supplemented, or otherwise modified and (iv) the Loan Agreement, dated as of December 19, 2022, among MyFavoriteThings, Inc., as the borrower and Nu
      Skin Enterprises, Inc., as lender, and any other lenders from time to time party thereto, as amended, supplemented, or otherwise modified, and (v) that certain letter agreement, dated December 9, 2024, by and between Nu Skin International, Inc. and
      MyFavoriteThings, Inc.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>IRS</u>&#8221; means the Internal Revenue Service.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>IT Assets</u>&#8221; means computers, hardware, software, databases, applications, websites, systems, networks and other information
      technology assets and equipment owned by the Company or any of the Company&#8217;s Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Knowledge</u>&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>means (i) in the case of the
      Company, the actual knowledge of those individuals identified on <u>Section 1.1(b)(i)</u> of the Company Disclosure Schedule, in each case, after reasonable due inquiry of such individual&#8217;s direct reports, (ii) in the case of Seller, the actual
      knowledge of those individuals identified on <u>Section 1.1(b)(ii)</u> of the Company Disclosure Schedule, in each case, after reasonable due inquiry of such individual&#8217;s direct reports and (iii) in the case of Purchaser, the actual knowledge of
      those individuals identified on <u>Section </u><u>1.1(b)(iii)</u> of Purchaser Disclosure Schedule, in each case, after reasonable due inquiry of such individual&#8217;s direct reports.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Labor Agreement</u>&#8221; means any collective bargaining agreement or other Contract with any labor union, labor organization, or
      works council.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Law</u>&#8221; means <font style="color: rgb(0, 0, 0);">any federal, national, state, provincial, local, municipal or other law,
        statute, constitution, legislation, principle of common law, case law, resolution, order (including extension order), ordinance, code, edict, directive, license, permit, decree, rule, regulation, ruling or requirement issued, enacted, adopted,
        promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Authority and, with respect to any Person, any orders, writs, injunctions, awards, judgments and decrees applicable to such Person or such Person&#8217;s
        subsidiaries or to any of their respective securities, assets, properties or businesses</font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Leased Real Property</u>&#8221; has the meaning specified in <u>Section 3.16(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Liability</u>&#8221; means <font style="color: rgb(0, 0, 0);">all debts, indebtedness, guarantees, liabilities, commitments and
        obligations, whether accrued or fixed, absolute or contingent, matured or unmatured, determined or determinable, liquidated or unliquidated, asserted or unasserted, known or unknown, whenever or however arising, regardless of whether such debt,
        liability, commitment or obligation would be required to be reflected on a balance sheet prepared in accordance with GAAP or disclosed in the notes thereto, and regardless of whether such debt, liability, commitment or obligation is immediately due
        and payable</font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-11-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Lien</u>&#8221; means, with respect to any asset, any mortgage, easement, encroachment, equitable interest, right of way, deed of
      trust, lien (statutory or otherwise), pledge, charge, security interest, title retention device, conditional sale or other security arrangement, collateral assignment, claim, community property interest, charge, adverse claim of title, ownership or
      right to use, license, right of first refusal, restriction or other encumbrance of any kind in respect of such asset.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Losses</u>&#8221; means any and all deficiencies, judgments, settlements, assessments, Liabilities, losses, Taxes, damages, interest,
      fines, penalties, costs, and expenses (including reasonable legal, accounting and other costs and expenses of professionals).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Material Contracts</u>&#8221; has the meaning specified in <u>Section 3.11(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Minimum Cash Amount</u>&#8221; means $2,300,000.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Multiemployer Plan</u>&#8221; means any &#8220;multiemployer plan&#8221; as defined in Section 3(37) of ERISA.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Net Working Capital</u>&#8221; means (i) the Specified Current Assets, <u>minus</u> (ii) the Specified Current Liabilities, in each
      case, as of 11:59 p.m. Pacific Time on the day immediately preceding the Closing Date and as determined pursuant to the financial accounting methods, policies, practices and principles set forth in <u>Exhibit B</u>, and in accordance with the sample
      calculation set forth in such exhibit; <u>provided</u>, that Net Working Capital shall exclude all income Tax assets and income Tax liabilities and all deferred Tax assets and deferred Tax liabilities.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Net Working Capital Adjustment</u>&#8221; means an amount (which may be positive or negative) equal to (i) if Net Working Capital is
      greater than the Net Working Capital Upper Target, (a) Net Working Capital <u>minus</u> (b) the Net Working Capital Upper Target, (ii) if Net Working Capital is less than the Net Working Capital Lower Target, (x) Net Working Capital <u>minus</u>
      (y) the Net Working Capital Lower Target, and (iii) if Net Working Capital is not greater than the Net Working Capital Upper Target and not less than the Net Working Capital Lower Target, 0.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Net Working Capital Lower Target</u>&#8221; means $8,000,000.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Net Working Capital Upper Target</u>&#8221; means $9,000,000.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Nonparty Affiliates</u>&#8221; has the meaning specified in <u>Section 9.9</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>NUS Business</u>&#8221; means the Business of Seller, Nu Skin Enterprises, Inc. and/or their respective controlled Affiliates and
      parent entities and their respective successors and assigns (other than the Company and its Subsidiaries) as of the date of this Agreement and/or the Closing Date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Open Source Software</u>&#8221; means all software (in source or object code form) that is subject to (i) a license or other
      agreement commonly referred to as an open source, free software, copyleft or community source code license (including but not limited to any code or library licensed under the GNU Affero General Public License, GNU General Public License, GNU Lesser
      General Public License, BSD License, Apache Software License, or any other public source code license arrangement) or (ii) any other license or other agreement that requires, as a condition of the use, modification or distribution of software subject
      to such license or agreement, that such software or other software linked with, called by, combined or distributed with such software be (A) disclosed, distributed, made available, offered, licensed or delivered in source code form, (B) licensed for
      the purpose of making derivative works, (C) licensed under terms that allow reverse engineering, reverse assembly, or disassembly of any kind, or (D) redistributable at no charge, including without limitation any license defined as an open source
      license by the Open Source Initiative as set forth on www.opensource.org.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-12-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Order</u>&#8221; means any order, injunction, judgment, decree, ruling, writ, assessment or arbitration award of a Governmental
      Authority of competent jurisdiction.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Owned Real Property</u>&#8221; has the meaning specified in <u>Section 1.1(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>party</u>&#8221; and &#8220;<u>parties</u>&#8221; have the meaning specified in the <u>Preamble</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Pass-Through Returns</u>&#8221; means all Tax Returns of the Company and its Subsidiaries reflecting items of taxable income or loss
      that pass through to Seller or the Seller Equityholders for federal and, where applicable, state and local income Tax purposes, with respect to any taxable year or period that ends on or before the Closing Date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Permits</u>&#8221; means any licenses, franchises, permits, certificates, approvals and authorizations from Governmental Authorities.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Permitted Liens</u>&#8221; means (i) liens for Taxes, assessments or other governmental charges not yet due and payable or the amount
      or validity of which is being contested in good faith in appropriate procedures and for which adequate reserves have been made on the books of the Company in accordance with GAAP, (iii) mechanics&#8217;, carriers&#8217;, workers&#8217;, repairers&#8217;, construction
      contractors&#8217;, landlords&#8217; and similar Liens arising or incurred in the ordinary course of business or the amount or validity of which is being contested in good faith, (iv) zoning, building codes, entitlement and other land use and environmental
      regulations by any Governmental Authority, none of which materially and adversely impact the current use of the affected property, (v) such other imperfections in title, charges, easements, rights of way, licenses, restrictions, covenants,
      conditions, defects, exceptions and encumbrances that do not individually or in the aggregate materially and adversely impact the value or current use and operation of the affected property, (vi) restrictions on transfers of securities under
      applicable securities Laws or under the Company Organizational Documents and (vi) nonexclusive licenses entered into in the ordinary course of business.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Person</u>&#8221; means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock
      company, trust, unincorporated organization, Governmental Authority or other entity (whether or not having legal personality).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>PTET Election</u>&#8221; means any election under applicable state or local income Tax Law made by the Company, pursuant to which the
      Company will incur or otherwise be liable for any state or local income Tax liability under applicable state or local income Tax Law that would have been borne (in whole or in part) by the direct or indirect equity owners of the Company had no such
      election been made; <u>provided</u>, for the avoidance of doubt, a PTET Election will exclude any determination to not cause the Company to make an election pursuant to Section 6226 of the Code (or analogous or similar federal, state or local Tax
      Law) in connection with any audit or other proceeding with respect to income Taxes.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-13-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Personal Information</u>&#8221; means information about an identified or identifiable individual Person or household, including any
      information that is defined as &#8220;personally identifiable information,&#8221; &#8220;personal data,&#8221; &#8220;individually identifiable health information,&#8221; or &#8220;PII&#8221; or similar term under applicable Law.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Pre-Closing Occurrences</u>&#8221; has the meaning specified in <u>Section 6.4</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Pre-Closing Tax Period</u>&#8221; means any Tax period ending on or prior to the Closing Date and, with respect to any Straddle
      Period, the portion of such Straddle Period through the end of the Closing Date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Pre-Closing Termination</u>&#8221; has the meaning specified in <u>Section 1.1(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Present Fair Salable Value</u>&#8221; has the meaning specified in <u>Section 5.9</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Privacy Laws</u>&#8221; means any Laws, statutes, rules, regulations, ordinances, orders, judgements, decisions, rulings or other
      applicable legal requirement that govern the receipt, collection, compilation, use, storage, processing, sharing, safeguarding, security, disposal, destruction, disclosure or transfer of Personal Information, and any such legal requirement governing
      privacy, data security, data or security breach notification, including, without limitation, Section 5 of the Federal Trade Commission, the California Consumer Privacy Act as amended by the California Privacy Rights Act of 2020 (the &#8220;<u>CCPA</u>&#8221;),
      the Children&#8217;s Online Privacy Protection Act, and other applicable United States or state laws concerning privacy, data protection, and / or data security, the CAN-SPAM Act, the Telephone Consumer Protection Act and any analogous legislation in any
      jurisdiction in which the Company carries on its business and / or from which the Company collects Personal Information.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Privacy Policy</u>&#8221; means all posted policies with respect to privacy or Personal Information.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Privacy Requirements</u>&#8221; has the meaning specified in <u>Section 3.12(m)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Products</u>&#8221; means all products and services (including software used to make any service available) developed, produced,
      marketed, licensed, sold, distributed or performed by or on behalf of the Company or any of its Subsidiaries and all products and services currently under development by the Company or any of its Subsidiaries.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Profits Interest Units</u>&#8221; means the Profits Interest Units, as defined in the Company Organizational Documents.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser</u>&#8221; has the meaning specified in the <u>Preamble</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Common Stock</u>&#8221; means common stock, $0.001 par value per share, of Purchaser.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Disclosure Schedule</u>&#8221; has the meaning specified in <u>Article V</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Documents</u>&#8221; has the meaning specified in <u>Section 5.2</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Financial Statements</u>&#8221; has the meaning specified in <u>Section 5.8(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-14-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Group</u>&#8221; means Purchaser and its Subsidiaries (including, from and after the Closing, the Company and its
      Subsidiaries).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Indemnified Parties</u>&#8221; has the meaning specified in <u>Section 7.2</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Material Adverse Effect</u>&#8221; means any effect, event, change, occurrence or circumstance that prevents or materially
      impairs or delays Purchaser&#8217;s ability to perform its obligations under this Agreement and/or consummate the transactions contemplated hereby pursuant to and in accordance with the terms herein.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Preferred Stock</u>&#8221; means preferred stock, $0.001 par value per share, of Purchaser.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Released Claim</u>&#8221; has the meaning specified in <u>Section 9.11(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Released Person</u>&#8221; has the meaning specified in <u>Section 9.11(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Releasing Party</u>&#8221; has the meaning specified in <u>Section 9.11(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Purchaser Securities</u>&#8221; has the meaning specified in <u>Section 5.5(c)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Quick Refund</u>&#8221; has the meaning set forth on <u>Section 6.8(h)</u> of the Purchaser Disclosure Schedule.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>R&amp;W Insurance Policy</u>&#8221; shall mean the Representations and Warranties Insurance Policy placed on or before the Closing
      Date for the benefit of the Purchaser in substantially the same form as the form attached on <u>Exhibit E</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Real Property</u>&#8221; has the meaning specified in <u>Section 3.16(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Real Property Leases</u>&#8221; has the meaning specified in <u>Section 3.16(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Related Party Agreement</u>&#8221; means, as of any time, any Contract between any of the Company or its Subsidiaries, on the one
      hand, and any members of the Seller Group, on the other hand.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Relevant Items</u>&#8221; has the meaning set forth on Section 6.8(h)(i) of the Purchaser Disclosure Schedule.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Representative</u>&#8221; means, with respect to any Person, any officer, director, principal, partner, manager, member, attorney,
      accountant, agent, employee, consultant, financial advisor or other authorized representative of such Person.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Resolution Period</u>&#8221; has the meaning specified in <u>Section 2.5(c)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Resolved Matters</u>&#8221; has the meaning specified in <u>Section 2.5(c)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Restricted Cash</u>&#8221; means any cash or cash equivalents that are required to be classified as restricted cash in accordance
      with GAAP.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-15-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Restricted Person</u>&#8221; means any Person that is the subject or target of any prohibition or restriction under any Sanctions or
      Trade Control Laws, including (i) any Person located, operating, organized or resident in a Sanctioned Jurisdiction; (ii) the government, including any Governmental Authority, political subdivision, agency or instrumentality thereof, of any
      Sanctioned Jurisdiction or of Venezuela; (iii) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<u>OFAC</u>&#8221;) or the U.S. Department of
      State, the United Nations Security Council, the European Union, any member state of the European Union or the United Kingdom; (iv) any Person that has been designated on any list or Order of prohibited or restricted Persons promulgated under Trade
      Control Laws, including the Denied Persons List, Entity List, Unverified List or Military End User List of the U.S. Department of Commerce or the Debarred List or Nonproliferation Sanctions List of the U.S. Department of State; and (v) any Person
      that is directly or indirectly owned or controlled by, or acts for or on behalf of, any of the foregoing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Review Period</u>&#8221; has the meaning specified in <u>Section 2.5(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Sanctioned Jurisdiction</u>&#8221;<font style="font-weight: bold;">&#160;</font>means, at any time, a country or territory that is itself
      the subject or target of comprehensive Sanctions (as of the date of this Agreement, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the non-governmental controlled oblasts of Zaporizhzhia and Kherson, the so-called Donetsk People&#8217;s
      Republic region of Ukraine and the so-called Luhansk People&#8217;s Republic region of Ukraine).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Sanctions</u>&#8221; means economic and financial sanctions and trade embargoes imposed, administered, or enforced from time to time
      by (i) the U.S. government, including those administered by OFAC and the U.S. Department of State and (ii) the United Nations Security Council, the European Union, any European Union member state, and the United Kingdom.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>SEC</u>&#8221; means the United States Securities and Exchange Commission.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Securities</u>&#8221; has the meaning specified in <u>Section 3.5(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller</u>&#8221; has the meaning specified in the <u>Preamble</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Consolidated Group</u>&#8221; means any consolidated Tax group for purposes of filing income Tax returns whose parent entity
      is Rhyz Inc., Nu Skin Enterprises, Inc. or any parent entity of the foregoing (other than such a group consisting solely of the Company and its Subsidiaries).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Corporate Policies</u>&#8221; has the meaning specified in <u>Section 6.4</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Equityholders</u>&#8221; means the Founders and Rhyz Inc., a Delaware corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Group</u>&#8221; means Seller and its Affiliates (other than the Company and its Subsidiaries).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Material Adverse Effect</u>&#8221; means a material adverse effect on the ability of Seller to consummate the transactions
      contemplated by this Agreement.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Names</u>&#8221; shall mean any right, title or interest in any Trademark containing Nu Skin, Rhyz or any confusingly similar
      variations, translations, transliterations or derivatives thereof, whether used alone or in combination with other words.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-16-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Released Claim</u>&#8221; has the meaning specified in <u>Section 9.11(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Released Person</u>&#8221; has the meaning specified in <u>Section 9.11(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Releasing Party</u>&#8221; has the meaning specified in <u>Section 9.11(b)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Seller Support Arrangements</u>&#8221; means all obligations of any member of the Seller Group under any Contract, arrangement or
      other obligation to support, facilitate or provide credit enhancement for the Business or Purchaser or its Affiliates for which any member of the Seller Group is or may be liable as guarantor, collateral provider, original tenant, primary or
      secondary obligor, Person required to provide financial support or collateral in any form whatsoever, or otherwise (including by reason of performance guarantees, bonds or letters of credit or arrangements with insurance carriers to secure retained
      layers, deductibles, retentions or other amounts under Insurance Policies) as set forth in <u>Section 3.11(a)(vi)</u> of the Company Disclosure Schedule.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Shared Company Benefit Plan</u>&#8221; means any Benefit Plan of the Seller Group in which any Company Employee or Former Company
      Employee (or beneficiary thereof) participates.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Shortfall Amount</u>&#8221; has the meaning set forth in <u>Section 2.5(f)(ii)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Solvency</u>&#8221; has the meaning specified in <u>Section 3.2</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Solvent</u>&#8221; has the meaning specified in <u>Section 5.9</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Specified Tax Refunds</u>&#8221; has the meaning set forth in Section 6.8(h) of the Purchaser Disclosure Schedule.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Specified Current Assets</u>&#8221; has the meaning specified in <u>Exhibit B</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Specified Current Liabilities</u>&#8221; has the meaning specified in <u>Exhibit B</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>STB</u>&#8221; means Simpson Thacher &amp; Bartlett LLP.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Stock Consideration</u>&#8221; means $20,000,000 in shares of Purchaser Common Stock.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Straddle Period</u>&#8221; means a taxable period that begins before or on and ends after the Closing Date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Subsidiary</u>&#8221; of any Person (such Person for purposes of this definition, the &#8220;<u>Controlling Company</u>&#8221;) means any other
      Person (i) of which a majority of the outstanding voting securities or other voting equity interests, or a majority of any other interests having the power to direct or cause the direction of the management and policies of such other Person, are
      owned, directly or indirectly, by the Controlling Company and/or (ii) with respect to which the Controlling Company or its Subsidiaries is a general partner or managing member.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-17-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Tax</u>&#8221; or &#8220;<u>Taxes</u>&#8221; means any and all U.S. federal, state, local or non-U.S. income, sales and use, excise, franchise,
      real and personal property, gross income, gross receipt, capital stock, unincorporated business, production, business and occupation, registration, alternative or add-on minimum, transfer, <font style="font-style: italic;">ad valorem</font>, imputed
      underpayment, profits, capital gains, natural resources, environmental, premium, special assessment, contributions, lease, service, service use, license, franchise, stamp, utility, windfall profit, customs, duties, social security, disability,
      worker&#8217;s compensation, employment, payroll, severance, estimated, or withholding tax or other tax, of any kind whatsoever in the nature of a tax, or any other like charges, fees, levies, imposts, duties or other assessment of a similar nature,
      imposed by any Taxing Authority, whether disputed or not, including all interest, penalties, fines, and additions to tax imposed by any Taxing Authority in connection with any of the foregoing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Tax Return</u>&#8221; means any return, report, declaration, election, claim for refund, estimate, information return or statement
      required to be filed with any Governmental Authority with respect to Taxes, including any schedule, exhibits or attachment thereto, and including any amendment thereof.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Taxing Authority</u>&#8221; means any Governmental Authority responsible for the imposition or collection of any Tax, and the agency
      (if any) charged with the collection of such Tax for such Governmental Authority.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Terminated Individual</u>&#8221; has the meaning specified in <u>Section 1.1(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Trade Control Laws</u>&#8221; means (i) all applicable export control, import and antiboycott Laws and regulations imposed,
      administered or enforced by the U.S. government, including the Arms Export Control Act (22 U.S.C. &#167; 1778), the International Emergency Economic Powers Act (50 U.S.C. &#167;&#167; 1701&#8211;1706), Section 999 of the Internal Revenue Code, the U.S. customs Laws at
      Title 19 of the U.S. Code, the Export Control Reform Act of 2018 (50 U.S.C. &#167;&#167; 4801-4861), the International Traffic in Arms Regulations (22 C.F.R. Parts 120&#8211;130), the Export Administration Regulations (15 C.F.R. Parts 730-774), the U.S. customs
      regulations at 19 C.F.R. Chapter 1 and the Foreign Trade Regulations (15 C.F.R. Part 30); and (ii) all applicable export control, import and antiboycott Laws and regulations imposed, administered or enforced by the EU and the UK, except to the extent
      inconsistent with U.S. Law.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Transaction Expenses</u>&#8221; means, without duplication, solely the following, to the extent unpaid as of the Closing, (i) the
      out-of-pocket fees and expenses payable to third parties (including all fees, expenses, disbursements and other similar amounts payable to attorneys, financial advisors or accountants) incurred by Nu Skin Enterprises, Inc. or any of its Subsidiaries
      prior to the Closing solely to effect the negotiation, documentation and consummation of the transactions contemplated by this Agreement; (ii) any obligation of the Company or any of its Subsidiaries in respect of any change of control, success,
      retention, incentive, severance, termination or similar payments which vest or become payable to any current or former director, officer, employee or service provider of the Company or any of its Subsidiaries solely as a result of the consummation of
      the transactions contemplated by this Agreement and the employer share of any payroll or other Taxes with respect thereto; (iii) all amounts payable in connection with the December 30, 2024 termination of the employment (the &#8220;<u>Pre-Closing
        Termination</u>&#8221;) of the individual set forth on Section 2.2(b)(ix) of the Purchaser Disclosure Schedule (the &#8220;<u>Terminated Individual</u>&#8221;) (including, but not limited to, such amounts that become payable to the Terminated Individual in
      connection with a separation agreement executed after the Closing Date)&#160; and <font style="color: rgb(0, 0, 0);">the employer portion of payroll and employment-related Taxes with respect thereto</font>; (iv) the employer portion of payroll Taxes with
      respect to the Profits Interest Units; (v) 50% of the fees and expenses in connection with Purchaser obtaining the R&amp;W Insurance Policy; (vi) 50% of the filing fees payable under the HSR Act; (vii) 50% of the fees and expenses of the Escrow Agent
      and (viii) certain legal costs and expenses incurred by the Founders as agreed by Seller. For the avoidance of doubt, &#8220;Transaction Expenses&#8221; shall not include (x) any Transfer Taxes for which Seller is responsible under <u>Section 6.8(a)</u> or (y)
      any amount taken into account in determining Indebtedness or Net Working Capital.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-18-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Transaction Tax Deductions</u>&#8221; means the aggregate amount, assuming the Transactions are consummated, of any fees, costs and
      expenses of the Company and its Subsidiaries that are deductible in a Pre-Closing Tax Period for Tax purposes and economically borne by Seller or the Seller Equityholders, and without duplication, related to or arising out of the Transactions or
      reflected as a liability on the Closing Statement, including (i) any employee bonuses, change in control payments, severance payments, retention payments or similar payments made by the Company or any of its Subsidiaries in connection with the
      transactions contemplated by this Agreement or included in the computation of Indebtedness or Net Working Capital; (ii) the fees, expenses, debt prepayment fees, debt issuance costs or capitalized debt costs, and interest (including amounts treated
      as interest for U.S. federal income tax purposes) incurred by the Company or any of its Subsidiaries with respect to the payment of Indebtedness as contemplated by this Agreement or in connection with the transactions contemplated by this Agreement;
      and (iii) the amount of any fees and expenses of the Company or any of its Subsidiaries incurred in connection with the negotiation and execution of this Agreement and the consummation of the Transactions, including any Transaction Expenses or
      amounts that would be Transaction Expenses except for the fact that such expenses were paid prior to the Closing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Transfer Taxes</u>&#8221; has the meaning specified in <u>Section 6.8(a)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Transition Services Agreement</u>&#8221; has the meaning specified in <u>Section 6.5</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>Unresolved Matters</u>&#8221; has the meaning specified in <u>Section 2.5(c)</u>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<u>WARN Act</u>&#8221; means the Worker Adjustment and Retraining Notification Act of 1988 and all similar foreign, state, or local
      applicable Laws, each as amended.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Other
            Definitional and Interpretive Matters</u>.&#160; Unless otherwise expressly provided herein, for purposes of this Agreement, the following rules of interpretation shall apply:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Calculation





            of Time Period</u>.&#160; When calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be
          excluded.&#160; If the last day of such period is a non-Business Day, the period in question shall end on the next succeeding Business Day.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Dollars</u>.&#160;





          Any reference in this Agreement to Dollars or $ shall mean U.S. dollars.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Exhibits/Schedules</u>.&#160;





          The Exhibits to this Agreement and the Company Disclosure Schedule and Purchaser Disclosure Schedule are hereby incorporated and made a part hereof and are an integral part of this Agreement.&#160; The Company may, at its option, include in the
          Company Disclosure Schedule, and Purchaser may, at its option, include in Purchaser Disclosure Schedule, items that are not material in order to avoid any misunderstanding, and such inclusion, or any references to dollar amounts, shall not be
          deemed to be an acknowledgement or representation that such items are material, to establish any standard of materiality or to define further the meaning of such terms for purposes of this Agreement or otherwise.&#160; Any matter set forth in any
          Section of any Company Disclosure Schedule or any Purchaser Disclosure Schedule shall be deemed to be referred to and incorporated in any Section to which it is specifically referenced or cross-referenced, and also in all other Sections of the
          Company Disclosure Schedule or Purchaser Disclosure Schedule, respectively, to which such matter&#8217;s application or relevance is reasonably apparent on its face without any further knowledge of such fact or matter.&#160; Nothing contained in the Company
          Disclosure Schedule or Purchaser Disclosure Schedule should be construed as an admission of Liability or responsibility of any party to any third party in connection with any pending or threatened legal proceeding or otherwise.&#160; Any capitalized
          terms used in any Exhibit, Company Disclosure Schedule or Purchaser Disclosure Schedule but not otherwise defined therein shall be defined as set forth in this Agreement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-19-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Gender





            and Number</u>.&#160; Any reference in this Agreement to gender shall include all genders, and words imparting the singular number only shall include the plural and vice versa.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Headings</u>.&#160;





          The provision of a Table of Contents, the division of this Agreement into Articles, Sections and other subdivisions and the insertion of headings are for convenience of reference only and shall not affect or be utilized in construing or
          interpreting this Agreement.&#160; All references in this Agreement to any &#8220;Section&#8221; are to the corresponding Section of this Agreement unless otherwise specified.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Herein</u>.&#160;





          The words such as &#8220;herein,&#8221; &#8220;hereinafter,&#8221; &#8220;hereof,&#8221; and &#8220;hereunder&#8221; refer to this Agreement as a whole and not merely to a subdivision in which such words appear unless the context otherwise requires.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Including</u>.&#160;





          The word &#8220;including&#8221; or any variation thereof means &#8220;including, without limitation&#8221; and shall not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Or</u>.&#160;





          The word &#8220;or&#8221; is not exclusive, unless the context otherwise requires.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Reflected





            On or Set Forth In</u>.&#160; An item arising with respect to a specific representation or warranty shall be deemed to be &#8220;reflected on&#8221; or &#8220;set forth in&#8221; a balance sheet or financial statements, to the extent any such phrase appears in such
          representation or warranty, if (A) there is a reserve, accrual or other similar item underlying a number on such balance sheet or financial statements that related to the subject matter of such representation, or (B) such item is otherwise set
          forth or reflected on the balance sheet or financial statements.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Made





            Available or Provided</u>.&#160; All documents or items which have been made available to Purchaser or its Representatives, including by posting such document or item in the electronic data room maintained by or on behalf of the Company or Seller,
          at least twenty-four (24) hours prior to the execution of this Agreement shall be deemed &#8220;made available,&#8221; &#8220;provided&#8221; and &#8220;disclosed&#8221; to Purchaser pursuant to this Agreement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Ordinary





            Course of Business</u>.&#160; When used herein, &#8220;ordinary course of business&#8221; means an action taken, or omitted to be taken, in the ordinary and usual course of the Company and the Company&#8217;s Subsidiaries&#8217; business.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The parties hereto
          have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no
          presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-20-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE II</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>UNIT PURCHASE</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Unit Purchase</u>.&#160; At the Closing, upon the terms and subject to the conditions set forth
      in this Agreement, Seller shall sell, assign, transfer and deliver to Purchaser, and Purchaser shall purchase from Seller, through its Subsidiary, Mavrck, all of the issued and outstanding Company Units held by Seller, free and clear of all Liens
      other than those arising under applicable securities Laws, in exchange for the consideration set forth in <u>Section 2.3</u> and <u>Section 2.5</u>, such that, at the Closing, Mavrck shall become the holder of all of the issued and outstanding
      Company Units.&#160; Notwithstanding anything in this agreement to the contrary, in no event will Purchaser pay an amount of consideration to Seller in the aggregate in the excess of or less than the Final Cash Purchase Price plus the Stock Consideration,
      with the shares of Purchaser Common Stock comprising the Stock Consideration valued at $10 per share.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Subject to the
          terms and conditions of this Agreement, the closing of the transactions contemplated hereby (the &#8220;<u>Closing</u>&#8221;) will take place at 8:00 a.m. (Pacific Time) on the date hereof via conference call or virtual meeting and the electronic exchange
          of executed documents, or such other time, date and/or place as determined by Seller and Purchaser.&#160; The date on which the Closing occurs is referred to in this Agreement as the &#8220;<u>Closing Date</u>.&#8221;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">At or prior to the
          Closing, the Company or Seller, as applicable, shall deliver, or cause to be delivered to Purchaser, the following:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the Escrow Agreement,
          duly executed by the Escrow Agent and Seller;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the Transition
          Services Agreement, duly executed by Seller (or one of its Affiliates as designated by Seller) and the Company;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the Commercial
          Services Agreement, duly executed by Seller (or one of its Affiliates as designated by Seller);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the joinders to the
          Amended and Restated Stockholders Agreement, duly executed by each Seller Equityholder;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the joinders to the
          Registration Rights Agreement, duly executed by each Seller Equityholder;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">evidence reasonably
          satisfactory to Purchaser of the resignation or removal of each of the managers and each of the officers of the Company and of each Subsidiary of the Company in office immediately prior to the Closing as managers and/or officers, as applicable,
          of the Company and of each such Subsidiary, effective no later than the Closing;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">an IRS Form W-9 duly
          executed by Seller;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">an Accredited Investor
          Questionnaire duly executed by each Founder indicating that such Founder is an Accredited Investor;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">duly executed unit
          powers evidencing the transfer of all of the Company Units to Mavrck;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-21-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a certificate of the
          Secretary of the Company dated as of the Closing Date, in form and substance reasonably satisfactory to Purchaser, as to the Company being in good standing (including attaching a certificate of good standing dated not more than five Business Days
          prior to the Closing Date issued by the Secretary of State of the State of Delaware);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a duly executed
          officer&#8217;s certificate executed by each of NuSkin Enterprises, Inc. and Bank of America, N.A. in the form attached hereto as <u>Exhibit E;</u></font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a duly executed
          intercompany agreement termination letter executed by each of NuSkin Enterprises, Inc., MyFavorite Things, Inc., Rhyz, Inc. and Nu Skin International, Inc., in the form attached hereto as <u>Exhibit F</u>;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xiii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a duly executed
          termination of the Company&#8217;s Amended and Restated Limited Liability Company Agreement, dated July 24, 2024, to be effective immediately following the Closing;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xiv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a duly executed copy of
          each Intellectual Property Assignment Agreements, the consideration for which is included in the Estimated Cash Purchase Price; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a duly executed
          acknowledgment of the termination of the employee covenant agreements in the form attached hereto as <u>Exhibit G</u> duly executed by Nu Skin Enterprises, Inc.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">At or prior to the
          Closing, Purchaser shall deliver, or cause to be delivered to Seller, the following:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the





          Escrow Agreement, duly executed by Purchaser;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the





          Transition Services Agreement, duly executed by Purchaser;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the





          Commercial Services Agreement, duly executed by Purchaser;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the





          payments set forth in <u>Sections 2.3(a)</u>, <u>2.3(b)</u>, <u>2.3(d)</u>&#160;<u>2.3(d)</u> and <u>2.3(e)</u>; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the





          Stock Consideration set forth in <u>Section 2.3(c)</u>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing Payments by Purchaser</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Determination
            of Estimated Cash Purchase Price</u>.&#160; Prior to the Closing Date, the Company shall have delivered to Purchaser the Company&#8217;s good faith calculation and estimate of the aggregate amount of the Estimated Cash Purchase Price, (y) each of the
          Estimated Cash Purchase Price Elements.&#160; The calculations described above in the foregoing sentence are collectively referred to herein as the &#8220;<u>Estimated Closing Statement</u>.&#8221; The Estimated Closing Statement shall have been prepared in a
          manner consistent with the terms of (including the definitions contained in) this Agreement, including <u>Exhibit B</u>, and shall include all components required to make the payments set forth in <u>Sections 2.3(b)</u>, <u>2.3(d)</u>, <u>2.3(d)</u>
          and <u>2.3(e)</u>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Payment of
            Estimated Cash Purchase Price</u>.&#160; At the Closing, subject to <u>Section 6.9</u>, Purchaser shall pay, or cause to be paid, to Seller or its designee(s) an amount equal to the Estimated Cash Purchase Price by wire transfer of immediately
          available funds to the account identified in the Estimated Closing Statement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-22-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Payment of
            Stock Consideration</u>.&#160; At the Closing, Purchaser shall (i) issue, or cause to be issued, to Seller or its designee the Stock Consideration (which such shares of Purchaser Common Stock shall be duly authorized, validly issued, nonassessable
          and free of preemptive rights) to the account or accounts identified by Seller and (ii) deliver to Seller (or its designee(s)) evidence of book-entry shares representing the number of whole shares of the Stock Consideration issued to Seller (or
          its designee(s)).&#160; Immediately following receipt of such Stock Consideration, Seller shall distribute such Stock Consideration to the Seller Equityholders in the manner agreed upon among the Seller Equityholders; <u>provided</u>, that, in
          connection with such distribution, Seller shall deliver stock powers evidencing such transfer.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Payment of
            Estimated Transaction Expenses</u>.&#160; At the Closing, Purchaser shall pay, or cause to be paid, the Estimated Transaction Expenses to the applicable recipients identified in, and in accordance with, the Estimated Closing Statement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Payment of
            Escrow Amount</u>.&#160; At the Closing, Purchaser shall pay, or cause to be paid, to&#160; (i) the Adjustment Escrow Account, by wire transfer of immediately available funds, an amount equal to the Adjustment Escrow Amount for deposit in accordance with
          this Agreement and the Escrow Agreement and (ii) the Profits Interest Units Escrow Account, by wire transfer of immediately available funds, an amount equal to the Profits Interest Units Escrow Amount for deposit in accordance with this Agreement
          and the Escrow Agreement.&#160; The Escrow Amount will not be used for any purpose except as expressly provided in this Agreement or the Escrow Agreement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certain Indebtedness and Liens</u>.&#160; Substantially simultaneously with the consummation of
      the Closing, (i) all obligations of the Company and its Subsidiaries with respect to Indebtedness outstanding under the Debt Agreements (other than, in each case, contingent expense or indemnification obligations for which no claim or demand has been
      made) and (ii) all Liens on the Company Units and assets of the Company and its Subsidiaries securing the obligations of the Company and its Subsidiaries pursuant to the Debt Agreements (including precautionary Liens or Liens arising out of &#8220;fall
      back&#8221; security) shall, in each case, be released, terminated and cancelled in all respects.&#160; Promptly following the consummation of the Closing, Seller shall file or cause to be filed a UCC termination statement evidencing the release of such Liens.
      As of the Closing, with respect to each of the letters of credit, surety obligations and other similar arrangements of the Company and its Subsidiaries issued pursuant to Indebtedness of the Company and its Subsidiaries or commitments under
      agreements governing Indebtedness of the Company and its Subsidiaries, Purchaser shall cause such letter of credit to be returned to the issuers thereof or otherwise satisfy the issuers of such letters of credit as to the disposition or retention of
      such letters of credit under the applicable credit facilities (e.g., cash collateralizing such obligations).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Post-Closing Determination of Additional Cash Purchase Price</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">From the delivery
          of the Closing Statement until the determination of the Final Closing Statement pursuant to this <u>Section 2.5</u>, upon reasonable prior written notice, Purchaser and the Company shall, and shall cause their respective Subsidiaries to, permit
          Seller (and any accounting firm retained pursuant to clause (y) of <u>Section 2.5(b)</u>) access, during normal business hours upon reasonable advance notice and without undue interruption to the business to (i) the books, records, contracts and
          other documents (including auditor&#8217;s work papers) of the Company and/or its Subsidiaries that are or could reasonably be relevant to the calculations set forth in the Closing Statement, a Dispute Notice or otherwise related to the negotiation
          and/or resolution of the Final Closing Statement and (ii) the personnel and accountants who worked on the Closing Statement and are knowledgeable about the information and calculations contained therein.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-23-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Following the
          Closing, Purchaser shall prepare a good faith calculation of the Final Cash Purchase Price, the Final Cash Purchase Price Elements and the Additional Cash Purchase Price (if any). The calculations described in the foregoing sentence are
          collectively referred to herein as the &#8220;<u>Closing Statement</u>.&#8221; Purchaser shall deliver the Closing Statement, together with reasonable supporting detail as to each of the calculations (including with respect to the Final Cash Purchase Price
          Elements) set forth in the Closing Statement, to Seller no later than ninety (90) days following the Closing Date.&#160; If Purchaser fails to timely deliver the Closing Statement in accordance with the immediately preceding sentence within such
          ninety (90)-day period, then, at the election of Seller in its sole discretion, either (x) the Estimated Closing Statement delivered by the Company to Purchaser pursuant to <u>Section 2.3(a)</u> shall be deemed to be the Final Closing Statement
          for all purposes herein or (y) Seller shall retain (at the sole cost and expense of Purchaser) a nationally recognized independent accounting firm to analyze the Company&#8217;s books, determine the calculation of, and prepare, the Closing Statement
          consistent with the provisions of this <u>Section 2.5</u>, the determination of such accounting firm being conclusive, final and binding on the parties hereto; <u>provided</u>, <u>however</u>, that, notwithstanding the foregoing, Seller
          reserves any and all other rights granted to it in this Agreement. Purchaser shall promptly reimburse Seller upon its request for all of the fees, costs and expenses incurred by Seller in connection with the foregoing clause (y).&#160; Notwithstanding
          anything herein to the contrary, the parties agree that the Closing Statement, and the component items and calculations therein, including the Final Cash Purchase Price Elements, shall be prepared in a manner consistent with the terms of
          (including the definitions contained in) this Agreement, including <u>Exhibit B</u>.&#160; The Closing Statement will entirely disregard (A) any and all effects on the Company and its Subsidiaries (including the assets and liabilities of the Company
          and its Subsidiaries) as a result of the transactions contemplated by this Agreement (including fees and expenses resulting therefrom) or of any debt or equity financing arrangements entered into at any time by Purchaser or its Affiliates or any
          other transaction entered into by Purchaser or its Affiliates in connection with the consummation of the transactions contemplated by this Agreement and (B) any of the plans, transactions, fundings, payments or changes that any Purchaser or its
          Affiliates initiates or makes or causes to be initiated or made after the Closing with respect to the Company and its Subsidiaries or their business or assets, or any facts or circumstances that are unique or particular to Purchaser or its
          Affiliates or any of their respective assets or liabilities.&#160; The Closing Statement shall be conclusive, final and binding on all parties absent manifest error unless Seller gives Purchaser written notice (a &#8220;<u>Dispute Notice</u>&#8221;) of any
          disputes or objections thereto (collectively, the &#8220;<u>Disputed Items</u>&#8221;) with reasonable supporting detail as to such Disputed Items, within sixty (60) days after receipt of the Closing Statement (such period, the &#8220;<u>Review Period</u>&#8221;).&#160; In
          the event Seller fails to give Purchaser a Dispute Notice prior to the expiration of the Review Period or otherwise earlier notifies Purchaser in writing that Seller has no disputes or objections to the Closing Statement, payments shall be made
          by Purchaser, in accordance with <u>Section 2.5(f)</u>.&#160; In the event Seller gives Purchaser a Dispute Notice prior to the expiration of the Review Period then, within two (2) Business Days after such Dispute Notice has been given to Purchaser,
          payments shall be made by Purchaser, in accordance with <u>Section 2.5(f)</u> solely to the extent applicable in light of, and to the extent which, Seller has not objected to the calculation set forth in the Closing Statement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-24-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Purchaser and
          Seller shall, for a period of thirty (30) days (or such longer period as Purchaser and Seller may agree in writing) following delivery of a Dispute Notice to Purchaser (the &#8220;<u>Resolution Period</u>&#8221;), attempt in good faith to resolve their
          differences (all such discussions and communications related thereto shall (unless otherwise agreed by Purchaser and Seller in writing) be governed by Rule 408 of the Federal Rules of Evidence and any applicable similar state rule), and any such
          resolution by them as to any Disputed Items shall be conclusive, final and binding on all parties absent manifest error.&#160; Any Disputed Items agreed to by Purchaser and Seller in writing, together with any items or calculations set forth in the
          Closing Statement not disputed or objected to by Seller in the Dispute Notice, are collectively referred to herein as the &#8220;<u>Resolved Matters</u>.&#8221; Any Resolved Matters shall be conclusive, final and binding on all parties absent manifest error,
          except to the extent such component could be affected by other components of the calculations set forth in the Closing Statement that are the subject of a Dispute Notice.&#160; If at the end of the Resolution Period, Purchaser and Seller have been
          unable to resolve any differences that they may have with respect to the matters specified in the Dispute Notice, either of Purchaser or Seller may, upon written notice to the other, refer all matters that remain in dispute with respect to the
          Dispute Notice (the &#8220;<u>Unresolved Matters</u>&#8221;) for resolution to the Independent Accountant.&#160; If one or more Unresolved Matters are submitted to the Independent Accountant for resolution, Purchaser and Seller shall enter into a customary
          engagement letter with, and to the extent necessary each party to this Agreement will waive and cause its controlling Affiliates to waive any conflicts with, the Independent Accountant at the time such dispute is submitted to the Independent
          Accountant and shall cooperate with the Independent Accountant in connection with its determination pursuant to this <u>Section 2.5</u>.&#160; Within ten (10) days after the Independent Accountant has been retained, each of Purchaser and Seller shall
          furnish, at its own expense, to the Independent Accountant and substantially simultaneously to the other a written statement of its position with respect to each Unresolved Matter.&#160; Within five (5) Business Days after the expiration of such ten
          (10)-day period, each of Purchaser and Seller may deliver to the Independent Accountant its response to the other&#8217;s position on each Unresolved Matter; <u>provided</u>, that it delivers a copy thereof substantially simultaneously to the other.&#160;
          With each submission, each of Purchaser and Seller may also furnish to the Independent Accountant such other information and documents as it deems relevant or such information and documents as may be requested by the Independent Accountant; <u>provided</u>,
          that it delivers a copy thereof substantially simultaneously to the other.&#160; The Independent Accountant may, at its discretion, conduct one or more conferences (whether in person or by teleconference) concerning the disagreement and each of
          Purchaser and Seller shall have the right to present additional documents, materials and other information and to have present its Representatives at such conferences.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Independent
          Accountant shall be directed to promptly, and in any event within thirty (30) days after its appointment pursuant to <u>Section 2.5(c)</u>, render its decision on the Unresolved Matters (and not on any other matter or calculation set forth in
          the Closing Statement).&#160; The Independent Accountant&#8217;s determination as to each Unresolved Matter shall be set forth in a written statement delivered to each of Purchaser and Seller, which shall include the Independent Accountant&#8217;s (i)
          determination as to the calculation of each of the Unresolved Matters and (ii) the corresponding corrective calculations set forth in the Closing Statement that are derived from its determination as to the calculations of the Unresolved Matters,
          all of which shall be conclusive, final and binding on all parties absent manifest error.&#160; In resolving any Unresolved Matter, the Independent Accountant may not assign a value to such item greater than the greatest value for such item claimed by
          Purchaser in the Closing Statement or by Seller in the Dispute Notice or less than the lowest value for such item claimed by Purchaser in the Closing Statement or by Seller in the Dispute Notice.&#160; The Independent Accountant shall also determine
          the proportion of its fees and expenses to be paid by each of Purchaser and Seller based on the degree (as determined by the Independent Accountant) to which the Independent Accountant has accepted the positions of Purchaser and Seller.&#160; For the
          avoidance of doubt, the Independent Accountant&#8217;s fees and expenses payable by Purchaser (if any) shall be paid to the Independent Accountant directly by Purchaser, and the Independent Accountant&#8217;s fees and expenses payable by Seller (if any)
          shall be paid by Seller.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">For purposes of
          this Agreement, subject to the fourth sentence of <u>Section 2.5(b)</u>, the &#8220;<u>Final Closing Statement</u>&#8221; shall be (i) in the event that no Dispute Notice is delivered by Seller to Purchaser prior to the expiration of the Review Period, the
          Closing Statement delivered by Purchaser to Seller pursuant to <u>Section 2.5(b)</u>, (ii) in the event that a Dispute Notice is delivered by Seller to Purchaser prior to the expiration of the Review Period, the Closing Statement delivered by
          Purchaser to Seller pursuant to <u>Section 2.5(b)</u>, as adjusted pursuant to the agreement of Purchaser and Seller in writing, or (iii) in the event that a Dispute Notice is delivered by Seller to Purchaser prior to the expiration of the
          Review Period and Purchaser and Seller are unable to agree on all matters set forth in such Dispute Notice, the Closing Statement delivered by Purchaser to Seller pursuant to <u>Section 2.5(b)</u>, as adjusted by the Independent Accountant to be
          consistent with (A) the Resolved Matters and (B) the Independent Accountant&#8217;s determination as to the calculation of the Unresolved Matters in accordance with <u>Sections 2.5(c)</u> and <u>2.5(d)</u>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-25-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Payment of the
            Additional Cash Purchase Price</u>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If
          the Final Cash Purchase Price exceeds the Estimated Cash Purchase Price (the &#8220;<u>Excess Amount</u>&#8221;), then within three (3) Business Days after the final determination of the Final Closing Statement, (x) Purchaser shall pay to Seller or its
          designee(s) an amount equal to the Excess Amount and (y) Purchaser and Seller shall deliver joint written instructions to the Escrow Agent to cause the Escrow Agent to release and pay to Seller or its designee(s) the funds in the Adjustment
          Escrow Account. All distributions of funds from Purchaser pursuant to and in accordance with this <u>Section 2.5(f)(i)</u> shall be made to one or more accounts designated in writing by Seller within (2) Business Days of the final determination
          of the Final Closing Statement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If
          the Estimated Cash Purchase Price exceeds the Final Cash Purchase Price (the &#8220;<u>Shortfall Amount</u>&#8221;), then within three (3) Business Days after the final determination of the Final Closing Statement, Purchaser and Seller shall deliver joint
          written instructions to the Escrow Agent to cause the Escrow Agent to (x) release from the Adjustment Escrow Account and pay to Purchaser an amount equal to the lesser of the Shortfall Amount and the Adjustment Escrow Amount and (y) distribute
          the balance, if any, of the funds in the Adjustment Escrow Account to Seller or its designee(s); <u>provided</u>, that, in the event that the Shortfall Amount exceeds the Adjustment Escrow Amount, Seller shall pay to Purchaser, via wire transfer
          of immediately available funds, the amount by which the Shortfall Amount exceeds the Adjustment Escrow Amount.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If





          the Final Cash Purchase Price is equal to the Estimated Cash Purchase Price, then Purchaser and Seller shall deliver joint written instructions to the Escrow Agent to cause the Escrow Agent to release and pay to Seller or its designee(s) the
          funds in the Adjustment Escrow Account.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">All payments
          pursuant to <u>Section 2.5(f)</u> shall be treated as an adjustment to the Final Cash Purchase Price for all foreign, federal, state, provincial and local income Tax purposes, unless otherwise required under applicable Law.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The parties agree
          that Seller may engage BDO USA, LLP (the &#8220;<u>Accounting Advisor</u>&#8221;) and its Affiliates to advise or represent them in connection with the determination of any Additional Cash Purchase Price and the matters addressed by this <u>Section 2.5</u>.&#160;





          Each party shall (and shall cause its controlling Affiliates to) enter into such waivers, indemnities and other agreements as the Accounting Advisor and its Affiliates shall reasonably require to permit the Accounting Advisor and its Affiliates
          to provide such advice or representation.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Except for any
          claim for Fraud, the purchase price adjustment provided for in this <u>Section 2.5</u> shall be the exclusive remedy for the matters addressed in this <u>Section 2.5</u> and neither Purchaser nor any other member of the Purchaser Group shall
          have any other claim or remedy against any other member of the Seller Group in respect thereof.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Withholding Taxes</u>.&#160; Notwithstanding anything to the contrary contained in this
      Agreement, Purchaser and its Affiliates shall be entitled to deduct and withhold from any payment payable pursuant to this <u>Article II</u> such amounts as may be required to be deducted and withheld with respect to the making of such payment under
      the Code, or under any provision of state, local or foreign Tax Law; <u>provided</u>, that, except for (i) any deduction or withholding arising from the failure to provide the IRS Form W-9 as contemplated in <u>Section 2.2(b)(vi)</u> or (ii) any
      deduction or withholding in respect of payments treated as compensation for U.S. federal income Tax or employment Tax purposes, including amounts described in <u>Section 2.8</u> hereof, prior to making any such deduction or withholding, Purchaser
      shall use commercially reasonable efforts to (i) provide reasonable advance notice to the recipient of the amounts subject to withholding and a reasonable opportunity for such recipient to provide forms or other documentation or evidence that would
      reduce or eliminate such withholding tax and (ii) cooperate with such recipient to reduce or eliminate any amounts that would otherwise be deducted or withheld to the extent permitted by applicable Tax Law.&#160; To the extent any amounts are deducted and
      withheld and paid over to the appropriate Taxing Authority, including through the payroll of MyFavoriteThings, Inc., such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction
      and withholding was made.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-26-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Changes in Purchaser Common Stock</u>.&#160; If at any time between the date of this Agreement
      and the Closing Date, the outstanding shares of Purchaser Common Stock shall have been increased, decreased, changed into or exchanged for a different number or kind of shares or securities as a result of a subdivision, reorganization,
      recapitalization, reclassification, stock dividend, stock split, reverse stock split, cash dividend, redemption, transfer, repurchase, waiver, release, assumption or discharge of liability, combination or other change in capitalization, the
      definition of Stock Consideration shall be equitably adjusted to reflect such change.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">2.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Profits Interest Units Payroll Mechanics</u>.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>Notwithstanding anything to the contrary in this Agreement, payment of the aggregate portion of the Estimated Cash Purchase Price payable in respect of the Profits Interest Units is subject to the
      provisions set forth in Schedule 2.8 of the Purchaser Disclosure Schedule.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE III</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Except as set forth in the disclosure schedule delivered by the Company to Purchaser concurrently with the execution of this Agreement (the &#8220;<u>Company





        Disclosure Schedule</u>&#8221;), the Company hereby represents and warrants to Purchaser, that:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Organization, Standing and Power</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company is a
          limited liability company duly organized, validly existing and in good standing under the Laws of the State of Delaware and has all requisite limited liability company power and authority to own or lease all of its properties and assets and to
          carry on its business as it is now being conducted.&#160; The Company is duly licensed or qualified to do business and is in good standing (or the equivalent thereof, if applicable) in each jurisdiction in which the nature of the business conducted by
          it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification required by Law, except where the failure to be so licensed, qualified or in good standing (or the equivalent thereof, if
          applicable) would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Each of the
          Company&#8217;s Subsidiaries is duly organized, validly existing and in good standing (or the equivalent thereof, if applicable) under the Laws of the jurisdiction of its organization except where the failure to be so organized, existing and in good
          standing (or the equivalent thereof, if applicable) would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.&#160; No Subsidiary of the Company is in violation of any of its organizational
          documents in any material respect.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company has
          made available to Purchaser complete and correct copies of the certificate of formation of the Company and the Company Organizational Documents, each as amended to the date of this Agreement, and the Company is not in violation of any of the
          provisions contained in such documents in any material respect.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-27-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Authorization</u>.&#160; The Company has all necessary limited liability company power and
      authority to execute and deliver this Agreement and to perform its obligations hereunder and to consummate the transactions contemplated hereby.&#160; The execution, delivery and performance by the Company of this Agreement, and the consummation by the
      Company of the transactions contemplated hereby, have been duly and validly authorized by all requisite limited liability company action of the Company.&#160; This Agreement has been duly executed and delivered by the Company and, assuming due
      authorization, execution and delivery hereof by the other parties hereto, constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that such enforceability (i) may be
      limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar Laws of general application affecting or relating to the enforcement of creditors&#8217; rights generally and (ii) is subject to general principles of
      equity, whether considered in a proceeding at Law or in equity (the &#8220;<u>Bankruptcy and Equity Exception</u>&#8221;).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Noncontravention</u>.&#160; Neither the execution and delivery of this Agreement by the Company
      nor the consummation by the Company of the transactions contemplated hereby, nor compliance by the Company with any of the terms or provisions hereof, will (i) conflict with or violate any provision of the Company Organizational Documents or (ii) (A)
      assuming that the authorizations, consents and approvals referred to in <u>Section 3.4</u> are obtained and the filings referred to in <u>Section 3.4</u> are made, violate any Law, Privacy Requirement or Order applicable to the Company or any of
      the Company&#8217;s Subsidiaries, (B) with or without notice, lapse of time or both, violate or constitute a default under any of the terms, conditions or provisions of any Material Contract or accelerate or give rise to a right of termination,
      cancellation or acceleration of any of the Company&#8217;s or, if applicable, the Company&#8217;s Subsidiaries&#8217;, obligations under any such Material Contract or to the loss of any benefit under a Material Contract, or (C) result in the creation of any Lien
      (other than any Permitted Lien) on the Company Units or any properties, rights or assets of the Company or any of the Company&#8217;s Subsidiaries, except, in the case of clauses (ii)(A) and (ii) (B) for such violations, defaults, accelerations, rights,
      losses and Liens as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governmental Approvals</u>.&#160; Except for filings required under, and compliance with other
      applicable requirements of, the HSR Act, no consents, authorizations, or approvals of, or filings, declarations or registrations with, any Governmental Authority are necessary for the execution, delivery and performance of this Agreement by the
      Company and the consummation by the Company of the transactions contemplated hereby.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Capitalization</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Section 3.5(a)</u>
          of the Company Disclosure Schedule sets forth a complete and accurate list of (i) the issued and outstanding Company Units, (ii) the record and beneficial holders of such Company Units, and (iii) with respect to any Profits Interest Unit, (A) the
          grant date, (B) the applicable distribution threshold, (C) the vesting schedule and (D) whether such Profits Interest Unit is subject to accelerated vesting.&#160; Such Company Units represent all of the authorized and issued equity interests,
          securities and/or interests of any kind to the profits or losses of the Company.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-28-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Except as set forth
          in the Company Organizational Documents or on <u>Section 3.5(a)</u> of the Company Disclosure Schedule, as of the date hereof, there are (i) no outstanding shares of capital stock of, or other equity or voting interests in, the Company, (ii) no
          outstanding securities of the Company convertible into or exchangeable for shares of capital stock of, or other equity or voting interests in, the Company, (iii) no outstanding options, warrants, rights or other commitments or agreements to
          acquire from the Company, or that obligate the Company to issue or register, or that restrict the transfer or voting of, any shares of capital stock of, or other equity or voting interests in, or any securities convertible into or exchangeable
          for shares of capital stock of, or other equity or voting interests in, the Company, (iv) no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar
          agreement or commitment relating to any shares of capital stock of, or other equity or voting interests (including any voting debt) in, the Company (the items in clauses (i), (ii), (iii) and (iv), together with the shares of capital stock of the
          Company, being referred to collectively as &#8220;<u>Securities</u>&#8221;) and (v) no other obligations by the Company to make any payments based on the price or value of any Securities or dividends paid thereon or revenues, earnings or financial
          performance or any other attribute of the Company.&#160; There are no outstanding agreements of any kind which obligate the Company to repurchase, redeem or otherwise acquire any Securities, or obligate the Company to grant, extend or enter into any
          such agreements, and the Company does not have any outstanding bonds, debentures, notes or other obligations, the holders of which have the right to vote with the holders of Company Units on any matter.&#160; No direct or indirect Subsidiary of the
          Company owns any Company Units.&#160; All outstanding Company Units have been duly authorized and validly issued and are free of preemptive rights.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsidiaries</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">A list of the names
          of the Company&#8217;s Subsidiaries, including their jurisdiction of organization and the name of any equityholder other than the Company or any Subsidiary of the Company is set forth on <u>Section 3.6(a)</u> of the Company Disclosure Schedule.&#160; Each
          outstanding partnership or limited liability company unit or share of capital stock of each Subsidiary of the Company is duly authorized, validly issued, (in the case of shares of capital stock) fully paid and nonassessable and free of preemptive
          rights and is held, directly or indirectly, by the Company or another Subsidiary of the Company free and clear of all Liens other than restrictions arising under securities laws.&#160; There are no subscriptions, options, warrants, rights, calls,
          contracts or other commitments, understandings, restrictions or arrangements relating to the issuance, acquisition, redemption, repurchase or sale of any shares of capital stock or other ownership interests of any Subsidiary of the Company,
          including any right of conversion or exchange under any outstanding security, instrument or agreement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">As of the date
          hereof, there are no obligations of any Subsidiary of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock of, or
          other equity or voting interest (including any voting debt) in, any Subsidiary of the Company.&#160; There are no outstanding agreements of any kind which obligate any Subsidiary of the Company to repurchase, redeem or otherwise acquire any
          securities.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The only assets of
          the Company consist of the equity interests in MyFavoriteThings, Inc. and any de minimis amount of cash or other assets to administer the Company.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Financial Statements; Undisclosed Liabilities</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Section 3.7(a)</u>
          of the Company Disclosure Schedule sets forth the unaudited condensed combined carve-out balance sheets of the Company and its consolidated Subsidiaries as at December 31, 2022 and December 31, 2023 and the related unaudited combined carve-out
          statements of operations, comprehensive loss income, changes in invested equity and cash flows of the Company and its consolidated Subsidiaries for the eleven months ended November 30, 2024 (the &#8220;<u>Financial Statements</u>&#8221;).</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Financial
          Statements have been prepared in all material respects in accordance with GAAP consistently applied during the periods involved and fairly present, in all material respects, the consolidated financial position and the results of operations of the
          Company and its consolidated Subsidiaries at the dates, and for the periods, presented therein.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-29-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">None of the Company
          or any of the Company&#8217;s Subsidiaries has any Liabilities, except Liabilities (i) reflected or reserved against on the unaudited condensed consolidated balance sheets of the Company and its consolidated Subsidiaries as of November 30, 2024 (the &#8220;<u>Balance





            Sheet Date</u>&#8221;) (including the notes thereto) included in the Financial Statements, (ii) as contemplated by this Agreement or otherwise in connection with the transactions contemplated hereby, (iii) as set forth on <u>Section 3.7(b)</u> of
          the Company Disclosure Schedule or (iv) or as would not, individually or in the aggregate, be material to the business of the Company and its Subsidiaries, take as a whole.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Absence of Certain Changes</u>.&#160; Since the Balance Sheet Date,</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">through the date
          of this Agreement, except for the transactions contemplated hereby, the Business has been conducted in all material respects in the ordinary course of business;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">there has not been
          any effect, event, change, occurrence or circumstance that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"> through the date
          of this Agreement, neither the Company nor any of its Subsidiaries has taken:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">amended





          (whether by merger, consolidation or otherwise) the certificate of formation or limited liability company agreement (or equivalent organizational documents) of the Company or its Subsidiaries;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">split,





          combined or reclassified any Company Units or declared, set aside or paid any dividend or other distribution in respect of any Company Units;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">issued





          or sold any Company Units or any equity interests of its Subsidiaries (other than any issuances by the Company&#8217;s Subsidiaries to the Company or other wholly-owned Subsidiaries of the Company);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">acquired





          (whether by merger, consolidation, acquisition of stock or assets or otherwise), directly or indirectly, any material assets;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">disposed





          of (whether by merger, consolidation, disposition of stock or assets or otherwise), directly or indirectly, any material assets (other than Intellectual Property, which is the subject of clause (xiii) below, or obsolete assets);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">amended,





          voluntarily terminated or waived any material rights under any Material Contract;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">commenced





          a lawsuit other than (A) for the routine collection of bills or (B) in such cases where the Company or such Subsidiary, as applicable, in good faith determines that failure to commence a lawsuit would result in the material impairment of a
          valuable aspect of its business;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">made





          any change to the Company&#8217;s or its Subsidiaries&#8217; methods of financial accounting, except as required by changes in GAAP, the SEC or applicable Law;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">adopted





          a plan or agreement of complete or partial liquidation or dissolution;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-30-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">(A)





          negotiated, modified, extended, or entered into any Labor Agreement or (B) recognized or certified any labor union, labor organization, works council, or group of employees as the bargaining representative for any employees of the Company or its
          Subsidiaries;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">made





          (inconsistent with past practice), revoked or changed any material election relating to Taxes, adopted or changed any material Tax accounting method, prepared or filed a material Tax Return in a manner inconsistent with past practice, filed any
          amended material Tax Return, settled or compromised any material Tax claim or assessment, surrendered any right to claim a material Tax refund or credited, consented or requested any waiver or extension of time to assess or collect any material
          Taxes, changes any material annual Tax accounting period or entered into any closing agreements in respect of material Taxes, in each case, except to the extent such action is with respect to a Tax Return of a Seller Consolidated Group, or is
          required as a result of the Restructuring;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xii)</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';">affirmatively





          waived in any material respect any noncompetition, non-solicitation, nondisclosure, noninterference, nondisparagement or other restrictive covenant obligation of any current or former employee or independent contractor;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xiii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">sold,





          exclusively licensed, assigned, transferred or otherwise disposed of, abandoned, let lapse or permitted to enter the public domain any material Company Intellectual Property owned or purported to be owned by the Company or its Subsidiaries
          (except for any statutory expirations of Intellectual Property);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xiv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">except





          as required by applicable Law or the terms of a Company Benefit Plan or Shared Company Benefit Plan in effect on the date hereof, (A) increased the compensation or benefits provided to any Company Employee, (B) established, adopted, entered into
          or materially amended any material Company Benefit Plan or, to the extent applicable to any Company Employee, a Shared Company Benefit Plan, (C) accelerated the vesting, payment or funding of any compensation, or (D) hired or engaged, or
          terminated (other than for cause) the services of, any employee or individual service provider; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">agreed





          or committed to do any of the foregoing.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Proceedings</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">None of the
          Company or its Subsidiaries is, or, in the past five (5) years, has been subject to any actual, or to the Company&#8217;s Knowledge, threatened Action.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company is not
          subject to any actual or, to the Company&#8217;s Knowledge, threatened Action against or concerning the Company that would reasonably be expected, individually or in the aggregate, to materially impair the Company&#8217;s ability to perform or comply with
          its obligations under this Agreement or consummate the transactions contemplated hereby.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.10</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance With Laws; Permits</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company and
          its Subsidiaries are and, for the past five (5) years, have been in compliance in all material respects with all applicable Laws.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company and
          its Subsidiaries hold all Permits necessary for operation of the Business, except where the absence of any such Permit would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.&#160; As of the date
          of this Agreement, there are no Actions pending or, to the Company&#8217;s Knowledge, threatened which would reasonably be expected to result in the revocation or termination of any such Permit, except for any such revocation or termination that would
          not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-31-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">In the past <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>five (5) years, none of the Company, its Subsidiaries or any of their respective directors, officers, employees, or, to the Knowledge of the Company, their respective
          agents or representatives has, directly or indirectly, made, offered, promised or authorized, or solicited, received or agreed to receive, any payment or gift of any money or anything of value to, from or for the benefit of any Government
          Official or other Person for the purpose of (a) influencing any official act or decision of such Government Official, (b) inducing such Government Official to use his, her or its influence to affect any act or decision of a Governmental Authority
          or (c) securing any improper advantage, in the case of (a), (b) and (c) above in order to assist the Company in obtaining or retaining business for or with, or directing business to, any Person.&#160; In the past five (5) years, none of the Company,
          its Subsidiaries or any of their respective directors, officers, employees, or, to the Knowledge of the Company, their respective agents or representatives has made or authorized any bribe, rebate, payoff, influence payment, kickback or other
          unlawful payment of funds or received or retained any funds in violation of any Law, rule or regulation, including any Anti-Corruption Laws. None of the Company, its Subsidiaries or any of their officers, directors, employees, or, to the
          Knowledge of the Company, their respective agents or representatives is the subject of any allegation, voluntary disclosure, investigation, prosecution or other enforcement action related to any Anti-Corruption Laws, nor, to the Knowledge of the
          Company, are there any actions, conditions, facts or circumstances that would reasonably be expected to give rise to any future claims with respect to any Anti-Corruption Laws.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company and
          its Subsidiaries have conducted its export, import and related transactions at all times in material compliance with all applicable Sanctions (since April 24, 2019) and Trade Control Laws (in the past five (5) years).&#160; Without limiting the
          foregoing, the Company and its Subsidiaries have obtained or have been otherwise qualified to rely upon, and are in compliance with, any required import and export licenses and other required consents, authorizations, waivers, approvals and
          Orders, and have made or filed any and all necessary notices, registrations, declarations and filings with any Governmental Authority, and have met the requirements of any license exceptions or exemptions, as required in connection with (i) the
          import, export, re-export or transfer of products, services, software (including source code) or technology or (ii) releases of technical data, software (including source code) or technology to foreign nationals located in the United States and
          abroad.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"> None of the
          Company, its Subsidiaries or any of their respective officers, directors, employees, or, to the Knowledge of the Company, agents or representatives (i) is a Restricted Person or (ii) has engaged in any transaction, act, dealing or practice in,
          with, or for the benefit of any Sanctioned Jurisdiction or Restricted Person in violation of applicable Sanctions (since April 24, 2019) or Trade Controls Laws (in the past five (5) years).&#160; Without limiting the foregoing, neither the Company nor
          any of its Subsidiaries has exported, re-exported, distributed, sold, leased, transferred, furnished, assigned, provided, or otherwise disposed of any products, software (including source code), technology or services, directly or indirectly, to
          or on behalf of any Sanctioned Jurisdiction or Restricted Person, in each case in violation of applicable Sanctions or Trade Controls Laws.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">There are no
          pending or, to the Company&#8217;s Knowledge, threatened inquiries, investigations, enforcement actions, voluntary disclosures or other claims against the Company of any of its Subsidiaries with respect to material violations of the Sanctions or Trade
          Control Laws.&#160; There are no actions, conditions, facts or circumstances pertaining to the Company&#8217;s or its Subsidiaries&#8217; import, export and related transactions that would reasonably be expected to give rise to any future inquiries,
          investigations, enforcement actions, voluntary disclosures or other claims with respect to material violations of Sanctions or Trade Control Laws.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-32-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.11</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Material Contracts</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Section 3.11(a)</u>
          of the Company Disclosure Schedule sets forth a complete and accurate list of Contracts to which the Company or any of its Subsidiaries is a party (which does not include any Company Benefit Plans, Shared Company Benefit Plans, Related Party
          Agreements or Intercompany Agreements) that fall within the following categories and are existing as of the date hereof (collectively, the &#8220;<u>Material Contracts</u>&#8221;):</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Real Property Lease which as of the date hereof requires an annual rent payment in excess of $150,000;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract for the purchase of services, equipment or other assets (A) providing for annual payments by the Company or its Subsidiaries of $150,000 or more; or (B) giving rise to anticipated receipts by the counterparty of more than $150,000 in any
          calendar year;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract with a customer of the Company or its Subsidiaries which generates annual payments to the Company or such Subsidiary of $150,000 or more;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          material partnership, joint venture or other similar Contract;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract relating to the acquisition or disposition of any business (whether by merger, sale of stock, sale of assets or otherwise) pursuant to which the Company or its Subsidiaries or the Business has continuing obligations in excess of $150,000
          following the date of this Agreement;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          trust indenture, mortgage, promissory note, loan agreement or other Contract for the borrowing of money, any currency exchange, commodities or other hedging arrangement or any leasing transaction of the type required to be capitalized in
          accordance with GAAP and any Contract as obligor or guarantor relating to Indebtedness, other than any such arrangements exclusively among the Company and its Subsidiaries;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract containing covenants expressly limiting the freedom of the Company or any of its Subsidiaries to compete with any Person in a product line or line of business or operate in any jurisdiction in a manner that is material to the business of
          the Company and its Subsidiaries, taken as a whole;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract relating to any swap, forward, futures, warrant, option or other derivative transaction;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          agency, dealer, sales representative, marketing or other similar Contract generating annual payments to the Company or its Subsidiary of $150,000 or more;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract pursuant to which (A) the Company or any of its Subsidiaries is granted a right or license to any Intellectual Property of any other Person, other than (i) any non-exclusive licenses for commercially available off-the-shelf software for
          annual or aggregate payments of no more than $150,000 that is not embedded into the software of any Product, (ii) licenses for Open Source Software, (iii) Contracts with employees, contractors or consultants of the Company or any of its
          Subsidiaries entered into in the ordinary course of business, substantially in the form of the Company&#8217;s or any of its Subsidiaries&#8217; forms of proprietary information and invention assignment agreement or (iv) contractor agreement, copies of which
          have been provided to Purchaser, and nondisclosure agreements entered into in the ordinary course of business, or (B) the Company or any of its Subsidiaries grants to any other Person any right or license with respect to any Intellectual
          Property, other than (i) customer agreements entered into in the ordinary course of business, substantially in the form of the Company&#8217;s or any of its Subsidiaries&#8217; form of customer agreement, copies of which have been provided to Purchaser, (ii)
          Contracts where any license of any Intellectual Property is incidental to such agreement and/or where such license is ancillary to the primary purpose of such Contract, and (iii) nondisclosure agreements entered into in the ordinary course of
          business (collectively, (A) and (B), &#8220;<u>Material IP Contracts</u>&#8221;);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-33-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any
          Contract that provides for a settlement, conciliation or similar arrangement in connection with any pending or threatened litigation, arbitration or administrative proceedings, which includes any effective and outstanding non-monetary remedies;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract containing a &#8220;take or pay&#8221; or similar provision requiring the Company or any Subsidiary to make minimum purchases of a particular product or service from a vendor, supplier or subcontractor in excess of $150,000 per year in the
          aggregate;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xiii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract (A) with any of its officers, directors, managers, employees or stockholders or any member of their immediate families or (B) between or among the Company or its Subsidiaries, on the one hand, and any member of the Seller Group, on the
          other hand, other than offer letters and employment agreements entered into in the ordinary course of business with employees of the Company that do not deviate in any material respect from the Company&#8217;s standard form offer letters and employment
          agreements that have been provided to the Purchaser;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xiv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract pursuant to which the Company or any Subsidiary is a lessor or lessee of any machinery, equipment, motor vehicles, office furniture, fixtures or other personal property involving in excess of $150,000 per annum;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract with any Governmental Authority;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xvi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Labor Agreement;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xvii)</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';">any





          Contract that is for the employment or engagement of any directors, officers, employees or independent contractors at annual compensation in excess of $150,000; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(xviii)</font><font style="font-size: 10pt;">&#160; <font style="font-family: 'Times New Roman';">Company





          Benefit Plans or Shared Company Benefit Plans that provides severance, transaction, retention, change in control, termination or similar payment.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">All Material
          Contracts are in written form. Each Material Contract is a valid and binding agreement of the Company and its Subsidiaries, as applicable, and is in full force and effect. <font style="color: rgb(0, 0, 0);">There exists no default or event of
            default or event, occurrence, condition or act, with respect to the Company or any Subsidiary or to the knowledge of the Company, with respect to any other contracting party, that, with the giving of notice, the lapse of time or the happening
            of any other event or condition, would reasonably be expected to (i) become a default or event of default under any Material Contract or (ii) give any third party (A) the right to declare a default or exercise any remedy under any Material
            Contract, (B) the right to a rebate, chargeback, refund, credit, penalty or change in delivery schedule under any Material Contract, (C) the right to accelerate the maturity or performance of any obligation of the Company or any Subsidiary
            under any Material Contract or (D) the right to cancel, terminate or modify any Material Contract. Neither the Company nor any Subsidiary has waived any of its material rights under any Material Contract. Neither the Company nor any Subsidiary
            has received any notice or other communication regarding any actual or possible violation or breach of, default under, or intention to cancel or modify any Material Contract.&#160; True, correct and complete copies of all Material Contracts have
            been provided to Purchaser prior to the Agreement Date.&#160; The Company and its Subsidiaries have no material dispute with a customer concerning the provision of services by the Company or its Subsidiaries under any Contract with a customer, and
            no material customer has communicated any material dissatisfaction with the provisions of services by the Company and its Subsidiaries under any Contract with a customer.</font></font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-34-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Intellectual
            Property; Privacy and Security</u><u>.</u></font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Section 3.12(a)</u>
          of the Company Disclosure Schedule sets forth a complete and accurate list of all Patents owned or purported to be owned by or filed in or issued under the name of the Company or any of its Subsidiaries, registered Trademarks owned or purported
          to be owned by or filed in or issued under the name of the Company or any of its Subsidiaries, and registered Copyrights owned or purported to be owned by or filed in or issued under the name of the Company or any of its Subsidiaries, in each
          case including, to the extent applicable, (i) the owner of such filing, issuance or registration, (ii) the date of filing, issuance or registration, (iii) the filing, issuance or registration number, (iv) the name of the body where the filing,
          issuance or registration was made and (v) in the case of domain names and social media accounts, the domain registrar and social media handles.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">(i) The Company or
          its Subsidiaries, as applicable, solely and exclusively own (or will, upon execution of the IP Assignment Agreement, solely and exclusively own), free and clear of all Liens (other than any Permitted Liens), all material Company Intellectual
          Property owned or purported to be owned by the Company or its Subsidiaries and (ii) there is no claim pending or, to the Company&#8217;s Knowledge, threatened against any of the Company or its Subsidiaries challenging the use, ownership, validity or
          enforceability of any material Company Intellectual Property owned or purported to be owned by the Company or its Subsidiaries.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">All material
          Company Intellectual Property owned or purported to be owned by the Company or its Subsidiaries that have been the subject of an application filed with, are issued by, or registered with, as applicable, the U.S. Patent and Trademark Office, the
          U.S. Copyright Office or any similar office or agency anywhere in the world are (A) registered in the name of the Company or one of its Subsidiaries; and (B) have been duly maintained (including the payment of maintenance fees) and are not
          expired, cancelled or abandoned.&#160; All material registered Company Intellectual Property owned or purported to be owned by the Company or its Subsidiaries is valid and enforceable.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">(i) Neither the
          operation of the Business as currently conducted nor any activity by the Company or any of its Subsidiaries is infringing on, misappropriating or otherwise violating, or in the past six (6) years has infringed on, misappropriated or otherwise
          violated any rights to any Intellectual Property of a third party, or subject matter thereof, in any material respect, (ii) there is no claim pending or, to the Company&#8217;s Knowledge, threatened in writing against any of the Company or its
          Subsidiaries alleging the same, (iii) to the Company&#8217;s Knowledge, no third party is infringing, violating or misappropriating (or in the past five (5) years, has infringed, violated or misappropriated) any material Company Intellectual Property
          owned or purported to be owned by the Company or any of its Subsidiaries or subject matter thereof and (iv) no claim is pending by the Company or any of its Subsidiaries against any third party alleging the infringement, violation or
          misappropriation of any Company Intellectual Property.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Subject to the
          execution of the IP Assignment Agreements, all former and current employees, consultants and contractors of the Company or any of its Subsidiaries who have created or developed while employed or engaged by the Company or a Subsidiary any material
          inventions, original works of authorship, developments, improvements, concepts, processes, designs, discoveries, ideas, technology advances, unique solutions to business problems, trademarks, trade secrets or other Intellectual Property that
          relates to the current or demonstrably anticipated Business, research or development, was developed within the scope of performance of services for the Company or any of its Subsidiaries, or was developed using the Company&#8217;s or any of its
          Subsidiaries&#8217; equipment, supplies, facilities or trade secret information have executed written instruments with the Company or one of its Subsidiaries, as applicable, that assign to the Company or such Subsidiary all rights, title and interest
          (including all Intellectual Property) in and to all of the forgoing.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-35-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company and
          its Subsidiaries have taken all reasonable measures to protect the confidentiality and value of the subject matter of all Trade Secrets within the Company Intellectual Property.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Neither the
          Company nor any of its Subsidiaries has (A) granted, directly or indirectly, any current or contingent rights, licenses or interests in or to any material source code of any of the Products, or (B) provided or disclosed any material source code
          of any Product to any person or entity other than employees or contractors (who are bound by written confidentiality and non-use obligations protecting such source code) working on the behalf of the Company or its Subsidiaries.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Each Product
          currently sold by the Business performs in accordance with its documented specifications and as the Company or any of its Subsidiaries has warranted to its customers in all material respects.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Products and
          IT Assets do not contain any viruses, worms, time&#8209;bombs, key-locks, or any other items intentionally created to disrupt or interfere with the operation of the Products or equipment upon which the Products operate, or the safety, security or
          integrity of the data, information or signals the Products produce or process in a manner adverse to the Company, any Subsidiary, or any customer, licensee or recipient.&#160; The Products do not include or install undocumented or unauthorized
          portals, key-logs, codes, commands or other access (including backdoors) to the Products or the data, information or signals the Products produce or process, or any spyware, adware, or other similar software that monitors the use of the Products
          in an unauthorized manner or contacts any remote computer without the knowledge and express consent of the user(s) of the applicable Product and remote computer, as applicable.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company has
          made available to the Purchaser an accurate and complete, in all material respects, list of all items of Open Source Software that it has embedded, linked, or distributed in connection with any Products, including the name of each such item and
          the license(s) applicable to each such item.&#160; Except as set forth in <u>Section 3.12(j)</u> of the Company Disclosure Schedule, the licensing, availability of or development of any Product with any such Open Source Software, and the
          incorporation, linking, calling, distribution or other use in, by or with any such Product of any such Open Source Software, does not obligate the Company to disclose, make available, offer or deliver to any third party any portion of the source
          code of such Product or component thereof other than the applicable Open Source Software. The Company and each of its Subsidiaries are in compliance in all material respects with all licenses for Open Source Software that it uses.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company and
          each of its Subsidiaries use all Generative AI Tools in compliance in all material respects with all license terms, consents, Contracts, Privacy Policies and Laws.&#160; Neither the Company nor any of its Subsidiaries have included and do not include
          any Personal Information or Trade Secrets of the Company or any of its Subsidiaries, or of any third party under an obligation of confidentiality by the Company or any of its Subsidiaries, in any prompts or inputs into any Generative AI Tools,
          except in cases where the applicable owner of such Generative AI Tools has agreed in writing (i) to keep such information, prompts, and services confidential and not to use them for any purpose other than providing the applicable Generative AI
          Tool to the Company or one of its Subsidiaries, as applicable, and (ii) not to use such information, prompts or services to train the machine learning or algorithm of the applicable Generative AI Tools or any other products or services. Neither
          the Company nor any Subsidiary has used Generative AI Tools to develop any Product or subject matter of Company Intellectual Property that is material to the Business.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-36-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">No funding,
          facilities or personnel of any Governmental Authority, university, college, other educational institution or research center was used directly or indirectly in connection with the development of any material Company Intellectual Property owned or
          purported to be owned by the Company or its Subsidiaries in such a manner as to give any of the foregoing any claim or right, current or contingent, in or to any such Company Intellectual Property</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Neither the
          Company nor any Subsidiary is, or has ever been, a member or promoter of, or a contributor to, any industry standards body or similar organization which, as a result thereof, has a legal right to compel the Company or such Subsidiary, as
          applicable, to grant or offer to any other person or entity any license or right to any material Company Intellectual Property.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company
          complies, and for the past five (5) years has complied, in all material respects, with all: (i) applicable Privacy Laws; (ii) Privacy Policies, (iii) contractual obligations the primary purpose of which is the receipt, collection, compilation,
          use, storage, processing, sharing, safeguarding, security, disposal, destruction, disclosure or transfer of Personal Information; and (iv) all applicable binding industry standards, including, without limitation, the Payment Card Industry &#8211; Data
          Security Standard ((i)-(iv) collectively, the &#8220;<u>Privacy Requirements</u>&#8221;).</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company has,
          in all material respects, (i) taken all required organizational, physical, administrative, and technical measures under the Privacy Requirements to protect: (A) the integrity, security, and operations of all IT Assets with commercially reasonable
          backup, security and disaster recovery technology and (B) all Personal Information and all other confidential data owned, controlled, or stored by the Company from and against data security incidents or other misuse and (ii) implemented
          reasonable procedures, satisfying the requirements of applicable Privacy Requirements, to detect data security incidents and to protect Personal Information against loss and against unauthorized access, use, modification, disclosure, or other
          misuse.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(p)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The IT Assets are
          adequate for, and operate and perform in all material<font style="color: rgb(0, 0, 0);"> respects in accordance with their documentation and functional specifications and otherwise as required in connection with, the operation of the business of
            the Company as currently conducted and as conducted over the past five (5) years. In the past five (5) years, the IT Assets have not malfunctioned or failed in a manner that resulted in material ongoing disruptions to the operation of the
            Company's business.</font></font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(q)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">In the past five
          (5) years, there have been no material data security incidents, personal data breaches or ransomware incidents related to any (i) IT Assets or (ii) Personal Information, or confidential Company data in the custody or control of (x) the Company or
          (y) to the Company&#8217;s Knowledge, any service provider acting on behalf of the Company.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(r)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="color: rgb(0, 0, 0);">The Company has not sold (as defined in the CCPA) Personal Information processed by it to a third party, except with respect to any </font>use of analytics, advertising, and other tracking technologies on the
          Company&#8217;s and/or its Subsidiary&#8217;s website, such as cookies or pixels, which may result in the "sale" of Personal Information as broadly defined under the CCPA.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(s)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">In the past five
          (5) years, there have not been any material Actions filed against the Company or its Subsidiaries by any Person or Governmental Authority related to any data security incidents, ransomware incidents, or any violations of any Privacy Requirements,
          other than any individual data subject requests or complaints made in the ordinary course of business.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-37-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.13</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Employee Benefits Matters</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Set forth in <u>Section





            3.13(a)</u> of the Company Disclosure Schedule is an accurate and complete list as of the date hereof of each Company Benefit Plan and material Shared Company Benefit Plan.&#160; For each Company Benefit Plan and each material Shared Company Benefit
          Plan, the Company has made available to Purchaser, as applicable, (i) a copy of all documents embodying or governing such plan (or, if such plan is unwritten, a description thereof), including all material amendments thereto, (ii) the most recent
          determination or opinion letter issued by the IRS with respect to such plan, (iii) the current summary plan description or other summary given to participants, including any summaries of material modification, (iv) the most recently filed annual
          return/report (Form 5500), (v) the last three (3) years of non-discrimination testing results and (vi) all non-routine correspondence to and from any Governmental Authority.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">None of the
          Company or any of its ERISA Affiliates or any predecessor thereof sponsors, maintains, contributes to, or has any Liability or obligation (including on account of any ERISA Affiliate), or has in the past sponsored, maintained, contributed to, or
          had any Liability (whether contingent or otherwise) with respect to: (i) any employee benefit plan that is subject to Title IV of ERISA, Section 412 of the Code, Section 302 of ERISA, (ii) a Multiemployer Plan, (iii) any funded welfare benefit
          plan within the meaning of Section 419 of the Code, (iv) any &#8220;multiple employer plan&#8221; (within the meaning of Section 210 of ERISA or Section 413(c) of the Code), or (v) any &#8220;multiple employer welfare arrangement&#8221; (as such term is defined in
          Section 3(40) of ERISA), and neither the Company nor any ERISA Affiliate has ever incurred any Liability under Title IV of ERISA that has not been paid in full.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Each Company
          Benefit Plan or Shared Company Benefit Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and has received a favorable determination or opinion letter from the Internal Revenue Service (the &#8220;<u>IRS</u>&#8221;) or has
          applied to the IRS for such a letter within the applicable remedial amendment period or such period has not expired, and, to the Knowledge of the Company, no event or omission has occurred that would cause any Company Benefit Plan or Shared
          Company Benefit Plan to lose such qualification or require corrective action with the IRS or under the Employee Plans Compliance Resolution System to maintain such qualification.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">(i) Each Company
          Benefit Plan has been maintained in material compliance with its terms and all applicable Law, including ERISA and the Code, including with respect to the timely making or accrual of contributions. (ii) As of the date hereof, there is no claim or
          cause of action pending (other than routine claims for benefits) or, to the Knowledge of the Company, threatened in writing (A) against any Company Benefit Plan, (B) involving any Company Benefit Plan before a Governmental Authority, or (C)
          involving the terms or conditions of employment, or compensation or employee benefits, of any Company Employee or Former Company Employee. (iii) No Company Benefit Plan is, or within the past six years has been, the subject of an application or
          filing under a government sponsored amnesty, voluntary compliance, or similar program, or been the subject of any self-correction under any such program. (iv) All payments and/or contributions required to have been timely made with respect to all
          Company Benefit Plans either have been made or have been accrued in accordance with the terms of the applicable Company Benefit Plan and applicable law.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Except as
          otherwise set forth in <u>Section 3.13(e)</u> of the Company Disclosure Schedule, none of the Company or any of its Subsidiaries has any obligation to provide any post-employment or post-retirement health or medical or life insurance benefits
          (other than coverage mandated by applicable Law), including in respect of any period of notice of termination under statute, Contract or common Law.&#160; No Company Benefit Plan provides health or long term disability benefits that are not fully
          insured through an insurance contract.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-38-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Except as
          otherwise set forth in <u>Section 3.13(f)</u> of the Company Disclosure Schedule, neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated herein (either alone or upon the occurrence of any
          additional or subsequent event), could (i)&#160; result in, or cause any payments or benefits to become due or payable to any Company Employee, (ii) result in, or cause any acceleration, vesting or material increase in payments or benefits to any
          Company Employee, or (iii) result in any &#8220;excess parachute payment&#8221; as defined in Section 280G of the Code.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">No Shared Company
          Benefit Plan will automatically transfer to Purchaser or any of its Affiliates (including the Company and its Subsidiaries), including by operation of applicable Law, in connection with the execution and delivery of this Agreement or the
          consummation of the transactions contemplated herein.&#160; Upon and following the Closing, Purchaser and its Affiliates (including the Company and its Subsidiaries) shall have no Liability under or with respect to any Shared Company Benefit Plan.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Any transfer of
          property which was subject to a substantial risk of forfeiture and which would otherwise have been subject to taxation under Section 83(a) of the Code is covered by a valid and timely filed election under Section 83(b) of the Code, and a copy of
          such election has been provided to the Company.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Each Company
          Benefit Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of Section 409A of the Code has been operated and maintained in all material respects in operational and documentary compliance with Section
          409A of the Code and applicable guidance thereunder. No payment to be made under any Company Benefit Plan is, or to the Knowledge of the Company, will be, subject to the penalties of Section 409A(a)(1) of the Code.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">No Company Benefit
          Plan is subject to the laws of any jurisdiction outside the United States.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Neither the
          Company nor any of its Subsidiaries has any obligation to provide for any tax &#8220;gross-up&#8221; or similar &#8220;make-whole&#8221; payments.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.14</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Labor</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Except as
          otherwise set forth in <u>Section 3.14(a)</u> of the Company Disclosure Schedule, (i) none of the Company or its Subsidiaries is a party to or subject to any Labor Agreement (nor is any such Labor Agreement presently being negotiated) and no
          employees of the Company or its Subsidiaries are represented by any labor union, works council, or other labor organization in connection with their employment for the Company or any of its Subsidiaries, (ii) to the Company&#8217;s Knowledge, there is
          no, and in the past three (3) years, there has not been any organizational campaign, demand, petition or other unionization activity seeking recognition or certification. There are no and, for the past three (3) years, there have not been any
          representation or certification proceedings pending or, to the Company&#8217;s Knowledge, threatened to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority. There are no, and in the past three
          (3) years there has not been any, labor strike, concerted slowdown or work stoppage, picketing, handbilling, or lockout or other material labor dispute pending or, to the Company&#8217;s Knowledge, threatened against or affecting the Company or its
          Subsidiaries, (iii) there are no, and in the past three (3) years there has not been any, unfair labor practice charges or complaints, labor arbitrations, or material labor grievances pending or, to the Company&#8217;s Knowledge, threatened against or
          affecting the Company or its Subsidiaries, and (iv) in the past three (3) years, except as would not be material to the Company and its Subsidiaries, taken as a whole, none of the Company or its Subsidiaries have failed to comply with the
          provisions of any Labor Agreement.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-39-</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company and
          its Subsidiaries are, and for the past three (3) years have been, in compliance in all material respects with all applicable Laws respecting labor, employment and employment practices, including all Laws respecting terms and conditions of
          employment, health and safety, wages and hours (including the classification of independent contractors and exempt and non-exempt employees, the payment of minimum wages and overtime, and provision of meals and rest breaks), pay equity, pay
          transparency, immigration (including the completion of Forms I-9 for all employees and the proper confirmation of employee visas), employment harassment, discrimination or retaliation, whistleblowing, disability rights or benefits, equal
          opportunity, plant closures and layoffs (including the WARN Act), employee trainings and notices, workers&#8217; compensation, labor relations, employee leave issues, restrictive covenants, the use of artificial intelligence or other similar automated
          decision-making tools in making employment decisions, affirmative action and unemployment insurance. To the Company&#8217;s Knowledge, no current or former employee or independent contractor of the Company or its Subsidiaries is in any material respect
          in violation of any term of any employment agreement, nondisclosure agreement, noncompetition agreement, nonsolicitation agreement, or other similar restrictive covenant obligation: (i) owed to the Company or its Subsidiaries; or (ii) solely as
          to current employees or independent contractors, owed to any third party with respect to such person&#8217;s right to be employed or engaged by the Company or its Subsidiaries.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">To the Company&#8217;s
          Knowledge, no Key Employee or any other current employee or group of employees with annualized compensation at or above $150,000 intends to terminate their employment prior to the one (1) year anniversary of the Closing.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">During the past
          three (3) years, the Company and its Subsidiaries have promptly, thoroughly and impartially investigated any sexual harassment and other material allegations of unlawful harassment, discrimination, or retaliation that have been reported to the
          Company or a Subsidiary or of which the Company otherwise has Knowledge. With respect to each such allegation with potential merit, the Company or its Subsidiaries have taken prompt corrective action that is reasonably calculated to prevent
          further harassment, discrimination or retaliation. The Company does not reasonably expect any material Liabilities with respect to any such allegations.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Within the past
          three (3) years, none of the Company or its Subsidiaries have implemented any plant closing or employee layoff triggering the WARN Act, nor is there presently any outstanding liability under the WARN Act, and no such future plant closings or
          employee layoffs are currently planned or have been announced. To the Company&#8217;s Knowledge, as of the date of this Agreement, there are no current or pending allegations made by any person against any officers, directors, employees, contractors or
          agents of the Company and its Subsidiaries that, if known to the general public, would be reasonably expected to bring the Company or its Subsidiaries into material disrepute.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: rgb(0, 0, 0);">3.15</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Tax Matters</u><u>.</u></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">All income and other material Tax
          Returns required to be filed by or with respect to the Company and its Subsidiaries have been timely filed (taking into account valid extensions) and all such Tax Returns were true, correct and complete in all material respects. All material
          Taxes of the Company and its Subsidiaries due and payable, whether or not shown or required to be shown on any Tax Returns, have been timely paid to the appropriate Taxing Authority, and no material Taxes of the Company and its Subsidiaries are
          delinquent. No waiver or extension of any statute of limitations on the assessment of any Taxes granted by the Company or any of its Subsidiaries is currently in effect, and no agreement to any extension of time for filing any Tax Return that has
          not been filed is currently in effect, other than customary extensions for which no approval is required.</font></font></div>
    <div style="font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">-40-</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%41%-%-%-->
    <div>
      <div>
        <div>
          <div style="text-align: justify; text-indent: 36pt;"> <font style="font-size: 10pt;"><a name="z_Ref101658977"></a></font></div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;There are no Liens for Taxes upon any of the assets of the Company or any of its Subsidiaries, other than Permitted Liens.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of the Company and its Subsidiaries (i) deducted, withheld and timely remitted to the applicable Taxing Authority all material Taxes required to be deducted,
            withheld and paid in connection with any amounts paid or owing to any employee, creditor, independent contractor, securityholder or other third party, and (ii) has complied in all material respects with the information reporting and record
            keeping requirements under all applicable Laws, including retention and maintenance of required records with respect thereto.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; There are no current or pending audits, examinations, claims, investigations, proceedings or notice of inquiry of any of the foregoing by any Taxing Authority with
            respect to material Taxes of any of the Company or its Subsidiaries, and no such audits, examinations, claims, investigations or other Actions have been proposed or threatened in writing by any Taxing Authority.&#160; None of the Company and its
            Subsidiaries has submitted a request for a private letter ruling, a request for administrative relief, a request for technical advice, or a request for a change of any method of accounting that is pending with any Taxing Authority that relates
            to Taxes or Tax Returns of the Company and its Subsidiaries. No power of attorney granted by the Company or any of its Subsidiaries with respect to any Taxes is currently in force.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No material deficiency for Tax has been asserted or assessed by any Taxing Authority in writing or orally against any of the Company or its Subsidiaries, which
            deficiency has not been satisfied by payment, settled or been withdrawn, and none of the Company and its Subsidiaries reasonably expects that any such assertion and assessment of Tax Liability will be made.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has never been a member of a consolidated, combined, unitary or aggregate group of entities that pay Taxes on a group wide basis. Neither of the
            Company nor any of its Subsidiaries has liability for the Taxes of any other Person pursuant to Section 1.1502-6 of the Treasury Regulations (or any similar provision of U.S. state, local, or <a name="z_9kMHG5YVt488ELL3yzgGGP0"></a>non-U.S.
            Tax law) by reason of being a member of an affiliated, consolidated, combined, or unitary group, as a transferee or successor, or by Contract.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Company nor any of its Subsidiaries has been a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; in a distribution intended to qualify under
            Section 355(a) of the Code in the two year period ending on the date hereof.<a name="z_Ref101747446"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Neither the Company nor any of its Subsidiaries has &#8220;participated&#8221; in any &#8220;listed transaction&#8221; within the meaning of Section 1.6011-4 of the Treasury Regulations or
            any similar or analogous provision of non-U.S. Law. Each of the Company and its Subsidiaries has disclosed on its Tax Returns any Tax reporting position taken in any Tax Return which could result in the imposition of penalties under Section
            6662 of the Code or any comparable provisions of state, local or non-U.S. Law.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Company nor any of its Subsidiaries is a party to, bound by or has any obligation under, any Tax sharing, indemnity or allocation agreement with
            respect to any Taxes (other than pursuant to customary commercial Contracts and not primarily related to Taxes).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of the Company and its Subsidiaries has collected all material sales and use Taxes required to be collected, and have remitted, or will remit on a timely
            basis, such amounts to the appropriate Taxing Authority, or has been furnished properly completed exemption certificates and has maintained in all material respects all such records and supporting documents in the manner required by all
            applicable sales and use Tax statutes and regulations.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-41-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No claim has ever been made by a Taxing Authority in a jurisdiction where the Company or any of its Subsidiaries does not file Tax Returns that the Company or such
            Subsidiary is or may be subject to taxation by that jurisdiction or may be required to file a Tax Return in that jurisdiction.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183511746"></a>(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; MyFavoriteThings, Inc. has not been a &#8220;United States real property holding corporation&#8221; within the meaning of Section 897 of the Code
            during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160; At all times since the Restructuring, the Company has been <font style="color: rgb(0, 0, 0);">properly classified as disregarded as a separate entity </font>(within
            the meaning of Treasury Regulations Section 301.7701-3)<font style="color: rgb(0, 0, 0);"> from Seller for U.S. federal (and applicable state and local) income Tax purposes.&#160; </font>MyFavoriteThings, Inc. was classified as a partnership from
            its formation until February 19, 2019, at which point it elected to be treated as a corporation for U.S. federal income tax purposes.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Neither the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of deduction from, taxable
            income for any taxable period (or portion thereof) beginning after the Closing Date as a result of any: (i) change in method of accounting for a taxable period ending on or prior to the Closing Date; (ii) use of an improper method of accounting
            for a taxable period ending on or prior to the Closing Date; (iii) &#8220;closing agreement&#8221; as described in Section 7121 of the Code (or any corresponding or similar provision of U.S. state, local or non-U.S. income Tax Law) entered into prior to
            the Closing; (iv) installment sale or open transaction disposition prior to the Closing; or (v) prepaid amount or deferred revenue received or accrued on or prior to the Closing Date. Neither the Company nor any of its Subsidiaries has any
            outstanding liability for Taxes under Section 965 of the Code.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and its Subsidiaries use the accrual method of accounting for U.S. federal and applicable state and local income Tax purposes. The taxable year of the
            Company and its Subsidiaries is (and always has been) the calendar year ending December 31.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Company, its Subsidiaries, nor any of their affiliates have deferred any Taxes under Section 2302 of the CARES Act or IRS Notice 2020-65 (or any
            corresponding or similar provision of state or local Law), which has not been repaid in full.&#160; The Company and its Subsidiaries have properly complied with all applicable Laws and duly accounted for any available Tax credits under Section 7001
            through 7005 of the Families First Coronavirus Response Act for 2020 (or any similar election under federal, state or local Law) and Section 2301 of the CARES Act (or any similar election under federal, state or local Law).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Company nor any of its Subsidiaries has made any PTET Election with respect to any Pre-Closing Tax Period.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of the Company and its Subsidiaries has timely paid over to the appropriate Governmental Authority all material amounts required to be paid over under all
            escheat and unclaimed property Laws, and has complied in all material respects with all escheat and unclaimed property, and all transfer pricing, Laws.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the Company nor any of its Subsidiaries is subject to Tax in any country other than its country of incorporation or formation by virtue of having a
            permanent establishment (as defined in any applicable tax treaty) or other fixed place of business in such other country.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-42-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; As of the Restructuring, neither the Company nor any of its Subsidiaries is a party to any joint venture, partnership or other arrangement or Contract treated or
            that could reasonably be expected to be treated as a partnership for U.S. federal income Tax purposes.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company has never engaged in any stand-alone business activity or operations or recognized any items of income, gain, loss or deduction at the entity level for
            U.S. federal income tax purposes.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref325021907"></a><a name="z_Toc183565428"></a><a name="z_Toc186369702"></a><font style="color: rgb(0, 0, 0);">3.16</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Real Property.</u><a name="z_Ref325023354"></a><a name="z_9kR3WTr2887DGGDHZN4CCtqtl"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993110"></a>(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Section 1.1(a)</u> of the Company Disclosure Schedule sets forth a correct and complete list, as of the date hereof, of all Real
            Property that is owned by the Company and its Subsidiaries (collectively, the &#8220;<u>Owned Real Property</u>&#8221;).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref101888716"></a><a name="z_Ref183993111"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Section 3.16(b)</u> of the Company Disclosure Schedule sets
            forth a correct and complete list, as of the date hereof, of all Real Property Leases and subleases (1) under which any of the Company or its Subsidiaries is a lessee or sublessee and (2) which requires an annual rent payment in excess of
            $150,000 (collectively, the &#8220;<u>Real Property Leases</u>,&#8221; and the real property leased or subleased thereunder, collectively, the &#8220;<u>Leased Real Property</u>&#8221;; the Leased Real Property, together with the Owned Real Property, are referred to
            collectively as the &#8220;<u>Real Property</u>&#8221;).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993112"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company and its Subsidiaries have good title to the Owned Real Property and the Company
            and its Subsidiaries have leasehold interests in the Leased Real Property, in each case except where the failure to have such good title or such leasehold interests would not reasonably be expected to have, individually or in the aggregate, to
            be material to the Company.&#160; None of the Real Property is subject to any Liens, except Permitted Liens.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref101888733"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; As of the date hereof and except as described in <u>Section 3.16(d)</u> of the Company
            Disclosure Schedule, (1) neither the whole nor any material portion of any Real Property is subject to any pending suit for condemnation, expropriation or other taking by any Governmental Authority, and (2) no such condemnation, expropriation
            or other taking is threatened in writing.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61674256"></a><a name="z_Toc183565429"></a><a name="z_Toc186369703"></a><font style="color: rgb(0, 0, 0);">3.17</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Insurance.</u>&#160; <u>Section 3.17</u>
            of the Company Disclosure Schedule contains a list of each of the current material policies of insurance maintained by or for the benefit of the Company and its Subsidiaries as of the date hereof that provide coverage with respect to the
            Business (the &#8220;Insurance Policies&#8221;).&#160; The Insurance Policies are valid, in full force and effect and, to the Knowledge of Company, enforceable against the insurer, subject to the Bankruptcy and Equity Exception.&#160; As of the date hereof, there
            are no outstanding claims under the Insurance Policies which are reasonably likely to exhaust the applicable limitation of liability.&#160; All premiums due on the Insurance Policies as of the date hereof have either been paid or accrued for or, if
            due and payable prior to the Closing, will be paid prior to the Closing in accordance with the payment terms of such Insurance Policies.&#160; None of the Company or its Subsidiaries are in material breach of, or material default under, any
            Insurance Policy. The Company and its Subsidiaries have not received any written notice of cancellation, nonrenewal, intent to cancel or not renew, or alteration of coverage with respect to the Insurance Policies. The Insurance Policies are in
            amounts and provide coverages as required by applicable Governmental Authorities, Laws and any Contractual Obligation relating to the Company and its Subsidiaries.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-43-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref324954184"></a><a name="z_Toc183565430"></a><a name="z_Toc186369704"></a><a name="z_Ref284596254"></a><font style="color: rgb(0, 0, 0);">3.18</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Environmental






              Matters.</u>&#160; Except as disclosed on <u>Section 3.18 </u>of the Company Disclosure Schedule:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993113"></a><a name="z_cp_text_1_7"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;as of the date of this Agreement, (i) during the past three (3)
            years, no written notice, order, request for information or complaint has been received by any of the Company or its Subsidiaries from any Governmental Authority, and (ii) there are no actions, claims, suits or proceedings pending against the
            Company or its Subsidiaries, in the case of each of (i) and (ii), which allege a violation of or liability under any Environmental Law by or of any of the Company or its Subsidiaries;</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993114"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the <a name="z_cp_text_1_11"></a>Company and its Subsidiaries are and have been for the
            past three (3) years in compliance with all Environmental Laws;</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993115"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company and its Subsidiaries have all Permits required by Environmental Law for the
            ownership or operation of their respective businesses; and</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup><a name="z_Ref183993116"></a>none of the Company or its Subsidiaries has released Hazardous Material at any Real Property in a matter reasonably likely to result in a requirement to investigate or remediate such release pursuant to
              Environmental Law.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref374459243"></a><a name="z_9kR3WTr2887CHIDJbN5xwxzF2nZR0KS3r52L9uE"></a><a name="z_Toc183565431"></a><a name="z_Toc186369705"></a><font style="color: rgb(0, 0, 0);">3.19</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Interested Party Transactions.</u>&#160; Except for employment relationships, compensation and benefits in the ordinary course of business or as disclosed in <u>Section 3.19</u> of the Company Disclosure Schedule, no
            member of the Seller Group and their respective Affiliates (other than the Company or its Subsidiaries) (a) owns any material property or right, tangible or intangible, which is used solely by the Company and its Subsidiaries, (b) has any claim
            or cause of action against any of the Company or its Subsidiaries (other than pursuant to intercompany accounts or Intercompany Agreements that will be terminated on or prior to the Closing Date), or (c) owes any money to, or is owed any money
            by, any of the Company or its Subsidiaries (other than pursuant to intercompany accounts or Intercompany Agreements that will be terminated on or prior to the Closing Date).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref325022764"></a><a name="z_9kR3WTr2887DEEEBLK4ypxCwswYj9v6dKCIGNNS"></a><a name="z_Toc183565432"></a><a name="z_Toc186369706"></a><font style="color: rgb(0, 0, 0);">3.20</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Brokers and Other Advisors.</u>&#160; Except for Evercore Group L.L.C. (the &#8220;<u>Financial Advisor&#8221;</u>), neither the Company nor its Subsidiaries has employed any investment banker, broker or finder or incurred any
            liability for any investment banking fees, brokerage fees, commissions or finders&#8217; fees in connection with the transactions contemplated by this Agreement.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc183565433"></a><a name="z_Ref183993117"></a><a name="z_Ref184009349"></a><a name="z_Ref186286370"></a><a name="z_Toc186369707"></a><font style="color: rgb(0, 0, 0);">3.21</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Title to Assets; Sufficiency of Assets.</u>&#160; Except as would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, the Company and its Subsidiaries have good, valid and
            marketable title to, or in the case of leased property and assets have valid, binding and enforceable leasehold interests in, all of the Company and its Subsidiaries&#8217; property and assets (whether real, personal, tangible or intangible), in each
            case free and clear of all Liens (other than Permitted Liens).&#160; Immediately following the Closing (and, for clarity, taking into account the execution of the IP Assignment Agreements), the Purchaser and its Affiliates will own or have the right
            to use (including by means of ownership of rights pursuant to licenses or other Contracts) all of the material assets, properties and rights necessary to conduct the Business in substantially the same manner, in all material respects, as
            conducted as of the date of this Agreement, taking into account all of the assets, services, products and property to be provided to, acquired by, leased or licensed to Purchaser and its Affiliates pursuant to this Agreement, the Transition
            Services Agreement and the other agreements contemplated hereby and thereby. Notwithstanding the foregoing, nothing in this Section 3.21 shall constitute a representation or warranty by the Company or any of its Subsidiaries with respect to the
            infringement, misappropriation or violation of the Intellectual Property of a third party.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-44-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;"><a name="z_Ref61672149"></a><a name="z_Ref61673121"></a><a name="z_Ref63073775"></a><a name="z_Toc183565434"></a><a name="z_Ref183993118"></a>ARTICLE IV</div>
          <div style="text-align: center; font-size: 10pt;"><a name="z_Ref184010549"></a><a name="z_Ref184009350"></a><a name="z_Toc186369708"></a><u>REPRESENTATIONS AND WARRANTIES OF SELLER</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">Except as set forth in the <a name="z_9kMLK5YVt4CC8BITHy0poDeJ50u7FMM7jcy1yFO"></a>Company Disclosure Schedule, each Seller hereby represents and warrants, severally and not
            jointly, to Purchaser that:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref425309816"></a><a name="z_Ref425310153"></a><a name="z_Ref425310700"></a><a name="z_Ref425313464"></a><a name="z_Toc183565435"></a><a name="z_Toc186369709"></a><font style="color: rgb(0, 0, 0);">4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Organization, Standing and Power; Capacity.</u> <a name="z_Ref425309817"></a>Seller is a limited <a name="z_9kMHzG6ZWu57779JVIz1qpE"></a>liability company duly organized, validly existing
            and in good standing under the <a name="z_9kMHG5YVt4998HHVCuD6u03pbl01624UO30CD9E"></a>Laws of the State of Delaware.&#160; Seller has all requisite limited <a name="z_9kMH0H6ZWu57779JVIz1qpE"></a>liability company power and authority to own or
            lease all of its properties and assets and to carry on its business as it is now being conducted.&#160; Seller is duly licensed or qualified to do business and is in good standing in each jurisdiction in which the nature of the business conducted by
            it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification required by Law, except where the failure to be so licensed, qualified or in good standing would not reasonably be expected
            to have, individually or in the aggregate, a Seller Material Adverse Effect.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc184019129"></a><a name="z_Ref425309819"></a><a name="z_Ref425310154"></a><a name="z_Ref425310701"></a><a name="z_Ref425313465"></a><a name="z_Ref425321541"></a><a name="z_Ref61645294"></a><a name="z_Toc183565436"></a><a name="z_Toc186369710"></a><font style="color: rgb(0, 0, 0);">4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorization.&#160;</u> Seller has all necessary limited <a name="z_9kMH1I6ZWu57779JVIz1qpE"></a>liability






            company power and authority to execute and deliver this Agreement and to perform its obligations hereunder and to consummate the transactions contemplated hereby.&#160; The execution, delivery and performance by Seller of this Agreement, and the
            consummation of the transactions contemplated hereby, has been duly and validly authorized by all requisite <a name="z_9kMI5L6ZWu57779DN4u1x3"></a>limited liability action of Seller.&#160; This Agreement has been duly executed and delivered by
            Seller and, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes a legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, subject to the Bankruptcy
            and Equity Exception.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc184019131"></a><a name="z_Ref425309820"></a><a name="z_Ref425310155"></a><a name="z_Ref425310702"></a><a name="z_Ref425313466"></a><a name="z_Ref425321546"></a><a name="z_Toc183565437"></a><a name="z_Toc186369711"></a><font style="color: rgb(0, 0, 0);">4.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Noncontravention.</u>&#160; <a name="z_Ref425309821"></a><a name="z_Ref61671508"></a><font style="color: rgb(1, 0, 0);">N</font>either
            the execution and delivery of this Agreement by Seller nor the consummation by Seller of the transactions contemplated hereby, nor compliance by Seller with any of the terms or provisions hereof, will (i) conflict with or violate any provision
            of the certificate of formation of Seller or Seller&#8217;s limited <a name="z_9kMIH5YVt4CC8DLYw2zrhC0znwxzF"></a>liability company agreement or (ii) (A) assuming that the authorizations, consents and approvals referred to in <u>Section 4.4</u> are
            obtained and the filings referred to in <u>Section 4.4</u> are made, violate any Law or Order applicable to Seller, (B) with or without notice, lapse of time or both, violate or constitute a default under any of the terms, conditions or
            provisions of any <a name="z_9kMJI5YVt4666AIcDrwv0koRP7DI0m6N"></a>material Contract to which Seller is a party or accelerate or give rise to a right of termination, cancellation or acceleration of any of Seller&#8217;s obligations under any such <a name="z_9kMKJ5YVt4666AIcDrwv0koRP7DI0m6N"></a>material Contract or to the loss of any benefit under any such <a name="z_9kMLK5YVt4666AIcDrwv0koRP7DI0m6N"></a>material Contract or (C) result in the creation of any Lien (other than any
            Permitted Lien) on any properties, rights or assets of Seller, except, in the case of clause (ii), for such violations, defaults, accelerations, rights, losses and Liens as would not reasonably be expected to have, individually or in the
            aggregate, a Seller Material Adverse Effect.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref425309823"></a><a name="z_Ref425310156"></a><a name="z_Ref425310703"></a><a name="z_Ref425313467"></a><a name="z_Ref425324139"></a><a name="z_Toc183565438"></a><a name="z_Toc186369712"></a><font style="color: rgb(0, 0, 0);">4.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Governmental Approvals.</u>&#160; Except for filings required under, and compliance with other applicable requirements of, the HSR Act, no consents, authorizations,
            or approvals of, or filings, declarations or registrations with, any Governmental Authority are necessary for the execution, delivery and performance of this Agreement by Seller and the consummation by Seller of the transactions contemplated
            hereby, other than such other consents, authorizations, approvals, filings, declarations or registrations that, if not obtained, made or given, would not reasonably be expected to have, individually or in the aggregate, a Seller Material
            Adverse Effect.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref62406690"></a><a name="z_Toc183565439"></a><a name="z_Toc186369713"></a><font style="color: rgb(0, 0, 0);">4.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Ownership.</u>&#160; Seller is the
            owner of 100% of the Company Units free and clear of Liens, other than those that are imposed by applicable securities Laws.<a name="z_Ref425309825"></a><a name="z_Ref61645316"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref425309828"></a><a name="z_Ref425310158"></a><a name="z_Ref425310705"></a><a name="z_Ref425313469"></a><a name="z_Toc183565440"></a><a name="z_Toc186369714"></a><font style="color: rgb(0, 0, 0);">4.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Proceedings.</u>&#160; Except as would not reasonably be expected to have, individually or in the aggregate, a Seller Material Adverse Effect, as of the date of this Agreement, there is no
            pending or, to the Knowledge of Seller, threatened, Action against Seller by or before any Governmental Authority related to Seller&#8217;s ownership of Company Shares, and Seller is not subject to any outstanding Order related to Seller&#8217;s ownership
            of Company Shares.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-45-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref425309832"></a><a name="z_Ref425310162"></a><a name="z_Ref425310709"></a><a name="z_Ref425313473"></a><a name="z_Ref61645350"></a><a name="z_Toc183565441"></a><a name="z_Toc186369715"></a><font style="color: rgb(0, 0, 0);">4.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Brokers and Other Advisors.</u>&#160; Except for the Financial Advisor, the fees and expenses of which will be paid by the Company, Seller has not employed any
            investment banker, broker or finder or incurred any liability for any investment banking fees, brokerage fees, commissions or finders&#8217; fees in connection with the transactions contemplated by this Agreement for which the Company or any of its
            Subsidiaries may become liable.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc185700652"></a><a name="z_Toc186369716"></a><font style="color: rgb(0, 0, 0);">4.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>IP Assignment Agreements</u><font style="font-style: italic;">.&#160;






            </font>Seller, on behalf of Nu Skin Enterprises, Inc. and its Affiliates, hereby represents and warrants to Purchaser that (a) neither Nu Skin Enterprises, Inc. nor any of its Affiliates (excluding the Company or its Subsidiary) has assigned,
            licensed, transferred, encumbered or otherwise granted any rights in any of the Employee Invention Rights (as defined in the IP Assignment Agreements) that are assigned to the Company&#8217;s Subsidiary pursuant to the IP Assignment Agreements, other
            than non-exclusive licenses, encumbrances or other grants of rights granted under Intellectual Property controlled by Nu Skin Enterprises, Inc. and/or its Affiliates, where the rights granted with respect to the Employee Invention Rights were
            incidental to such license, encumbrance or other grant of rights and not the purpose for which the license, encumbrance or other grant of rights was granted; and (b) the MFT Employees (as defined in the IP Assignment Agreements) are all of the
            individuals who are or were employed by either the Company or its Subsidiary and executed an Employee Covenant (as defined in the IP Assignment Agreements) or substantially similar agreement with Nu Skin Enterprises, Inc. or any of its
            Affiliates.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;"><a name="z_Ref372009364"></a><a name="z_9kR3WTr2887DHNG6yimpNBL32G6895L9AJFLQEA"></a><a name="z_Ref63073786"></a><a name="z_Toc183565442"></a><a name="z_Ref183993120"></a>ARTICLE






            V</div>
          <div style="text-align: center; font-size: 10pt;"><a name="z_Ref184009351"></a><a name="z_Ref184010580"></a><a name="z_Ref184011438"></a><a name="z_Toc186369717"></a><u>REPRESENTATIONS AND WARRANTIES OF PURCHASER</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">Except as set forth in the disclosure schedule delivered by Purchaser to the Company concurrently with the execution of this Agreement (the &#8220;<u>Purchaser </u><a name="z_9kMHG5YVt4CC8EMVCytn08FF0cVrur8H2"></a><u>Disclosure Schedule</u>&#8221;), Purchaser hereby represents and warrants to the Company and Seller that:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref60979765"></a><a name="z_Toc183565443"></a><a name="z_Toc186369718"></a><a name="z_Ref48222508"></a><font style="color: rgb(0, 0, 0);">5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Organization,






              Standing and Power.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993121"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchaser is a corporation duly organized, validly existing and in good standing under the
            Laws of Delaware and has all requisite corporate power and authority necessary to own, lease or operate all of its properties and assets and to carry on its business as it is now being conducted.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993122"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchaser is duly qualified or licensed to transact business in each jurisdiction in which
            the property and assets owned, leased or operated by it, or the nature of the business conducted by it, makes such qualification or licensing necessary.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref372070326"></a><a name="z_Ref372071204"></a><a name="z_9kR3WTr2887DINJLLBzv61A3y739"></a><a name="z_Toc183565444"></a><a name="z_Toc186369719"></a><font style="color: rgb(0, 0, 0);">5.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorization.</u>&#160; <a name="z_Ref325027542"></a>Purchaser has all necessary power and authority to execute and deliver this Agreement and each other <a name="z_9kMM4G6ZWu57778GR8wvjstvB"></a>agreement,


            document, instrument or certificate contemplated by this Agreement or to be executed by Purchaser in connection with the consummation of the transactions contemplated hereby and thereby (collectively, the &#8220;<u>Purchaser Documents</u>&#8221;), and to
            perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby.&#160; The execution, delivery and performance by Purchaser of this Agreement and each Purchaser Document, and the consummation by
            Purchaser of the transactions contemplated hereby and thereby, have been duly and validly authorized by all requisite <a name="z_9kMI9P6ZWu57779DN4u1x3"></a>action of Purchaser.&#160; This Agreement has been, and each Purchaser Document will be at
            or prior to the Closing, duly executed and delivered by Purchaser and, assuming due authorization, execution and delivery hereof and thereof by the other parties hereto and thereto, constitutes a legal, valid and binding obligation of
            Purchaser, enforceable against Purchaser in accordance with its terms, subject to the Bankruptcy and Equity Exception.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-46-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref372069776"></a><a name="z_Ref372069790"></a><a name="z_Toc183565445"></a><a name="z_Toc186369720"></a><font style="color: rgb(0, 0, 0);">5.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Noncontravention.</u><a name="z_Ref325027428"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61671597"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neither the execution and delivery of this Agreement or any Purchaser Document by Purchaser
            nor the consummation by Purchaser of the transactions contemplated hereby or thereby, nor compliance by Purchaser with any of the terms or provisions hereof or thereof, will (i) conflict with or violate any provision of the certificate of
            limited partnership, certificate of formation, certificate of incorporation, limited partnership <a name="z_9kMM5H6ZWu57778GR8wvjstvB"></a>agreement, limited liability <a name="z_9kMH5M6ZWu57779JVIz1qpE"></a>company <a name="z_9kMM6I6ZWu57778GR8wvjstvB"></a>agreement or bylaws (or other comparable governing documents) of Purchaser or (ii) (A) assuming that the authorizations, consents and approvals referred to in <u>Section 5.4</u> are obtained and the
            filings referred to in <u>Section 5.4</u> are made, violate any Law or Order applicable to Purchaser or (B) with or without notice, lapse of time or both, violate or constitute a default under any of the terms, conditions or provisions of any
            <a name="z_9kR3WTr2AA799LFx38qcw98kS1A2A"></a>Contract or Permit to which Purchaser is a party or accelerate or give rise to a right of termination, purchase, sale, cancellation, modification or acceleration of Purchaser&#8217;s obligations under any
            such <a name="z_9kMHG5YVt4CC9BBNHz5AseyBAmU3C4C"></a>Contract or Permit or to the loss of any benefit under a <a name="z_9kMIH5YVt4CC9BBNHz5AseyBAmU3C4C"></a>Contract or Permit, except, in the case of clause (ii), for such violations,
            defaults, accelerations or rights as would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61673679"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The votes or consents of Purchaser with respect to this Agreement and the transactions
            contemplated hereby (which have been obtained prior to the execution and delivery of this Agreement), are the only votes or consents of the holders of any class or series of capital stock or other equity interest of Purchaser necessary to
            approve and adopt this Agreement, any Purchaser Document or the transactions contemplated hereby or thereby.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref325026970"></a><a name="z_Toc183565446"></a><a name="z_Toc186369721"></a><font style="color: rgb(0, 0, 0);">5.4</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Governmental Approvals.</u>&#160;
            Except for filings required under, and compliance with other applicable requirements of, the HSR Act, no consents, authorizations or approvals of, or filings, declarations or registrations with, any Person or Governmental Authority are
            necessary for the execution, delivery and performance of this Agreement and any Purchaser Document by Purchaser and the consummation by Purchaser of the transactions contemplated hereby or thereby, other than such other consents,
            authorizations, approvals, filings, declarations or registrations that, if not obtained, made or given, would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183044496"></a><a name="z_Toc183565447"></a><a name="z_Toc186369722"></a><font style="color: rgb(0, 0, 0);">5.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Capitalization.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183609281"></a><a name="z_Ref183049198"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The authorized capital of Purchaser consists, as of the date of
            this Agreement, of:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt;"><a name="z_Hlk186613073"></a><a name="z_Ref183993123"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; 108,500,000 shares of Purchaser Common Stock,
            of which 1,642,387 shares are issued and outstanding and 4,606,064 of which are reserved for issuance upon exchange of Exchangeable Shares; and</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt;"><a name="z_Ref183993124"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160; 75,000,000 shares of Purchaser Preferred Stock, all of which have been
            designated Series A Preferred Stock, 49,901,537 of which are issued and outstanding and 22,500 of which will be sold pursuant to that certain Series A Preferred Stock Subscription Agreement following the Closing.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993125"></a><a name="z_Ref183609308"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; As of the date of this Agreement, there are (i) 7,564,532 Class
            A Exit Shares issued and outstanding and (ii) 407,310 Class B Exit Shares issued and outstanding.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-47-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183617263"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchaser has reserved 11,344,377 shares of Purchaser Common Stock for issuance to officers,
            directors, employees and consultants of Purchaser pursuant to its 2021 Stock Option Plan duly adopted by the Board of Directors of Purchaser and approved by the Purchaser&#8217;s stockholders (the &#8220;<u>Purchaser Stock Plan</u>&#8221;). Of such reserved
            shares of Purchaser Common Stock, (i) options to purchase 8,105,362 shares have been granted and are currently outstanding and (ii) 3,229,058 shares of Purchaser Common Stock remain available for issuance to officers, directors, employees and
            consultants pursuant to the Purchaser Stock Plan. Options to purchase 1,544,083 shares of Purchaser Common Stock have been granted and are currently outstanding pursuant to the terms of the 2013 Stock Option Plan and options to purchase
            1,166,592 shares of Purchaser Common Stock have been granted and are currently outstanding pursuant to the terms of the Victory Square Media Inc. Amended and Restated Stock Option Plan. The items in clauses (a), (b) and (c) are referred to
            collectively as &#8220;<u>Purchaser Securities</u>&#8221;.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993126"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except for (i) the rights set forth in each of the Amended and Restated Stockholders
            Agreement and the Registration Agreement and (ii) the Purchaser Securities and rights described in <u>Sections 5.5(a)</u>, <u>5.5(b)</u> and <u>5.5(c)</u>, as of the date hereof, there are (i) no outstanding shares of capital stock of, or
            other equity or voting interests in, Purchaser, (ii) no outstanding securities of Purchaser are convertible into or exchangeable for shares of capital stock of, or other equity or voting interests in, Purchaser, and (iii) no outstanding
            options, warrants, rights or other commitments or agreements to acquire from Purchaser, or that obligate Purchaser to issue or register, or that restrict the transfer or voting of, any shares of capital stock of, or other equity or voting
            interests in, or any securities convertible into or exchangeable for shares of capital stock of, or other equity or voting interests in, Purchaser, (iv) no obligations or Purchaser to grant, extend or enter into any subscription, warrant,
            right, convertible or exchangeable security or other similar agreement or commitment relating to any shares of capital stock of, or other equity or voting interests (including any voting debt) in, Purchaser (the items in clauses (i), (ii),
            (iii) and (iv), together with the shares of capital stock of Purchaser, being referred to collectively as &#8220;<u>Purchaser Securities</u>&#8221;) and (v) no other obligations by Purchaser to make any payments based on the price or value of any Purchaser
            Securities or dividends paid thereon or revenues, earnings or financial performance or any other attribute of Purchaser. There are no outstanding agreements of any kind which obligate Purchaser to repurchase, redeem or otherwise acquire any
            Purchaser Securities, or obligate the Company to grant, extend or enter into any such agreements, and Purchaser does not have any outstanding bonds, debentures, notes or other obligations, the holders of which have the right to vote with the
            holders of Purchaser Common Stock on any matter.&#160; No direct or indirect Subsidiary of Purchaser owns any Purchaser Securities.&#160; All outstanding Purchaser Securities have been duly authorized and validly issued.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref426732381"></a><a name="z_Ref183993127"></a><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Purchaser has and will keep available for issuance pursuant to
            the terms of this Agreement a number of shares of Purchaser Common Stock equal to the Stock Consideration, as may be adjusted pursuant to <u>Section 2.7</u>.&#160; All shares of Purchaser Common Stock issued as Stock Consideration pursuant to <u>Section






              2.3</u> will be duly authorized, validly issued, nonassessable and free of preemptive rights.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc183565448"></a><a name="z_Ref183993128"></a><a name="z_Ref184009352"></a><a name="z_Ref184015964"></a><a name="z_Toc186369723"></a><font style="color: rgb(0, 0, 0);">5.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Legal Proceedings.</u>&#160; Except as would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect, as of the date of this Agreement, (a) there is no pending or, to
            the Knowledge of Purchaser, threatened, legal or administrative Action against Purchaser and/or any of its properties, assets or businesses, by or before any Governmental Authority and (b) Purchaser is not subject to any outstanding Order.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref371965418"></a><a name="z_Ref371966866"></a><a name="z_Toc183565449"></a><a name="z_Toc186369724"></a><font style="color: rgb(0, 0, 0);">5.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compliance






              With Laws.</u>&#160; Except for such non-compliance as would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect, Purchaser is in compliance with all Laws applicable to Purchaser.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-48-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc183200235"></a><a name="z_Toc186369725"></a><font style="color: rgb(0, 0, 0);">5.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Purchaser Financial Statements; No Undisclosed Liabilities.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_9kR3WTr2999JJINrPOfv2y4OX1"></a><a name="z_9kR3WTr2AA79BdLcszv1NWysy47tcT274KlVHC6"></a><a name="z_Ref101659180"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Section







              5.8(a)</u> of Purchaser Disclosure Schedule sets forth the unaudited consolidated balance sheets of Purchaser and its consolidated Subsidiaries as at September 30, 2024 and the related audited consolidated statements of operations,
            comprehensive loss, stockholders&#8217; equity and <a name="z_9kMH6N6ZWu5777ABM4rz"></a>cash flows of Purchaser and its consolidated Subsidiaries for each of the fiscal year ended December 31, 2023 (collectively, the &#8220;<u>Purchaser </u><a name="z_9kMH1I6ZWu5DD9BHWFunornmqjm127124KQ"></a><u>Financial Statements</u>&#8221;).&#160; <a name="z_9kMHG5YVt4CC8HNjRjIHwpqtposlo349346MS"></a>The Purchaser Financial Statements have been prepared in all material respects in accordance with GAAP
            consistently applied during the periods involved and fairly present, in all material respects, the consolidated financial position and the results of operations of Purchaser and its consolidated Subsidiaries at the dates, and for the periods,
            presented therein (except as otherwise disclosed in the notes therein).<a name="z_9kR3WTr2999JKJNsLT0rtvXNw1yEGF2zOQ83IT3"></a><a name="z_Ref60979383"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;None of Purchaser or any of its Subsidiaries has any Liabilities which would be required
              to be reflected or reserved against on a consolidated balance sheet of Purchaser prepared in accordance with GAAP or the notes thereto, except <a name="z_9kMJ8N6ZWu57778IeLhbkvw5M"></a>liabilities (i) reflected or reserved against on the
              audited consolidated balance sheet of Purchaser and its consolidated Subsidiaries included in Purchaser <a name="z_9kMH2J6ZWu5DD9BHWFunornmqjm127124KQ"></a>Financial Statements, (ii) incurred after September 30, 2024 in the ordinary course
              of business, (iii) as contemplated by this Agreement or otherwise in connection with the transactions contemplated hereby, (iv) as set forth on <u>Section </u><a name="z_9kMHG5YVt4BBBLMLPuNV2tvxZPy30GIH41QSA5K"></a><u>5.8(a)</u> of
              Purchaser<a name="z_9kMHG5YVt4CC8EIdGpur7YI4zt6ELL6ibx0xEN8"></a> Disclosure Schedule or (v) as would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref284605862"></a><a name="z_9kR3WTr2887DJOQkXx5zsr3"></a><a name="z_Toc183565450"></a><a name="z_Toc186369726"></a><font style="color: rgb(0, 0, 0);">5.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;






            <u>Solvency.</u>&#160; Immediately after giving effect to the transactions contemplated by this Agreement, Purchaser, the Company and each of their respective Subsidiaries shall be Solvent.&#160; No transfer of property is being made and no obligation is
            being incurred in connection with the transactions contemplated by this Agreement with the intent to hinder, delay or defraud either present or future creditors of the Company or the Company&#8217;s Subsidiaries.&#160; For purposes of this Agreement, &#8220;<a name="z_9kR3WTr19A45CfVv3xq6"></a>Solvent&#8221; when used with respect to any Person, means that, as of any date of determination, (a) the Present Fair Salable Value of its assets will, as of such date, exceed all of its Liabilities, contingent or
            otherwise, as of such date, (b) such Person will not have, or have access to, as of such date, an unreasonably small amount of capital for the business in which it is engaged or will be engaged and (c) such Person will be able to pay its debts
            as they become absolute and mature, in the ordinary course of business, taking into account the timing of and amounts of <a name="z_9kMH8P6ZWu5777ABM4rz"></a>cash to be received by it and the timing of and amounts of <a name="z_9kMI0G6ZWu5777ABM4rz"></a>cash to be payable on or in respect of its <a name="z_9kMHG5YVt4666BCRMogfvzkuw2H"></a>indebtedness, in each case, after giving effect to the transactions contemplated by this Agreement.&#160; The term &#8220;Solvency&#8221;
            shall have a correlative meaning.&#160; For purposes of the definition of &#8220;<a name="z_9kMHG5YVt3BC67EhXx5zs8"></a>Solvent&#8221; (i) &#8220;<a name="z_9kR3WTr23349Blcbr"></a>debt&#8221; means Liability on a &#8220;claim&#8221; and (ii) &#8220;<a name="z_9kR3WTr23349Clihfs"></a>claim&#8221;
            means (A) any right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, secured or unsecured or (B) the right to an equitable remedy for a breach
            in performance if such breach gives rise to a right to payment, whether or not such equitable remedy is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or
            unsecured.&#160; &#8220;Present Fair Salable Value&#8221; means the amount that may be realized if the aggregate assets of such Person (including goodwill) are sold as an entirety with reasonable promptness in an arm&#8217;s length transaction under present
            conditions for the sale of comparable business enterprises.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref62853435"></a><a name="z_Toc183565451"></a><a name="z_Toc186369727"></a><font style="color: rgb(0, 0, 0);">5.10</font>&#160;&#160;&#160;&#160;&#160; <u>Investment Representation.</u>&#160;
            Purchaser is acquiring the Company Units for its own account with the present intention of holding such <a name="z_9kMJ1G6ZWu57779EgOfwC145r2"></a>securities for investment purposes and not with a view to, or for sale in connection with, any
            distribution of such <a name="z_9kMJ2H6ZWu57779EgOfwC145r2"></a>securities in violation of any federal, state or provincial <a name="z_9kMJ3I6ZWu57779EgOfwC145r2"></a>securities laws.&#160; Purchaser is an &#8220;accredited investor&#8221; as defined in <a name="z_9kR3WTr27779CdKgx3kt2y4U"></a>Regulation D promulgated by the SEC under the <a name="z_9kMHG5YVt4998EJhNevB034q1YD3"></a>Securities Act.&#160; Purchaser acknowledges that it is informed as to the risks of the transactions contemplated
            hereby and of ownership of the Company Units.&#160; Purchaser acknowledges that the Company Units have not been registered under the <a name="z_9kMIH5YVt4998EJhNevB034q1YD3"></a>Securities Act, or any state, provincial or foreign <a name="z_9kMJ4J6ZWu57779EgOfwC145r2"></a>securities laws and that the Company Units may not be sold, transferred, offered for sale, pledged, hypothecated or otherwise disposed of unless such transfer, sale, assignment, pledge, hypothecation or
            other disposition is pursuant to the terms of an effective registration statement under the <a name="z_9kMJI5YVt4998EJhNevB034q1YD3"></a>Securities Act and the Company Units are registered under any applicable state, provincial or foreign <a name="z_9kMJ5K6ZWu57779EgOfwC145r2"></a>securities laws or sold pursuant to an exemption from registration under the <a name="z_9kMKJ5YVt4998EJhNevB034q1YD3"></a>Securities Act and any applicable state, provincial or foreign <a name="z_9kMJ6L6ZWu57779EgOfwC145r2"></a>securities laws.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-49-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref101676858"></a><a name="z_Toc183565452"></a><a name="z_Toc186369728"></a><font style="color: rgb(0, 0, 0);">5.11</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Brokers and Other Advisors.</u>&#160;
            Purchaser has not employed any investment banker, broker or finder or incurred any liability for any investment banking fees, brokerage fees, commissions or finders&#8217; fees in connection with the transactions contemplated by this Agreement.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref325536435"></a><a name="z_Toc183565453"></a><a name="z_Toc186369729"></a><font style="color: rgb(0, 0, 0);">5.12</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Prior Agreements.</u>&#160; There
            are no Contracts between Purchaser or any of its Affiliates, on the one hand, and any member of the management, directors or <a name="z_9kMIH5YVt4666AGSL811I7y3tn2H"></a>equityholders of the Company or any of the its Subsidiaries, on the other
            hand, as of the date hereof, that relate in any way to the Company or any of the Company&#8217;s Subsidiaries or the transactions contemplated <a name="z_Ref183993129"></a>hereby.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009353"></a><a name="z_Toc186369730"></a><font style="color: rgb(0, 0, 0);">5.13</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Other Representations.</u> Except in the case of Fraud,
            in entering into this Agreement, Seller has relied solely upon the representations and warranties of Purchaser set forth in Article V (in each case, as modified by the Disclosure Schedules), and Seller acknowledges and agrees that, except for
            the representations and warranties of Purchaser set forth in Article V (in each case, as modified by the Disclosure Schedules) and in any certificate delivered pursuant hereto, none of Purchaser, Purchaser&#8217;s Affiliates nor any of their
            respective Representatives nor any other Person acting on Purchaser&#8217;s behalf makes or has made, and Seller is not relying on and has not relied on, any representation or warranty, either express or implied, with respect to Purchaser, its
            business or the transactions contemplated hereby.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;"><a name="z_Ref101674942"></a><a name="z_Toc183565454"></a>ARTICLE VI</div>
          <div style="text-align: center; font-size: 10pt;"><a name="z_Ref184009354"></a><a name="z_Toc186369731"></a><u>COVENANTS</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref60977945"></a><a name="z_Ref60977951"></a><a name="z_Ref60977963"></a><a name="z_Toc183565460"></a><a name="z_Toc186369732"></a><a name="z_Ref284596149"></a><a name="z_Ref284596400"></a><a name="z_Ref284597659"></a><a name="z_Ref291869501"></a><a name="z_Ref324174408"></a><a name="z_Ref327367631"></a><font style="color: rgb(0, 0, 0);">6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification, Exculpation and
              Insurance.</u><a name="z_Ref284606016"></a><a name="z_Ref371966836"></a><a name="z_Ref374952219"></a><a name="z_Ref374952255"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184010750"></a><a name="z_Ref61671793"></a><a name="z_Ref183993157"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;From and after the Closing Date,
            Purchaser shall, and shall cause the Company and its Subsidiaries to, continue to indemnify, defend and hold harmless, to the fullest extent permitted under applicable Law, the individuals who on or prior to the Closing Date were directors or
            officers of any of the Company or any of the Company&#8217;s Subsidiaries (collectively, the &#8220;<u>Indemnitees</u>&#8221;) with respect to all acts or omissions by them in their capacities as such or taken at the request of any of the Company or any of the
            Company&#8217;s Subsidiaries at any time on or prior to the Closing Date.&#160; Purchaser agrees that all rights of the Indemnitees to advancement of expenses, indemnification and exculpation from Liabilities for acts or omissions occurring on or prior to
            the Closing Date as provided in the certificate of limited partnership, certificate of formation, certificate of incorporation, limited partnership agreement, limited liability company agreement or bylaws (or comparable organizational
            documents) of any of the Company and any of the Company&#8217;s Subsidiaries, in each case, as now in effect, and any <a name="z_9kR3WTr2AA7A9qqmeoyvopngy739wq87v457NTP"></a>indemnification <a name="z_9kMN6H6ZWu57778GR8wvjstvB"></a>agreements of
            any of the Company or any of the Company&#8217;s Subsidiaries shall survive the Closing Date and shall continue in full force and effect in accordance with their terms.&#160; Such rights shall not be amended or otherwise modified in any manner that would
            adversely affect the rights of any of the Indemnitees, unless such modification is required by Law or approved by each such Indemnitee. In addition, Purchaser shall, or shall cause the Company and their respective Subsidiaries, as the case may
            be, to advance, pay and/or reimburse any expenses of any Indemnitee under this <u>Section 6.1</u> as incurred to the fullest extent permitted under applicable Law; <u>provided</u>, that the person to whom expenses are advanced provides an
            undertaking to repay such advances to the extent required by applicable Law.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-50-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993158"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Purchaser, from and after the Closing Date, shall cause (i) the limited liability company
            agreement (or comparable organizational documents) of the Company to contain provisions no less favorable to the Indemnitees with respect to limitation of Liabilities, advancement of expenses and indemnification than are set forth as of the
            date of this Agreement in each such document of the Company, and (ii) the certificate of limited partnership, certificate of formation, certificate of incorporation, limited partnership agreement, limited liability company agreement and bylaws
            (or comparable organizational documents) of each Subsidiary of the Company to contain provisions no less favorable with respect to limitation of Liability, advancement of expenses and indemnification of partners, members, directors, officers,
            employees and agents, than are set forth in each such document as of the date of this Agreement.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref376467662"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each of Purchaser and the Company shall cooperate, and cause their respective Affiliates to
            cooperate, in the defense of any claim that is subject to the limitation of Liability, advancement of expenses and/or indemnification as contemplated by this <u>Section 6.1</u> and shall provide access to properties and individuals as
            reasonably requested and furnish or cause to be furnished records, information and testimony, and attend such conferences, discovery proceedings, hearings, trials or appeals, as may be reasonably requested in connection therewith.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref284606079"></a><a name="z_Ref371972209"></a><a name="z_Ref371972436"></a><a name="z_Ref376179037"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Seller
            shall, and shall cause its Affiliates to, provide or maintain in effect for six (6) years from and after the Closing Date, directors&#8217; and officers&#8217; and company Liability insurance covering those individuals who are covered by the current
            directors&#8217; and officers&#8217; and company Liability <a name="z_9kMHG5YVt4666BFUM3BBspskYd61tux8"></a>insurance policy (the &#8220;<u>Existing Policy</u>&#8221;) on terms comparable in all respects to the Existing Policy and such coverage shall contain minimum
            aggregate limits of Liability for directors&#8217; and officers&#8217; and company Liability insurance coverage for directors and officers of the Company and the Company&#8217;s Subsidiaries with the amount of coverage at least equal to that of the Existing
            Policy and deductibles and/or retentions no larger than those of the Existing Policy. Seller shall cause any subsequent purchaser to maintain the directors&#8217; and officers&#8217; liability coverage in the event it is sold prior to the end of such six
            (6)-year period, or shall purchase a D&amp;O tail policy for such remaining period. Seller shall reasonably cooperate with Purchaser in and use commercially reasonable efforts to pursue the collection of all insurance proceeds in respect of
            claims made by Purchaser under the Existing Policy or any subsequently purchased tail policy. Seller shall use commercially reasonable efforts to make Purchaser a third-party beneficiary of the Existing Policy until the expiration of the six
            (6)-year period such that Purchaser is able to notice and pursue claims against the Existing Policy for its indemnification of any of the directors and officers of the Company and the Company&#8217;s Subsidiaries for pre-Closing acts, errors or
            omissions made after Closing.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61672829"></a><a name="z_Ref284839065"></a><a name="z_Ref61671940"></a><a name="z_Ref183993160"></a><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The
            obligations of Purchaser and the Company under this <u>Section 6.1</u> shall not be terminated or modified in such a manner as to adversely affect any Indemnitee to whom this <u>Section 6.1</u> applies without the consent of each affected
            Indemnitee (it being expressly agreed that the Indemnitees to whom this <u>Section 6.1</u> applies shall be third party beneficiaries of this <u>Section 6.1</u>).&#160; The provisions of this <u>Section 6.1</u> (i) are intended to be for the
            benefit of, and shall be enforceable by, each Indemnitee, his, her or its heirs and his or her <a name="z_9kMJI5YVt4666AJiMr5vxyuAyz8B8"></a>representatives and (ii) are in addition to, and not in substitution for, any other rights to
            indemnification or contribution that any such Person may have by Law, Contract or otherwise.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61671995"></a><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that any of the Company or any of its successors or assigns (i) consolidates or
            merges with or into any other Person and is not the continuing or surviving entity of such consolidation or <a name="z_9kMH6N6ZWu57779BXIuxlxC"></a>merger or (ii) transfers or conveys all or substantially all of its properties and assets to
            any Person, then, and in each such case, proper provision shall be made by Purchaser and such Company so that the successors and assigns of such Company shall assume all of the obligations thereof set forth in this <u>Section 6.1</u>.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61671890"></a><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Nothing in this Agreement is intended to, shall be construed to or shall release, waive or
            impair any rights to directors&#8217; and officers&#8217; insurance claims under any policy that is or has been in existence with respect to any of the Company or any of the Company&#8217;s Subsidiaries or any of their respective directors or officers, it being
            understood and agreed that the indemnification provided for in this <u>Section 6.1</u> is not prior to or in substitution for any such claims under such policies.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-51-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref284840412"></a><a name="z_Toc183565461"></a><a name="z_Toc186369733"></a><font style="color: rgb(0, 0, 0);">6.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Preservation of Records.</u>&#160;
            Purchaser shall, and shall cause the Company and its Subsidiaries to, preserve and keep the records held by them relating to the respective businesses of the Company and the Company&#8217;s Subsidiaries for a period of seven (7) years from and after
            the Closing Date (or longer if required by applicable Law) and shall make such records (or copies) and officers, management, employees, advisors and Representatives available, at reasonable times and upon reasonable advance notice, to Seller or
            any of its Affiliates and/or Representatives as may be reasonably requested by such Person in connection with any insurance claims by, Actions or Tax audits with respect to Pre-Closing Tax Periods against, governmental investigations of,
            compliance with legal requirements by, or the preparation of <a name="z_9kMML5YVt46669ESEtmnqmlpil016013JP"></a><a name="z_9kR3WTr2AA7AAoirklokjn6Fyz4yz1HNJJzdE6i"></a>financial statements or Tax Returns of, any Equityholder or any of their
            respective Affiliates and/or otherwise in connection with any other matter relating to or resulting from this Agreement.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref374962412"></a><a name="z_Toc183565462"></a><a name="z_Toc186369734"></a><a name="z_Ref284595234"></a><a name="z_Ref327367013"></a><font style="color: rgb(0, 0, 0);">6.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Publicity; Confidentiality.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref183993161"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; None of Seller or the Company, on the one hand, or Purchaser, on the other hand, shall issue
            any press release or public announcement or comment concerning this Agreement or the transactions contemplated hereby (except any press release, announcement or comment made in connection with any disclosure made pursuant to, and subject to the
            terms of, <u>Section 6.3(b)</u>) without obtaining the prior written approval of Purchaser or Seller, unless and only to the extent, in the judgment of such party upon the advice of its outside <a name="z_9kMML5YVt4666AFPH665xr"></a>counsel,
            disclosure is required by applicable Law (including the periodic and current reporting requirements under the <a name="z_9kMHG5YVt4998DJUSxihovnIB1"></a>Exchange Act) or under the rules of any <a name="z_9kMJAP6ZWu57779EgOfwC145r2"></a>securities






            exchange on which the <a name="z_9kMK2G6ZWu57779EgOfwC145r2"></a>securities of such party or any of its Affiliates are listed; <u>provided</u>, that to the extent so required by applicable Law, the party intending to make such release shall
            use its commercially reasonable efforts consistent with applicable Law to consult with the other parties in advance of such release with respect to the text thereof.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref284596508"></a><a name="z_Ref326083838"></a><a name="z_Ref326085461"></a><a name="z_Ref184009356"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each
            of Purchaser, Seller and the Company agrees that this Agreement and the Transition Services Agreement and the terms and conditions set forth herein and therein shall be kept confidential and shall not be disclosed or otherwise made available to
            any other Person and that copies of this Agreement and the Transition Services Agreement shall not be publicly filed or otherwise made available to the public, except (i) disclosure by Seller or its Affiliates as required by their respective
            credit agreements or other third-party debt documents and arrangements, (ii) where such disclosure, availability or filing, upon the advice of outside <a name="z_9kMNM5YVt4666AFPH665xr"></a>counsel, is required by applicable Law (including the
            periodic and current reporting requirements under the <a name="z_9kMIH5YVt4998DJUSxihovnIB1"></a>Exchange Act) and only to the extent required by such Law or under the rules of any <a name="z_9kMK3H6ZWu57779EgOfwC145r2"></a>securities
            exchange on which the <a name="z_9kMK4I6ZWu57779EgOfwC145r2"></a>securities of each Seller, Purchaser, the Company, or any Equityholder or their applicable Affiliates are listed, (iii) disclosure by such Persons of customary information to
            investors or potential investors or to their respective Affiliates who are subject to customary confidentiality obligations, (iv) disclosure by Seller or the Company to the Equityholders, (v) as otherwise agreed by each of Purchaser and Seller
            and (vi) disclosure in connection with the current report on Form 8-K filed with the SEC on or around the date of this Agreement.&#160; In the event that any such disclosure, availability or filing is required by applicable Law (including any filing
            required by the <a name="z_9kMJI5YVt4998DJUSxihovnIB1"></a>Exchange Act or the <a name="z_9kMLK5YVt4998EJhNevB034q1YD3"></a>Securities Act), each party agrees to use its commercially reasonable efforts to (x) give the other party a reasonable
            opportunity to review and comment on any such disclosure, availability or filing each time before any such document is filed and give reasonable and good faith consideration to any comments made by such party and its counsel and (y) obtain
            &#8220;confidential treatment&#8221; or similar treatment of this Agreement and to redact such terms of this Agreement and the Transition Services Agreement that either the Company (prior to the Closing) or Seller (at and after the Closing), in the case of
            Purchaser, or Purchaser, in the case of the Company and Seller, shall reasonably request (at the expense of the requesting party).<a name="z_Ref376465873"></a><a name="z_Ref284596475"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-52-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref325478378"></a><a name="z_Toc183565464"></a><a name="z_Toc186369735"></a><font style="color: rgb(0, 0, 0);">6.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Insurance Matters</u><u>.</u> <a name="z_Ref101708882"></a>Purchaser acknowledges that the policies and insurance coverage maintained on behalf of the Company and its Subsidiaries are part of the corporate insurance program maintained by Seller (the &#8220;<u>Seller Corporate
              Policies</u>&#8221;), and such coverage will not be available to the Purchaser Group for any matters arising from events that occur or are alleged to have occurred after the Closing, or transferred to the Purchaser Group. In furtherance and not in
            limitation of the foregoing, Purchaser agrees, on behalf of itself and the Purchaser Group, (i) not to bring any claim for recovery under any of Seller Corporate Policies, whether or not the Purchaser Group may be so entitled in accordance with
            the terms of such Seller Corporate Policies, for any matters arising from events that occur or are alleged to have occurred after the Closing and (ii) that it will be responsible for obtaining any and all insurance coverage for the Company and
            its Subsidiaries or claims that arise on or after the Closing.&#160; Notwithstanding the foregoing, Seller shall reasonably cooperate with Purchaser on any claim for coverage by or on behalf of Purchaser with respect to the Company and its
            Subsidiaries under Seller Corporate Policies with respect to Third-Party Claims arising from events that occurred or were alleged to have occurred prior to the Closing (&#8220;<u>Pre-Closing Occurrences</u>&#8221;).&#160; Seller shall not take any action to
            exclude or remove the Company or any of its Subsidiaries from coverage that may be available under any such Seller Corporate Policies with respect to Pre-Closing Occurrences.&#160; Seller shall reasonably cooperate with Purchaser in and use
            commercially reasonable efforts to pursue the collection of all insurance proceeds in respect of claims made by Purchaser with respect to Pre-Closing Occurrences.&#160; This <u>Section 6.4</u> shall not be considered as an attempted assignment of
            any policy of insurance or as a Contract of insurance, and nothing in this Section 6.4 is intended to waive or abrogate in any way Seller&#8217;s rights to insurance under Seller Corporate Policies.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc186369736"></a><font style="color: rgb(0, 0, 0);">6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Employee Benefits</u><font style="font-style: italic;">.&#160; </font>Purchaser shall, or
            shall cause the Company to, honor and assume all obligations under the annual bonus and commission plans or programs in effect for the fiscal year in which the Closing Date occurs, and shall pay such bonuses in the amounts and the times
            required by such plans or program.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref61646127"></a><a name="z_Toc183565465"></a><a name="z_Toc184729448"></a><a name="z_Toc186369737"></a><font style="color: rgb(0, 0, 0);">6.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>R&amp;W






              Insurance Policy.</u>&#160; <a name="z_Toc63963313"></a><a name="z_Ref509497820"></a>The R&amp;W Insurance Policy shall expressly provide that the Insurer thereunder irrevocably waives all claims (including with respect to subrogation,
            contribution or otherwise) against Seller and its Affiliates and any director, officer, employee, partner, representative or advisor thereof other than in respect of Fraud by the party against whom recourse is sought and Seller and its
            Affiliates and any director, officer, employee, partner, representative or advisor thereof are third-party beneficiaries of such waiver.&#160; Such waiver of claims under the R&amp;W Insurance Policy may not be amended or waived by Purchaser in any
            manner adverse to Seller and its Affiliates or any director, officer, employee, partner, representative or advisor thereof.&#160; Purchaser shall provide a copy of the bound R&amp;W Insurance Policy to Seller upon receipt.&#160; Each of Purchaser and
            Seller shall bear fifty percent (50%) of all costs and expenses of obtaining and binding the R&amp;W Insurance Policy (which, for the avoidance of doubt, shall include the policy premiums, underwriting fees, taxes and any fees of the insurance
            broker).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc186369738"></a><font style="color: rgb(0, 0, 0);">6.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Intercompany Agreements and Arrangements.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref101707766"></a><a name="z_Ref184653899"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as expressly set forth in <u>Section 6.3(b)</u>, the
            parties acknowledge and agree that all Intercompany Agreements, and all rights and obligations of the Business, the Company and its Subsidiaries, and Seller Group under such Intercompany Agreements will be terminated at or prior to the Closing
            and shall be of no further force or effect after the Closing.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref101707725"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of <u>Section 6.3(a)</u> shall not apply to any of the following Contracts
            (or to any of the provisions thereof):</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-53-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; this Agreement, the Transition Services Agreement, the Commercial Services
              Agreement or any other Contract, document, certificate or instrument contemplated hereby to be executed and delivered by the parties or their affiliates in connection with the transactions contemplated hereby; and</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; the Intercompany Agreements listed on <u>Section 6.3(b)</u> of the
              Company Disclosure Schedule.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref102143990"></a><a name="z_Toc183565468"></a><a name="z_Toc186369739"></a><font style="color: rgb(0, 0, 0);">6.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Use of Seller Names/Transferred
              IP.</u>&#160; Purchaser and its Affiliates shall cease using or permitting others to use Seller Names within ninety (90) days of the Closing, except (i) in a neutral, non-trademark manner to describe the history of the business of the Company and
            (ii) in internal Tax, legal, business, employment or similar records. Notwithstanding the foregoing, Purchaser and its Affiliates will have no obligation to remove any Seller Names from any previously published press releases, blog posts or
            other similar media.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref101678973"></a><a name="z_Toc183565469"></a><a name="z_Toc186369740"></a><font style="color: rgb(0, 0, 0);">6.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transition Services Agreement.</u>&#160;
            <a name="z_9kMLK5YVt4CC8DITNss5BYD10oxy0GM"></a>At the Closing, each of Purchaser, Seller and the Company shall duly execute and deliver to the other, the Transition Services Agreement in the form attached hereto as Exhibit D (the &#8220;Transition
            Services Agreement&#8221;).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref186285378"></a><a name="z_Toc186369741"></a><font style="color: rgb(0, 0, 0);">6.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Section 280G</u><font style="font-style: italic;">. </font>
            To the extent any payments made with respect to, or which arise as a result of, this Agreement, could be characterized as an &#8220;excess parachute payment&#8221; within the meaning of Section 280G(b)(1) of the Code, the Company has (a) disclosed its
            calculations with respect to the excess parachute payments to Purchaser, along with the assumptions used to make the calculations and the data necessary for Purchaser to confirm the accuracy of the calculations, (b) obtained the consent of the
            recipient of any such payment that would otherwise be due and owing that such payment shall not be due and owing, paid or retained, absent 280G Stockholder Approval (as defined below) and (c) caused all such payments to be adequately disclosed
            to, and obtained the vote (whether of approval or disapproval) and use commercially reasonable efforts to have all such payments approved by a vote of, the Stockholders meeting the requirements of the Code and the applicable treasury
            regulations (&#8220;<u>280G Stockholder Approval</u>&#8221;), in a manner reasonably satisfactory to Purchaser.&#160; Purchaser shall have the right to review and comment before such consent or disclosure was distributed.&#160; The Company shall not pay any amount
            that could be characterized as an &#8220;excess parachute payment&#8221; to the extent that it was unable to obtain the shareholder approval described in clause (c).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc184019167"></a><a name="z_Toc184019168"></a><a name="z_Toc183565471"></a><a name="z_Ref183993168"></a><a name="z_Ref184009357"></a><a name="z_Toc186369742"></a><font style="color: rgb(0, 0, 0);">6.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Wrong Pockets.</u>&#160; To the extent that, during the twenty-four (24) months following the date hereof, Purchaser or Seller discover that (a) any asset and/or liability that was intended by
            the parties to be held by Purchaser was not properly transferred, directly or indirectly, to Purchaser pursuant to this Agreement, Seller shall cause such asset and/or liability to be promptly assigned and shall transfer all right, title and
            interest in such asset and/or liability to Purchaser for no additional consideration, or (b) any asset and/or liability of the NUS Business that was intended by the parties to be retained by Seller was transferred, directly or indirectly, to
            Purchaser pursuant to this Agreement, Purchaser shall cause such asset and/or liability to be promptly assigned and shall transfer all right, title and interest in such asset and/or liability to Seller, in each case for no additional
            consideration.&#160; In addition, if (i) Seller or any of its Affiliates following the date hereof receives any payments in respect of the Business, including as a result of the settlement of accounts receivable or otherwise, Seller shall promptly
            remit (or cause to be remitted) the amount of such payments to Purchaser and (ii) Purchaser or any of its Subsidiaries following the date hereof receives any payments in respect of the NUS Business, including as a result of the settlement of
            accounts receivable or otherwise, Purchaser shall promptly remit (or cause to be remitted) the amount of such payments to Seller.<a name="z_Ref425309980"></a><a name="z_Ref425310219"></a><a name="z_Ref425310766"></a><a name="z_Ref425313530"></a><a name="z_Toc183565472"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009358"></a><a name="z_Ref61645649"></a></div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-54-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">6.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Tax Matters.</u></font></div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><font style="color: rgb(0, 0, 0);"> <br>
            </font></div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transfer Taxes</u>. All state and local transfer, sales, documentary, filing,
              recordation, use, stamp, registration or other similar Taxes and fees resulting from the transactions contemplated by this Agreement (&#8220;<u>Transfer Taxes</u>&#8221;) shall be borne and paid fifty percent (50%) by Purchaser and fifty percent (50%) by
              Seller.&#160; The party legally responsible for doing so will file all necessary Tax Returns and other documentation with respect to all such Transfer Taxes, and the other party will cooperate with respect to the filing of such Tax Returns and
              other documentation and the payment of such Transfer Taxes and, if required by law, shall join or cause its Affiliates to join in the execution of any such Tax Returns and other documentation.<a name="z_Ref183993169"></a></font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009360"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Cooperation on Tax Matters</u>. Purchaser, Seller, and the Company shall cooperate fully,
            as and to the extent reasonably requested by the other party, in connection with the preparation and filing of Tax Returns with respect to Pre-Closing Tax Periods.&#160; Such cooperation shall include the retention and (upon the other party&#8217;s
            request) the provision of records and information which are reasonably relevant to any such audit, litigation or other proceeding and making employees available on a mutually convenient basis to provide additional information and explanation of
            any material provided hereunder.&#160; Purchaser, Seller and the Company shall (i) retain all books and records with respect to Tax matters pertinent to the Company relating to any Taxable Period beginning before the Closing Date until the
            expiration of the applicable statute of limitations (and, to the extent notified by Purchaser or Seller, any extensions thereof) of the respective Taxable Periods, and abide by all record retention agreements entered into with any Taxing
            authority and (ii) give the other party reasonable written notice prior to transferring, destroying or discarding any such books and records and, if the other party so requests, Purchaser or Seller, as the case may be, shall allow the other
            party to take possession of such books and records.<a name="z_Ref183993170"></a> Notwithstanding anything to the contrary contained in this Agreement, under no circumstances shall Seller or its Affiliates be obligated to furnish or provide to
            Purchaser or its Affiliates or agents any Tax Returns of a Seller Consolidated Group.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009364"></a><a name="z_Ref184009365"></a><a name="z_Ref183993174"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Tax Actions</u>. Except as
            otherwise required by applicable Law or as specifically set forth in this Agreement or the Disclosure Schedules, none of Purchaser or the Company or any Affiliates thereof shall, without the prior written consent of Seller (not to be
            unreasonably withheld, conditioned or delayed) (i) amend, refile or otherwise modify or make any material election with respect to (or grant an extension of any statute of limitations with respect to) any Tax Return relating in whole or in part
            to the Company or any of its Subsidiaries with respect to any Pre-Closing Tax Period (including, for the avoidance of doubt, any Straddle Periods), (ii) make or change any material Tax election or take any other material Tax action with respect
            to the Company or any of its Subsidiaries that has retroactive effect and would affect Seller, or (iii) take any other action after the Closing outside the ordinary course of business and not otherwise contemplated by this Agreement, in each
            case, if such action&#160; could reasonably be expected to result in an increase in the Tax Liabilities of the Company and its Subsidiaries taken into account in determining the Final Cash Purchase Price, as finally determined or (z) could
            reasonably be expected to reduce any amount of Tax refunds to which Seller is entitled pursuant to <u>Section 6.8(h)</u>.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009774"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Allocation.</u> The parties acknowledge and agree that for income tax purposes, including
            Code Section 1060 and the Treasury Regulations promulgated thereunder, 100% of the Final Cash Purchase Price, as finally determined pursuant to <u>Section 2.5</u>, shall be allocated to the capital stock of MyFavoriteThings, Inc. held by the
            Company.&#160; The parties shall file all Tax Returns consistent with such allocation and shall not take any action inconsistent therewith upon any audit or examination of any Tax Return or in any other filing or proceeding relating to Taxes unless
            otherwise required by a &#8220;determination,&#8221; as defined in Code Section 1313; <u>provided</u>, that the parties acknowledge that the Purchaser and its Affiliates (including the Company following the Closing) may use a different methodology for
            financial reporting purposes.<a name="z_Ref183513578"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-55-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009366"></a><a name="z_Ref184010333"></a><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Straddle Period Allocation.</u> In the case of any Straddle
            Period, (A) the amount of any Taxes based on or measured by income, receipts, sales, use or payroll of the Company or any of its Subsidiaries for the Pre-Closing Tax Period shall be determined based on an interim closing of the books as of the
            close of business on the Closing Date (and for such purpose, the taxable period of any partnership or other pass-through entity or any non-U.S. entity in which the Company holds a beneficial interest shall be deemed to terminate at such time);
            provided, that in determining such amount, exemptions, allowances or deductions that are calculated on a periodic basis, such as the deduction for depreciation, shall be taken into account on a pro-rated basis in the manner described in clause
            (B), and (B) the amount of other Taxes of the Company or any of its Subsidiaries for a Straddle Period that relates to the Pre-Closing Tax Period shall be deemed to be the amount of such Tax for the entire taxable period multiplied by a
            fraction the numerator of which is the number of days in the taxable period ending on and including the Closing Date and the denominator of which is the number of days in such Straddle Period.<a name="z_Ref183993175"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009367"></a><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Tax Sharing Agreements.</u>&#160; Any and all existing Tax sharing or similar agreements
            between the Company or any of its Subsidiaries, on the one hand, and any Affiliate of the Company or such Subsidiary, on the other hand, shall be terminated, and all payables and receivables arising thereunder shall be settled, in each case
            prior to the Closing Date such that after the Closing Date neither the Company nor any of its Subsidiaries shall be bound thereby or have any Liability thereunder.<a name="z_Ref183993176"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Intended Tax Treatment</u><font style="font-style: italic;">.&#160; </font>The parties
              intend that for U.S. federal (and applicable state and local) income Tax purposes; (i) immediately following the Restructuring, Seller shall be treated as a continuation of the Company tax partnership under Section 708(a) of the Code and (ii)
              Purchaser&#8217;s purchase of the Company Units is a taxable purchase by the Purchaser from Seller of each asset of the Company governed by Section 1001 of the Code.&#160; No party shall take any position contrary to this Section 6.11(g) for any
              applicable U.S. or state income Tax purposes absent a final &#8220;determination&#8221; (within the meaning of Section 1313 of the Code) to the contrary.<a name="z_Ref184009368"></a></font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref186286439"></a><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Specified Tax Refunds</u>.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except to the extent such refund (or credit for overpayment) of Taxes was
              included in the determination of Accrued Income Taxes or in Net Working Capital as a Tax asset, as finally determined, any Specified Tax Refunds shall be for the account of Seller.&#160; The amount of such refunds to which Seller is entitled shall
              be determined on a &#8220;with and without basis&#8221; solely taking into account the Relevant Items.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; As soon as practicable after the Closing Date, but in no event more than
              thirty (30) days after the Closing Date, Seller shall prepare or cause to be prepared and Purchaser shall timely file or shall cause the Company or its Subsidiaries to timely file (in each case, at Seller&#8217;s sole cost and expense) IRS Form
              4466 (Corporation Application for a Quick Refund) and any corresponding state or local tax form to claim a Quick Refund.&#160; Within twenty-five (25) Business Days of receipt of any such Quick Refund, Purchaser or its Affiliates (including, after
              the Closing, the Company and its Subsidiaries) will pay to Seller an amount equal to the amount of such refund by wire transfer of immediately available funds to an account designated by Seller (net of Taxes or any reasonable out-of-pocket
              costs and expenses of Purchaser, Company and their Affiliates related to claiming such refund) to Seller.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; To the extent that the Company or its Subsidiaries does not obtain such a
              Quick Refund, Purchaser or its Affiliates (including, after the Closing Date, the Company and its Subsidiaries) shall pay over to Seller any refund of Taxes attributable to the amount of the applicable overpayment within twenty-five (25)
              Business Days of receipt by wire transfer of immediately available funds to an account designated by Seller, and shall cooperate with Seller at Seller&#8217;s expense in good faith to diligently pursue any such refund in order to legally maximize
              and obtain any such refund.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-56-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; To the extent that the Company or its Subsidiaries are subsequently
              required by the applicable Taxing Authority to repay any Tax refund paid over to Seller pursuant to this <u>Section 6.8(h)</u>, then Seller shall, upon request by Purchaser, repay to Purchaser the amount it was paid over pursuant to this <u>Section






                6.8(h)</u> together with any applicable interest, penalties or other additional amounts imposed by such Taxing Authority, and Purchaser shall timely remit such amounts to the applicable Taxing Authority.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; Any payment of Tax refunds pursuant to this Section shall be treated as an
              adjustment to the Final Cash Purchase Price for U.S. federal and applicable state and local income tax purposes, except as otherwise required by applicable Tax Law.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref186285522"></a><a name="z_Toc186369744"></a><a name="z_Ref324176909"></a><font style="color: rgb(0, 0, 0);">6.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Company Valuation</u>.
            Notwithstanding anything in this Agreement to the contrary, the Parties agree to undertake those actions, subject to those terms and conditions, as set forth in Schedule 6.9 of the Purchaser Disclosure Schedule.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc186369745"></a><font style="color: rgb(0, 0, 0);">6.10</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Tax Contests</u>.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each Party shall notify each other promptly after acquiring written or other reasonably
              certain knowledge of any inquiry, claim, audit, assessment, proceeding or similar event with respect to any Taxes of the Company for a Pre-Closing Tax Period (any such inquiry, claim, audit, assessment, proceeding or similar event, a &#8220;<u>Tax
                Contest</u>&#8221;). Any failure to so notify the Seller Parties of any Tax Contest shall not relieve Seller Parties of any liability with respect to such Tax Contest except to the extent that such failure shall have materially prejudiced the
              defense of such Tax Contest.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Seller shall have the right, at its own expense and upon written notice addressed and
              delivered to Purchaser, to control the conduct of any Tax Contest that relates solely to a Pass-Through Return (other than any Tax Contest that relates to a Pass-Through Return of the Company or any Subsidiary for which a &#8220;push-out&#8221; election
              under Section 6226 of the Code is relevant and available under applicable law, but is not (or has not been) made by Purchaser, the Company or any Subsidiary, which such Tax Return shall be controlled by Purchaser pursuant to the provisions of
              <u>Section 6.10(c)</u>); <u>provided</u>, that that if such Tax Contest would reasonably be expected to result in material Taxes for which the Company or its Affiliates are liable (i) Seller shall keep Purchaser reasonably informed of the
              progress of such Tax Contest, (ii) Seller shall provide Buyer the opportunity to participate in the defense of such Tax Contest at Purchaser&#8217;s expense and (iii) Seller shall not settle or compromise such Tax Contest without Purchaser&#8217;s prior
              written consent, which consent shall not be unreasonably withheld, conditioned, or delayed.&#160; Notwithstanding anything to the contrary contained in this Agreement, under no circumstances shall Seller or its Affiliates be obligated to furnish
              or provide to Purchaser or its Affiliates or agents any Tax Returns of a Consolidated Group.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchaser shall control any other Tax Contest; <u>provided</u>, <u>however</u>, that,
              with respect to any Tax Contest including for the avoidance of doubt any Tax Contest that relates to a Pass-Through Return of the Company or any Subsidiary for which a &#8220;push-out&#8221; election under Section 6226 of the Code is relevant and
              available under applicable law, but is not (or has not been) made by Purchaser, the Company or any Subsidiary, <a name="z_Hlk186358090"></a>that would reasonably be expected to result in material Taxes for which Seller or its Affiliates or
              the Founders are liable, (i) Purchaser shall keep Seller reasonably informed of the progress of such Tax Contest, (ii) Purchaser shall provide Seller the opportunity to participate in the defense of such Tax Contest at Seller&#8217;s expense and
              (iii) Purchaser shall not settle or compromise such Tax Contest without Seller&#8217;s prior written consent, which consent shall not be unreasonably withheld, conditioned, or delayed. Notwithstanding anything to the contrary contained in this
              Agreement, under no circumstances shall Purchaser or its Affiliates be obligated to furnish or provide to Seller or its Affiliates or agents any Tax Returns other than with respect to the Company and its Subsidiaries.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-57-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event of any conflict between this Section 6.10 and Section 7.3, this Section 6.10
              shall control.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">6.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <u>Pre-Closing Termination</u>.&#160; Following the date hereof, Seller will continue to
              negotiate a separation agreement with the Terminated Individual.&#160; Once a separation agreement between Seller and the Terminated Individual has been executed and becomes irrevocable, Seller will deliver a copy of such separation agreement to
              Purchaser. Any severance payments that become payable to the Terminated Individual in accordance with the terms and conditions of such separation agreement will be processed through the Company&#8217;s payroll.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">ARTICLE VII</div>
          <div style="text-align: center; font-size: 10pt;"><a name="z_Ref101674259"></a><a name="z_Ref101674260"></a><a name="z_Ref101674649"></a><a name="z_Ref101674736"></a><a name="z_Ref101674787"></a><a name="z_Ref101674801"></a><a name="z_Ref101674829"></a><a name="z_Ref101674846"></a><a name="z_Ref101674870"></a><a name="z_Ref101674881"></a><a name="z_Ref101674893"></a><a name="z_Ref101674905"></a><a name="z_Ref101674996"></a><a name="z_Ref101675007"></a><a name="z_Toc183565482"></a><a name="z_Toc186369746"></a><u>NO SURVIVAL</u><a name="z_Toc183565483"></a><a name="z_Ref183993196"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009401"></a><a name="z_Toc186369747"></a><font style="color: rgb(0, 0, 0);">7.1</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>No Survival.</u>&#160; <a name="z_Ref20240893"></a><a name="z_Ref94535505"></a>The parties, intending to modify any applicable statute of limitations, acknowledge and agree that the representations, warranties, covenants and agreements of the parties contained in this Agreement or any other
            agreement or document executed in connection with this Agreement shall terminate at the Closing and shall not survive beyond the Closing and there shall be no liability in respect thereof, whether such liability has accrued prior to or after
            the Closing, on the part of any party, its Affiliates or any of their respective partners, members, officers, directors, agents or Representatives, except for (i) those covenants and agreements that by their terms apply or are to be performed
            in whole or in part (and if in part, then only to the extent to be performed) after the Closing, (ii) this <u>Article VII</u>, (iii) <u>Article VIII</u>, (iv) <u>Article IX</u> and (v) Liability for Fraud. The indemnification obligations of
            Seller with respect to claims pursuant to <u>Section 7.2(a)(ii)</u> and <u>Section 7.2(a)(iv)</u> shall remain in full force and effect until the date that is twelve (12) months following the Closing Date and the indemnification obligations
            of Seller with respect to claims pursuant to <u>Section 7.2(a)(i)</u> and <u>Section 7.2(a)(iii)</u> shall remain in full force and effect until the date that is thirty (30) days after the expiration of the applicable statute of limitations;
            <u>provided</u>, <u>however</u>, in each case, that any Liability Claim pending as of such date for which a Claims Notice has been given in accordance with <u>Section 7.4</u> may continue to be asserted and indemnified against in accordance
            with this <u>Article VII</u> until finally resolved. Notwithstanding anything herein to the contrary, in no event shall Seller have any Liability greater than the amount of consideration received by such Seller pursuant to <u>Section 2.3</u>.&#160;






            <a name="z_Ref20240894"></a><a name="z_Ref183618006"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184888713"></a><a name="z_Toc186369748"></a><a name="z_Ref184009402"></a><a name="z_Toc183565484"></a><a name="z_Ref183993197"></a><a name="z_Ref465276575"></a><a name="z_Ref466544718"></a><a name="z_Toc101487270"></a><font style="color: rgb(0, 0, 0);">7.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification by Sellers</u>.</div>
          <div><font style="font-size: 10pt;"><br>
            </font> </div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; From and after the Closing, and subject to the terms of this Agreement, Seller shall
              indemnify and hold harmless Purchaser and its Affiliates (collectively, the &#8220;<u>Purchaser Indemnified Parties</u>&#8221;) from and against, and reimburse any Purchaser Indemnified Party for, all Losses that such Purchaser Indemnified Party may
              suffer or incur, or become subject to, to the extent resulting from, caused by or arising out of any:</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Indemnified Taxes;</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt;"><a name="z_Hlk186324517"></a><a name="z_Hlk186324526"></a><a name="z_Ref186213197"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160; the matter set
            forth on Section 7.2(a)(ii) of the Purchaser Disclosure Schedule;</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt;"><a name="z_Ref186213188"></a><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160; the matter set forth on Section 7.2(a)(iii) of the Purchaser Disclosure
            Schedule; and</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-58-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; the matter set forth on Section 7.2(a)(iv) of the Purchaser Disclosure
              Schedule.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Hlk186388666"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The indemnification obligations, covenants and agreements (x) contained in <u>Section
              7.2(a)(i)</u> and <u>Section 7.2(a)(iii)</u> will expire on the date that is thirty (30) days after the expiration of the applicable statute of limitation in respect of any such liabilities or claims and (y) contained in <u>Section
              7.2(a)(ii)</u> and <u>Section 7.2(a)(iv)</u> will expire on the twelve (12)-month anniversary of the Closing Date (with respect to each such liability and claim, the &#8220;<u>Applicable Expiration Date</u>&#8221;); <u>provided</u>, <u>however</u>,
            that any claim pursuant to this <u>Section 7.2</u> pending on such Applicable Expiration Date for which written notice has been given to Seller in accordance with <u>Section 9.6</u> on or before the Applicable Expiration Date may continue to
            be asserted and indemnified against in accordance with this <u>Section 7.2</u> until finally resolved. No Purchaser Indemnified Party shall be entitled to any indemnification for any Losses, and no indemnification payment shall be required to
            be made for any Losses, in each case, (i) pursuant to indemnification claims under <u>Section 7.2(a)(ii)</u> and<u> Section 7.2(a)(iv)</u> on a cumulative basis in an aggregate amount exceeding five percent (5%) of the Final Cash Purchase
            Price and (ii) without limiting the foregoing clause (i), pursuant to indemnification claims under this <u>Section 7.2</u> on a cumulative basis in an aggregate amount exceeding the Final Cash Purchase Price.&#160;Seller will not be obligated to
            indemnify a Person with respect to any claim that relates to Losses resulting from the passing of or change in any Law or any accounting policy, principle or practice (or the interpretation thereof by any Person) after the Closing Date, even if
            the change has retroactive effect or requires action at a future date. To the extent that a claim for indemnification by a Purchaser Indemnified Party hereunder relates to a liability incurred by the Company and there is an accrual on the
            Financial Statements as of the Balance Sheet Date in respect of such liability, then the determination of Losses in respect of such claim shall be net of such accrual. Notwithstanding anything to the contrary set forth herein, no Purchaser
            Indemnified Party shall be entitled to indemnification under this <u>Section 7.2</u>, or make a claim, for any amounts in respect of punitive damages, consequential, incidental or indirect damages, lost profits or diminution in value (except
            to the extent actually paid to a third party pursuant to a Third-Party Claim).&#160; Notwithstanding anything to the contrary set forth herein, Indemnified Taxes shall only be treated as a Loss pursuant to this <u>Section 7.2</u> to the extent that
            a Taxing Authority has made an assessment or claim with respect to such Taxes. Each Purchaser Indemnified Party acknowledges the common law duty to mitigate Losses. Upon making any payment of a claim for indemnification to Seller in respect of
            any Losses pursuant to this <u>Section 7.2</u>, Seller will, to the extent of such payment, be subrogated to all rights of the Purchaser Indemnified Party against any third party in respect of the Losses to which such payment relates. All
            payments pursuant to this <u>Section 7.2</u> shall be treated as adjustments to the Final Cash Purchase Price for all foreign, federal, state and local income Tax purposes, to the maximum extent permitted by applicable Law. The indemnification
            provided in this <u>Section 7.2</u>, subject to the limitations set forth herein, shall be the sole and exclusive post-Closing remedy available to any Purchaser Indemnified Party in connection with any Losses arising out of or resulting from
            the matters described in this <u>Section 7.2</u>.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payments by Seller pursuant to this <u>Article VII</u> shall be limited to the amount of
              any Loss that remains after deducting therefrom any insurance proceeds and any indemnity, contribution or other similar payment received by the Purchaser Indemnified Parties from any third parties (other than Seller) in respect of any such
              claim, net of any expenses incurred by such Purchaser Indemnified Party in collecting such amounts, including any incremental insurance premium costs. In the event that an insurance, indemnification, contribution or other recovery is made by
              a Purchaser Indemnified Party with respect to any Loss for which it has been indemnified by Seller pursuant to this Article VII, then a refund equal to the aggregate amount of such recovery or benefit (net of any expenses incurred by such
              Purchaser Indemnified Party in collecting such amounts) shall be paid promptly in immediately available funds to Seller.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc101631561"></a><a name="z_Toc101674240"></a><a name="z_Toc101631562"></a><a name="z_Toc101674241"></a><a name="z_Ref186285167"></a><a name="z_Toc186369749"></a></div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-59-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt;"> <font style="font-size: 10pt; color: rgb(0, 0, 0);">7.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice and Opportunity to Defend.</u></font></div>
          <div style="text-align: justify; text-indent: 36pt;"> <font style="font-size: 10pt;"><br>
            </font></div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notice of Asserted Liability</u>.&#160; As soon as is reasonably practicable after a Purchaser Indemnified Party becomes aware of any direct claim that such Purchaser
            Indemnified Party has under <u>Section 7.2</u> or any Third-Party Claim (as defined below) (each, a &#8220;<u>Liability Claim</u>&#8221;), such Purchaser Indemnified Party shall give written notice of such Liability Claim (a &#8220;<u>Claims Notice</u>&#8221;) to
            Seller; <u>provided</u> that any failure to so notify or any delay in notifying Seller shall not relieve Seller of its obligations hereunder except to the extent that it is materially prejudiced by such failure or delay.&#160; A Claims Notice must
            (to the extent reasonably known) describe the Liability Claim in reasonable detail (including the underlying factual and legal basis and the specific provisions of this Agreement implicated thereby) and must (to the extent reasonably known and
            quantifiable) indicate the amount and calculation (estimated, if necessary) of the Loss that has been or may be suffered by such Purchaser Indemnified Party. For the avoidance of doubt, no Claims Notice may be delivered with respect to Tax
            liabilities unless and until a Taxing Authority has made a claim with respect to such Taxes. To the extent Seller makes any payment to Purchaser with respect to a Liability Claim pursuant to <u>Section 7.2(a)(iii)</u>, Purchaser shall promptly
            use such amounts to pay the applicable Taxing Authority in satisfaction of such Taxing Authority&#8217;s claim, unless already paid by Purchaser. As promptly as practicable after delivery of a Claims Notice to Seller, the Purchaser Indemnified Party
            shall, and shall cause its Affiliates and its and its Affiliates&#8217; Representatives to, (A) be available to Seller and its and its Affiliates&#8217; Representatives during normal business hours to discuss such Liability Claim, (B) render to Seller and
            its and its Affiliates&#8217; Representatives such assistance as may reasonably be requested, (C) provide reasonable access to such properties and books, records and other documents or information in their possession as Seller and/or its and its
            Affiliates&#8217; Representatives may reasonably require, and (D) otherwise cooperate with Seller and its and its Affiliates&#8217; Representatives in good faith in connection with its review of such Liability Claim.&#160; Without limiting the foregoing, such
            cooperation shall include the retention and, upon Seller&#8217;s written request, the provision to Seller and its and its Affiliates&#8217; Representatives of books, records and other documents and information which are reasonably relevant to such
            Liability Claim.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Opportunity to Defend</u>.&#160; Seller has the right, exercisable by written notice to the Purchaser Indemnified Party within thirty (30) Business Days after
            receipt of a Claims Notice from the Purchaser Indemnified Party of the commencement or assertion of such Third-Party Claim, to assume and control the defense of any Liability Claim relating to a third-party claim in respect of which indemnity
            may be sought under <u>Section 7.2</u> (each, a &#8220;<u>Third-Party Claim</u>&#8221;) in accordance with the limits set forth in this Agreement with counsel selected by Seller.&#160; If Seller does not assume the defense of a Third-Party Claim in accordance
            with this <u>Section 7.3(b)</u>, the Purchaser Indemnified Party may continue to control the defense of the Third-Party Claim in accordance with the limits set forth in this Agreement.&#160; If Seller has assumed control of the defense of a
            Third-Party Claim as provided in this <u>Section 7.3(b)</u>, Seller will not be liable for any costs or expenses subsequently incurred by the Purchaser Indemnified Party in connection with the defense of the Liability Claim.&#160; Such Purchaser
            Indemnified Party has the right (but not the obligation) to participate in (but not control), at its own expense, the defense of any Third-Party Claim that the other is defending as provided in this Agreement.&#160; Notwithstanding the foregoing, if
            the defendants in any Third-Party Claim include both Seller and a Purchaser Indemnified Party and outside counsel of the Purchaser Indemnified Party issues an opinion that there would be a conflict between the positions of Seller and the
            Purchaser Indemnified Party in conducting the defense of any such action or that there would be legal defenses available to it that are different from or additional to those available to Seller, then the Purchaser Indemnified Party shall have
            the right to select separate counsel to assume such legal defenses and to otherwise participate in (but not control) the defense of such action on behalf of such Purchaser Indemnified Party, in which case the reasonable fees and expenses of
            such counsel shall be at the expense of Seller.&#160; In connection with the defense of any Third-Party Claim, the Purchaser Indemnified Party and Seller shall keep each other fully informed concerning the status of such Third-Party Claim and any
            related proceedings at all stages thereof.&#160; In connection with the defense of any such Third-Party Claim, the Purchaser Indemnified Party shall make its and its Affiliates&#8217; Representatives available and render to Seller such assistance and
            provide such books, records and other documents or information in their possession as Seller and/or its and its Affiliates&#8217; Representatives may reasonably require, and shall otherwise reasonably cooperate with Seller and its and its Affiliates&#8217;
            Representatives in good faith in order to ensure the proper and adequate defense of such Third-Party Claim.&#160; Without limiting the foregoing, such cooperation shall include the retention of books, records and other information which are
            reasonably relevant to such Third-Party Claim.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-60-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Settlement</u>.&#160; Seller, if it has assumed the defense of any Third-Party Claim as provided in this Agreement, may not, without the prior written consent of the
            Purchaser Indemnified Party (which consent shall not be unreasonably withheld, conditioned or delayed), consent to a settlement of, or the entry of any judgment arising from, any such Third-Party Claim that (i) does not include as an
            unconditional term thereof the giving by the claimant or the plaintiff to the Purchaser Indemnified Party of a complete release from all liability in respect of such Third-Party Claim (including, if applicable, criminal liability) or (ii)
            grants any injunctive or equitable relief.&#160; Notwithstanding anything herein to the contrary, whether or not Seller shall have assumed the defense of such Third-Party Claim, no Purchaser Indemnified Person shall settle, compromise, discharge or
            pay any Third-Party Claim without the prior written consent of Seller (which consent shall not be unreasonably withheld, conditioned or delayed).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Final Resolution</u>.&#160; A Claims Notice, any amounts claimed therein and any other matters set forth therein shall be deemed to be finally resolved for purposes
            of this <u>Article VII</u> when (i) such Claims Notice, amounts and matters have been resolved by a written agreement executed by Seller and such Purchaser Indemnified Party or (ii) such Claims Notice, amounts and matters have been resolved by
            a final, non-appealable order, decision or ruling of a court of competent jurisdiction or arbitrator with respect to such matter in dispute, or portion thereof (clauses (i) and (ii), together, a &#8220;<u>Final Resolution</u>&#8221;).</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc466451378"></a><a name="z_Toc468812253"></a><a name="z_Toc469074080"></a><a name="z_Toc186369750"></a><font style="color: rgb(0, 0, 0);">7.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Manner






              of Payment.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any indemnification with respect to any Liability Claim pursuant to <u>Section 7.2</u> shall be paid within five (5) Business Days after the Final Resolution
            thereof by wire transfer of immediately available funds from Seller to the accounts designated in writing by such applicable Purchaser Indemnified Party.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All payments pursuant to this <u>Article VII</u> shall be treated as adjustments to the Final Cash Purchase Price for all foreign, federal, state and local income
            Tax purposes, to the maximum extent permitted by applicable Law.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Toc186369751"></a><font style="color: rgb(0, 0, 0);">7.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exclusive Remedy.</u>&#160; Except for any claim for Fraud, the parties intend for the R&amp;W
            Insurance Policy to be the sole and exclusive remedy in respect of any losses and damages incurred by Purchaser and its Affiliates, equityholders, directors, managers, officers, representatives, successors, and assigns arising out of
            inaccuracies or breaches of any representations and warranties set forth in this Agreement.&#160; </div>
          <div style="font-size: 10pt;">&#160;</div>
          <font style="font-size: 10pt;"><a name="z_Ref324176401"></a><a name="z_Toc183565486"></a></font>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-61-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">ARTICLE VIII</div>
            <div style="text-align: center; font-size: 10pt;"><a name="z_Ref101679901"></a><a name="z_Ref101712461"></a><a name="z_Toc183565485"></a><a name="z_Toc186369752"></a><u>ADDITIONAL AGREEMENTS</u></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><font style="color: rgb(0, 0, 0);"> <br>
            </font></div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">8.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Other Representations.</u>&#160; Except for any claim for Fraud, in entering into this
              Agreement, Purchaser specifically acknowledges and agrees that it has relied solely upon the representations and warranties of the Company set forth in <u>Article III</u> and the representations and warranties of Seller set forth in <u>Article






                IV</u> (in each case, as modified by the Disclosure Schedules), and Purchaser acknowledges and agrees that, except for the representations and warranties of the Company expressly set forth in <u>Article III</u> and the representations and
              warranties of Seller set forth in <u>Article IV</u> (in each case, as modified by the Disclosure Schedules), none of Seller, the Company nor any of their respective Representatives nor any other Person acting on Seller&#8217;s or the Company&#8217;s
              behalf makes or has made, and Purchaser is not relying on and has not relied on, any representation or warranty, either express or implied, with respect to the Company, its business, or the transactions contemplated hereby.<a name="z_Ref284595250"></a><a name="z_Ref284595302"></a><a name="z_Ref284596038"></a><a name="z_Ref284598325"></a><a name="z_Ref284598348"></a>&#160; Purchaser acknowledges that it has conducted to its satisfaction its own independent
              investigation of the condition, operations and business of the Company and the Company&#8217;s Subsidiaries and, in making its determination to proceed with the transactions contemplated by this Agreement, Purchaser has relied on the results of its
              own independent investigation.&#160; Except for any claim for Fraud, Purchaser hereby waives, on behalf of itself and its Subsidiaries (including, after the Closing, the Company and its Subsidiaries) and its Affiliates, from and after the Closing,
              to the fullest extent permitted under applicable Law, any and all rights, claims and causes of action it may have against any direct or indirect equityholder of the Company, Seller, any of their respective Affiliates or any officer, director,
              manager, member, partner, employee, agent, consultant or Representative of any of the foregoing, and agrees no recourse shall be sought or granted against any of them, relating to the operation of any of the Company, the Company&#8217;s
              Subsidiaries or their respective business or relating to the subject matter of this Agreement (including representations, warranties and covenants contained herein, and any certificate, instrument, opinion or other documents delivered
              hereunder) and the transactions contemplated hereby, whether arising under or based upon any federal, state, local or foreign statute, law, ordinance, rule or regulation or otherwise (including any right, whether arising at law or in equity,
              to seek indemnification, contribution, cost recovery, damages, or any other recourse or remedy, including as may arise under common law).</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">ARTICLE IX</div>
          <div style="text-align: center; font-size: 10pt;"><a name="z_Ref101712462"></a><a name="z_Toc183565487"></a><a name="z_Toc186369754"></a><u>MISCELLANEOUS</u><a name="z_Ref374977087"></a><a name="z_Toc183565488"></a><a name="z_Ref284594834"></a><a name="z_Ref284595189"></a><a name="z_Ref284597785"></a><a name="z_Ref289888624"></a><a name="z_Ref289890072"></a><a name="z_Ref324176250"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009404"></a><a name="z_Ref184016210"></a><a name="z_Ref184017617"></a><a name="z_Toc186369755"></a><font style="color: rgb(0, 0, 0);">9.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies.</u></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The parties hereto agree that irreparable damage would occur and that the parties would not
              have any adequate remedy at law in the event that any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached, and that money damages or other legal remedies would not be an adequate
              remedy for any such failure to perform or breach.&#160; Accordingly, the parties hereto acknowledge and hereby agree that in the event of any breach or threatened breach by the Company or Seller, on the one hand, or Purchaser, on the other hand,
              of any of their respective covenants or obligations set forth in this Agreement, Purchaser, on the one hand, and the Company and Seller, on the other hand, shall be entitled to seek an injunction or injunctions to prevent or restrain breaches
              or threatened breaches of this Agreement by the other (as applicable), and to seek to specifically enforce the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants
              and obligations of the other (as applicable) under this Agreement, without proof of actual damages or inadequacy of legal remedy and without bond or other <a name="z_9kMK6K6ZWu57779EgOfwC145r2"></a>security being required.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0); font-size: 10pt;">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any and all remedies herein expressly conferred upon a party will be deemed cumulative
              with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise at any time of any other remedy.</font></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009405"></a><a name="z_Ref324177190"></a><a name="z_Toc183565489"></a><a name="z_Toc186369756"></a><font style="color: rgb(0, 0, 0);">9.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Expenses.</u>&#160;
            Except as otherwise provided in this Agreement, each of the Company and Seller, on the one hand, and Purchaser, on the other hand, shall bear its own expenses incurred in connection with the negotiation and execution of this Agreement and each
            other <a name="z_9kMO7H6ZWu57778GR8wvjstvB"></a>agreement, document and instrument contemplated by this Agreement and the consummation of the transactions contemplated hereby and thereby.<a name="z_Ref62857471"></a><a name="z_Ref62858315"></a><a name="z_Toc183565490"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-62-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009406"></a><a name="z_Toc186369757"></a><font style="color: rgb(0, 0, 0);">9.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement; Amendments and Waivers.</u>&#160; This
            Agreement (including the Exhibits hereto, the <a name="z_9kMPO5YVt4CC8BITHy0poDeJ50u7FMM7jcy1yFO"></a>Company Disclosure Schedule and Purchaser<a name="z_9kMIH5YVt4CC8EIdGpur7YI4zt6ELL6ibx0xEN8"></a> Disclosure Schedule) and the
            Confidentiality Agreement represent the entire understanding and <a name="z_9kMO8I6ZWu57778GR8wvjstvB"></a>agreement between the parties hereto with respect to the subject matter hereof.&#160; This Agreement may only be amended, supplemented or
            changed by a written instrument signed by each of the parties hereto.&#160; Each provision in this Agreement may only be waived by written instrument making specific reference to this Agreement signed by the party against whom enforcement of any
            such provision so waived is sought.&#160; No <a name="z_9kML3G6ZWu57779DN4u1x3"></a>action taken pursuant to this Agreement, including any investigation by or on behalf of any party, shall be deemed to constitute a waiver by the party taking such <a name="z_9kML4H6ZWu57779DN4u1x3"></a>action of compliance with any representation, warranty, covenant or <a name="z_9kMO9J6ZWu57778GR8wvjstvB"></a>agreement contained herein.&#160; The waiver by any party hereto of a breach of any provision of
            this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a waiver of any other or subsequent breach.&#160; No failure on the part of any party to exercise, and no delay in exercising, any right, power
            or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy.<a name="z_Ref50747529"></a><a name="z_Toc183565491"></a><a name="z_Ref183993198"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009407"></a><a name="z_Ref184017606"></a><a name="z_Toc186369758"></a><font style="color: rgb(0, 0, 0);">9.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing Law.</u>&#160; <a name="z_Ref372070875"></a><a name="z_Ref62857658"></a>This Agreement, and all claims or causes of <a name="z_9kML5I6ZWu57779DN4u1x3"></a>action (whether in <a name="z_9kMNM5YVt46668HTHz5Asey"></a>contract, tort or otherwise) that may be
            based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of <a name="z_9kML6J6ZWu57779DN4u1x3"></a>action based upon, arising out of or related to any
            representation or warranty made in or in connection with this Agreement) shall be governed by and construed in accordance with the <a name="z_9kMKJ5YVt4666BIaCu"></a><a name="z_9kMHG5YVt4998FJZCu9tz2oakz0513TN2zBC8D"></a>law of the State of
            Delaware, regardless of the <a name="z_9kMLK5YVt4666BIaCu"></a>laws that might otherwise govern under applicable principles of conflicts of <a name="z_9kMML5YVt4666BIaCu"></a>laws.&#160; Each of the parties hereto hereby irrevocably and
            unconditionally (a) submits, for itself and its property, to the exclusive jurisdiction of the Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any Federal court of
            the United States of America sitting in the State of Delaware), and any appellate court from any thereof, in any Action arising out of or relating to this Agreement or the negotiation, execution or performance of this Agreement (including any
            claim or cause of <a name="z_9kML8L6ZWu57779DN4u1x3"></a>action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement), or for recognition or enforcement of any judgment, and
            agrees that all claims in respect of any such Action shall be heard and determined in such Delaware Court of Chancery (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any Federal court of the
            United States of America sitting in the State of Delaware), (b) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any Action arising out of or relating
            to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of <a name="z_9kMLBO6ZWu57779DN4u1x3"></a>action based upon, arising out of or related to any representation or warranty made in or
            in connection with this Agreement) in the Delaware Court of Chancery, any Federal court of the United States of America sitting in the State of Delaware, or in any <a name="z_9kR3WTr2664CIP6liuvrwYixy3"></a><a name="z_9kR3WTr26659EP6liuvrwYixy3"></a>Delaware State court, (c) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such Action in any such court and (d) agrees that a final judgment in
            any such Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.&#160; Each of the parties hereto agrees that service of process, summons, notice or document by registered
            mail addressed to it at the applicable address set forth in <u>Section 9.6</u> below shall be effective service of process for any Action brought in any such court.<a name="z_Ref376980642"></a><a name="z_Toc183565492"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009408"></a><a name="z_Toc186369759"></a><font style="color: rgb(0, 0, 0);">9.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Waiver of Jury Trial.</u>&#160; THE PARTIES HEREBY IRREVOCABLY
            AND UNCONDITIONALLY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE TRANSITION SERVICES AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY THE ACTIONS OF THE
            PARTIES IN THE NEGOTIATION, EXECUTION, PERFORMANCE AND ENFORCEMENT OF THIS AGREEMENT, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE.&#160; THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS
            PARAGRAPH WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE TRIAL BY JURY AND THAT ANY ACTION OR PROCEEDING WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT, THE
            TRANSITION SERVICES AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY SHALL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.<a name="z_Ref291865287"></a><a name="z_Ref324176765"></a><a name="z_Toc183565493"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-63-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009409"></a><a name="z_Ref184017672"></a><a name="z_Toc186369760"></a><font style="color: rgb(0, 0, 0);">9.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices.</u>&#160; All notices and
            other communications under this Agreement shall be in writing and shall be deemed given (a) when delivered personally by hand (with written confirmation of receipt, by other than automatic means, whether electronic or otherwise), (b) when sent
            by e-mail (with electronic confirmation of transmission) or (c) one (1) Business Day following the day sent by an internationally recognized overnight courier (with written confirmation of receipt), in each case, at the following addresses (or
            to such other address as a party may have specified by notice given to the other party pursuant to this provision):</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-left: 72pt; font-size: 10pt;">If to Seller, or, prior to the Closing, the Company, to the applicable party as follows:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-left: 72pt; font-size: 10pt;"><a name="z_Hlk185858843"></a>Mavely Seller LLC</div>
          <div style="margin-left: 72pt; font-size: 10pt;">75 West Center St</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Provo, Utah 84601</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Attention: Chayce Clark</div>
          <div style="margin-left: 72pt; font-size: 10pt;">E-mail: cclark@nuskin.com</div>
          <div style="margin-left: 72pt; font-size: 10pt;"> <br>
          </div>
          <div style="margin-left: 72pt; font-size: 10pt;">with copies (which shall not constitute actual or constructive notice) to:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Simpson Thacher &amp; Bartlett LLP</div>
          <div style="margin-left: 72pt; font-size: 10pt;">2475 Hanover Street</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Palo Alto, California 94304</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Attention:&#160; Atif Azher, Fred de Albuquerque</div>
          <div style="margin-left: 72pt; font-size: 10pt;">E-mail: aazher@stblaw.com, fred.dealbuquerque@stblaw.com</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-left: 72pt; font-size: 10pt;">If to Purchaser, or, following the Closing, the Company, to the applicable party as follows:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-right: 36pt; margin-left: 72pt; font-size: 10pt;">Clout.io Holdings, inc.</div>
          <div style="text-align: justify; text-indent: -21.6pt; margin-left: 93.6pt; font-size: 10pt;">200 State St. Marketplace Center</div>
          <div style="text-align: justify; text-indent: -21.6pt; margin-left: 93.6pt; font-size: 10pt;">North Building, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor</div>
          <div style="text-indent: -21.6pt; margin-left: 93.6pt; font-size: 10pt;">Boston, MA 02109</div>
          <div style="margin-left: 72pt; font-size: 10pt;">E-mail: Erin Ryskamp</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Attention: erin.ryskamp@later.com</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-left: 72pt; font-size: 10pt;">with a copy (which shall not constitute actual or constructive notice) to:</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Goodwin Procter LLP</div>
          <div style="margin-left: 72pt; font-size: 10pt;">100 Northern Avenue</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Boston, MA 02210</div>
          <div style="margin-left: 72pt; font-size: 10pt;">E-mail: kgordon@goodwinlaw.com; DIsaacs@goodwinlaw.com</div>
          <div style="margin-left: 72pt; font-size: 10pt;">Attention: Ken Gordon; Daniel M. Isaacs<a name="z_Toc183565494"></a><a name="z_Ref183993199"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-64-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009410"></a><a name="z_Toc186369761"></a><font style="color: rgb(0, 0, 0);">9.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability.</u>&#160; If any condition, term or other provision
            of this Agreement is invalid, illegal, or incapable of being enforced by any Law or public policy, all other conditions, terms or provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
            substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party.&#160; Upon such determination that any term or other provision is invalid, illegal, or incapable of being enforced, the parties hereto
            shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in <a name="z_9kMH3K6ZWu5777ACZXthw"></a>order that the transactions contemplated hereby
            are consummated as originally contemplated to the greatest extent possible.&#160; Notwithstanding the foregoing, the parties intend that the provisions of <u>Article VIII</u> including the remedies (and limitations thereon) and the limitations on
            representations, warranties and covenants, be construed as integral provisions of this Agreement and that such provisions, remedies and limitations shall not be severable in any manner that diminishes a party&#8217;s rights hereunder or increases a
            party&#8217;s Liability or obligations hereunder.<a name="z_Toc183565495"></a><a name="z_Ref183993200"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009411"></a><a name="z_Toc186369762"></a><font style="color: rgb(0, 0, 0);">9.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Binding Effect; Assignment.</u><a name="z_Ref284597746"></a><a name="z_Ref284597749"></a><a name="z_Ref61673559"></a><a name="z_Ref62857539"></a><a name="z_Ref183993201"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009412"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; This Agreement shall be binding upon and inure to the benefit of the parties and their
            respective successors and permitted assigns.&#160; Nothing in this Agreement shall create or be deemed to create any third party beneficiary rights in any Person not a party to this Agreement except (i) <u>Section 6.1</u> shall be for the benefit
            of, and enforceable by, the Indemnitees, (ii) <u>Sections 6.2</u> and <u>9.2</u> shall be for the benefit of, and enforceable by, the Equityholders and Seller, (iii) <u>Article VII</u> shall be for the benefit of, and enforceable by, the
            Indemnified Parties, (iv) <u>Section 9.9</u> shall be for the benefit of, and enforceable by, the Nonparty Affiliates of the parties, (iv) <u>Section 9.10</u> shall be for the benefit of, and enforceable by, the Equityholders, STB and each
            other <a name="z_9kMHG5YVt3DE6CGOH665xr"></a>Counsel, and (viii) <u>Section 9.11</u> shall be for the benefit, and enforceable by, each Released Person.<a name="z_Ref183993202"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009413"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; No assignment of this Agreement or of any rights or obligations hereunder may be made,
            directly or indirectly (by operation of law or otherwise), by (i) any of the Company or its Subsidiaries, without the prior written consent of Purchaser, or (ii) any of Purchaser, without the prior written consent of either the Company (prior
            to the Closing) or Seller (at and after the Closing), respectively.&#160; Any attempted assignment without obtaining such required consent shall be null and void.&#160; Notwithstanding the foregoing, Purchaser may assign this Agreement (in whole but not
            in part) to one or more wholly owned Subsidiaries of Purchaser; <u>provided</u>, <u>however</u>, that no such assignment shall result in any incremental withholding or other Tax cost to Seller or its direct or indirect owners or relieve
            Purchaser of its obligations under this Agreement; <u>provided</u>, <u>further</u>, that in no event shall Purchaser be permitted to assign this Agreement to any Person to the extent that, as a result of such assignment, either (x) any
            additional consent or approval of, or filing, declaration or registration with, any Governmental Authority would be required under this Agreement or in connection with the transactions contemplated hereby or (y) any delay would occur with
            respect to any consent or approval of, or filing, declaration or registration with, any Governmental Authority that otherwise is required to be made under this Agreement or in connection with the transactions contemplated hereby.<a name="z_Ref284840416"></a><a name="z_Ref327369110"></a><a name="z_Ref371966444"></a><a name="z_Ref371972702"></a><a name="z_9kR3WTr2887DDADEBYU1fRjuDHG4"></a><a name="z_Toc183565496"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009414"></a><a name="z_Ref184009714"></a><a name="z_Ref184010000"></a><a name="z_Ref184011071"></a><a name="z_Ref184017415"></a><a name="z_Toc186369763"></a><font style="color: rgb(0, 0, 0);">9.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Non-Recourse.</u>&#160; Except to the ex<a name="z_9kMJI5YVt4CC8CKUHzrnmjuA6os1ARjMA9x679P"></a>tent otherwise set forth in the Confidentiality Agreement, all claims, obligations, Liabilities, or
            causes of <a name="z_9kMM6I6ZWu57779DN4u1x3"></a>action (whether in <a name="z_9kMON5YVt46668HTHz5Asey"></a>contract or in tort, in <a name="z_9kMNM5YVt4666BIaCu"></a>law or in equity, or granted by statute) that may be based upon, in
            respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution, or performance of this Agreement (including any representation or warranty made in, in connection with,
            or as an inducement to, this Agreement), may be made only against (and such representations and warranties are those solely of) the Persons that are expressly identified as parties in the preamble to this Agreement (the &#8220;<u>Contracting Parties</u>&#8221;).&#160;






            No Person who is not a Contracting Party, including any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate, agent, attorney, <a name="z_9kMKJ5YVt4666AJiMr5vxyuAyz8B8"></a>representative






            or assignee of, and any <a name="z_9kMH2J6ZWu5777AIWFunornmqRE6CAHHM"></a>financial advisor or lender to, any Contracting Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder,
            Affiliate, agent, attorney, <a name="z_9kMLK5YVt4666AJiMr5vxyuAyz8B8"></a>representative or assignee of, and any <a name="z_9kMH3K6ZWu5777AIWFunornmqRE6CAHHM"></a>financial advisor or lender to, any of the foregoing (collectively, but in each
            case excluding any Contracting Party, the &#8220;<u>Nonparty Affiliates</u>&#8221;), shall have any Liability (whether in <a name="z_9kMPO5YVt46668HTHz5Asey"></a>contract or in tort, in <a name="z_9kMON5YVt4666BIaCu"></a>law or in equity, or granted by
            statute) for any claims, causes of <a name="z_9kMM7J6ZWu57779DN4u1x3"></a>action, obligations, or Liabilities arising under, out of, in connection with, or related in any manner to this Agreement or based on, in respect of, or by reason of
            this Agreement or its negotiation, execution, performance, or breach (other than as set forth in <a name="z_9kMKJ5YVt4CC8CKUHzrnmjuA6os1ARjMA9x679P"></a>the Confidentiality Agreement), and, to the maximum extent permitted by Law, each
            Contracting Party hereby waives and releases all such Liabilities, claims, causes of <a name="z_9kMM8K6ZWu57779DN4u1x3"></a>action, and obligations against any such Nonparty Affiliates.&#160; Without limiting the foregoing, to the maximum extent
            permitted by Law, except to the extent otherwise set forth in the Confidentiality Agreement, (a) each Contracting Party hereby waives and releases any and all rights, claims, demands, or causes of <a name="z_9kMM9L6ZWu57779DN4u1x3"></a>action
            that may otherwise be available at <a name="z_9kMPO5YVt4666BIaCu"></a>law or in equity, or granted by statute, to avoid or disregard the entity form of a Contracting Party or otherwise impose Liability of a Contracting Party on any Nonparty
            Affiliate, whether granted by statute or based on theories of equity, agency, control, instrumentality, alter ego, domination, sham, single business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise; and (b) each
            Contracting Party disclaims any reliance upon any Nonparty Affiliates with respect to the performance of this Agreement or any representation or warranty made in, in connection with, or as an inducement to this Agreement.<a name="z_Ref284597697"></a><a name="z_Ref284597791"></a><a name="z_Ref284606467"></a><a name="z_Ref284606494"></a><a name="z_Toc183565497"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-65-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009415"></a><a name="z_Ref184010009"></a><a name="z_Ref184017400"></a><a name="z_Toc186369764"></a><font style="color: rgb(0, 0, 0);">9.10</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Provision






              Respecting Legal Representation.</u>&#160; It is acknowledged by each of the parties that Seller and the Company have retained STB and certain other legal counsel (each, a &#8220;<u>Counsel</u>&#8221;) to act as its counsel in connection with the transactions
            contemplated hereby and that STB and each other Counsel have not acted as counsel for any other party in connection with the transactions contemplated hereby and that none of the other parties has the status of a client of STB or any other
            Counsel for conflict of interest or any other purposes as a result thereof.&#160; Purchaser and Company hereby agree that, in the event that a dispute arises after the Closing between Purchaser or the Company or any of their respective Subsidiaries,
            on the one hand, and Seller or any of the Equityholders, on the other hand, STB and each other Counsel may represent any or all of Seller or the Equityholders in such dispute even though the interests of some or all of Seller and the
            Equityholders may be directly adverse to Purchaser, the Company or any of their respective Subsidiaries, and even though STB and/or such other Counsel formerly may have represented the Company and/or any of its Subsidiaries in a matter
            substantially related to such dispute; <u>provided</u>, <u>however</u>, that this sentence shall not apply if STB and/or such other Counsel, at the time of such dispute, is handling adversarial proceedings for Purchaser, the Company or any of
            their respective Subsidiaries.&#160; Company acknowledges and agrees that, in connection with any future dispute between Purchaser, the Company and/or any of their respective Affiliates, on the one hand, and any of Seller or the Equityholders and/or
            their respective Affiliates, on the other hand, with respect to the transactions contemplated by this Agreement, as to all communications among STB, each other Counsel, the Company, any of its Subsidiaries, Seller and/or any Equityholder that
            relate in any way to the transactions contemplated by this Agreement, the attorney-client privilege and the expectation of client confidence belongs to Seller or the applicable Equityholder and may be controlled by Seller or such Equityholder,
            as applicable, and shall not pass to or be claimed by Purchaser, the Company or any of their respective Affiliates.<a name="z_Ref61645605"></a><a name="z_Ref61645619"></a><a name="z_Ref61645629"></a><a name="z_Toc183565498"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009416"></a><a name="z_Ref184009724"></a><a name="z_Ref184011764"></a><a name="z_Ref184011772"></a><a name="z_Ref184011784"></a><a name="z_Ref184017357"></a><a name="z_Toc186369765"></a><font style="color: rgb(0, 0, 0);">9.11</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Release.</u><a name="z_Ref184317320"></a><a name="z_Ref184333605"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184316794"></a><a name="z_Ref184333515"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Effective as of the Closing, each of Purchaser and Company, and
            each of their respective former, present and future Affiliates, successors and assigns (each, a &#8220;<u>Purchaser Releasing Party</u>&#8221;), hereby fully and unconditionally releases, acquits and forever discharges each current, former and future
            stockholders, equity holders, controlling Persons, directors, officers, employees, general or limited partners, members, managers, agents or Affiliates of Seller, its Subsidiaries and each other member of the Seller Group, or any former,
            current or future stockholders, equity holders, controlling Persons, directors, officers, employees, general or limited partners, members, managers, agents or Affiliates of the foregoing (or a fiduciary of any employee benefit plan of the
            Company or of any of its present or former Subsidiaries) (including each other Nonparty Affiliate) (each of the foregoing, a &#8220;<u>Seller Released Person</u>&#8221;) from all debts, demands, causes of action, suits, covenants, torts, damages and any
            and all claims, defenses, offsets, judgments, demands and Liabilities whatsoever, of every name and nature, whether in Law or in equity, whether in Contract or in tort or otherwise, known or unknown or unforeseen, contingent or actual, accrued
            or unaccrued, whether now known or hereafter discovered, which have been, could have been or may be asserted against any Seller Released Person, which any Purchaser Releasing Party has, ever had or may have, in law or in equity, which arises
            out of, in connection with, or in any way relates to, or by reason of, events, circumstances or actions occurring, existing or taken prior to or as of the Closing Date in respect of matters relating to the Company and the Company&#8217;s Subsidiaries
            or the Business (each, a &#8220;<u>Purchaser Released Claim</u>&#8221;); <u>provided</u>, <u>however</u>, that the Purchaser Releasing Persons expressly do not release their rights and interests (a) under this Agreement, the Transition Services
            Agreement, the Commercial Services Agreement, the Confidentiality Agreement or any other Contract between any Purchaser Releasing Persons and any Seller Released Person or (b) with respect to any claim of, or liability to, the Company or its
            Subsidiaries (or any successor thereof) against any Seller Released Person to the extent resulting from the Seller Released Person&#8217;s status as an employee of the Company or its Subsidiaries.&#160; Purchaser covenants and agrees that it will honor
            such release and will not, and will cause the Company and its Affiliates not to, take any action inconsistent with this <u>Section 9.11(a)</u> (including commencing any Action with respect to, or, directly or indirectly, transferring to
            another Person, any Purchaser Released Claim).&#160; This <u>Section 9.11(a)</u> shall survive the Closing, is intended for the benefit of and may be enforced directly by each of the Seller Released Persons, and shall be binding on all successors
            and permitted assigns of each of Purchaser and the Company.</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-66-</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref185890553"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Effective as of the Closing, Seller, on behalf of itself and each other member of the Seller
            Group, and each of its respective former, present and future Affiliates, successors and assigns (each, a &#8220;<u>Seller Releasing Party</u>&#8221;) hereby fully and unconditionally releases, acquits and forever discharges each current, former and future
            stockholders, equity holders, controlling Persons, directors, officers, employees, general or limited partners, members, managers, agents or Affiliates of Purchaser or the Company and its Subsidiaries or any former, current or future
            stockholders, equity holders, controlling Persons, directors, officers, employees, general or limited partners, members, managers, agents or Affiliates of the foregoing (or a fiduciary of any employee benefit plan of the Company or of any of
            its present or former Subsidiaries) (including each other Nonparty Affiliate) (each of the foregoing, a &#8220;<u>Purchaser Released Person</u>&#8221;) from all debts, demands, causes of action, suits, covenants, torts, damages and any and all claims,
            defenses, offsets, judgments, demands and Liabilities whatsoever, of every name and nature, whether in Law or in equity, whether in Contract or in tort or otherwise, known or unknown or unforeseen, contingent or actual, accrued or unaccrued,
            whether now known or hereafter discovered, which have been, could have been or may be asserted against any Purchaser Released Person, which any Seller Releasing Party has, ever had or may have, in law or in equity, which arises out of, in
            connection with, or in any way relates to, or by reason of, events, circumstances or actions occurring, existing or taken prior to or as of the Closing Date in respect of matters relating to the Company and the Company&#8217;s Subsidiaries or the
            Business (each, a &#8220;<u>Seller Released Claim</u>&#8221;); <u>provided</u>, <u>however</u>, that the Seller Releasing Persons expressly do not release their rights and interests (a) under this Agreement, the Transition Services Agreement, the
            Commercial Services Agreement, the Confidentiality Agreement or any other Contract between any Seller Releasing Persons and any Purchaser Released Person or (b) with respect to any claim of, or liability to, the Company or its Subsidiaries (or
            any successor thereof) against any Purchaser Released Person to the extent resulting from the Purchaser Released Person&#8217;s status as an employee of the Company or its Subsidiaries.&#160; Seller covenants and agrees that it will honor such release and
            will not take any action inconsistent with this <u>Section 9.11(b)</u> (including commencing any Action with respect to, or, directly or indirectly, transferring to another Person, any Seller Released Claim).&#160; This <u>Section 9.11(b)</u>
            shall survive the Closing, is intended for the benefit of and may be enforced directly by each of the Purchaser Released Persons, and shall be binding on all successors and permitted assigns of Seller.<a name="z_Ref183095054"></a><a name="z_Ref183097421"></a><a name="z_Toc183565499"></a></div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;"><a name="z_Ref184009417"></a><a name="z_Toc183565500"></a><a name="z_Ref183993203"></a><a name="z_Toc186369766"></a><font style="color: rgb(0, 0, 0);">9.12</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts.</u>&#160;
            This Agreement may be executed in any number of counterparts (including by means of e-mail in .pdf format), each of which will be deemed to be an original copy of this Agreement and all of which, when taken together, will be deemed to
            constitute one and the same agreement.</div>
          <br>
          <div style="font-size: 10pt;">
            <div style="text-align: center; font-size: 10pt;"> [Remainder of page intentionally left blank]</div>
            <div style="text-align: center; font-size: 10pt;"> <br>
            </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div style="text-align: center; font-size: 10pt;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-weight: normal; font-style: normal; font-size: 8pt;">-67-</font></div>
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt; font-size: 10pt;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the date first written above.</div>
          <div><font style="font-size: 10pt;">&#160; </font>
            <table cellspacing="0" cellpadding="0" border="0" id="zfb51ea136ea34e8c9305c8469a9cf8c3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="vertical-align: top;" rowspan="1" colspan="3">
                    <div>CLOUT.IO HOLDINGS, INC.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
                  <td style="vertical-align: top;" rowspan="1" colspan="3">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="width: 23%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>/s/ Scott Sutton</div>
                  </td>
                  <td style="width: 22.5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Name:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>Scott Sutton</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Title:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>Chief Executive Officer</div>
                  </td>
                </tr>

            </table>
          </div>
          <div><font style="font-size: 10pt;"><br>
            </font> </div>
          <div>
            <div style="text-align: center; font-size: 10pt;">[Signature Page to Unit Purchase Agreement]</div>
          </div>
          <font style="font-size: 10pt;"><br>
          </font>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" id="zf147f77358eb45c4a561a485662a5185" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="vertical-align: top;" rowspan="1" colspan="3">
                    <div>COMPANY:</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="vertical-align: top;" rowspan="1" colspan="3">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="vertical-align: top;" rowspan="1" colspan="3">
                    <div>MAVRCK LLC</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="vertical-align: top;" rowspan="1" colspan="3">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="width: 23%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>/s/ Scott Sutton</div>
                  </td>
                  <td style="width: 22.5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Name:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>Scott Sutton</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Title:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>Chief Executive Officer</div>
                  </td>
                </tr>

            </table>
            <div> <font style="font-size: 10pt;"><br>
              </font> </div>
            <div>
              <div style="text-align: center; font-size: 10pt;">[Signature Page to Unit Purchase Agreement]</div>
            </div>
            <div> <font style="font-size: 10pt;"><br>
              </font> </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" id="z3846decae95d4ed2a0d679244851ccb9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="3" rowspan="1" style="vertical-align: top;">
                    <div>COMPANY:</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="3" rowspan="1" style="vertical-align: top;">
                    <div>MAVELY LLC</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="3" rowspan="1" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="width: 23%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>/s/ Ryan Napierski</div>
                  </td>
                  <td style="width: 22.5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Name:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>Ryan Napierski</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Title:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>President</div>
                  </td>
                </tr>

            </table>
            <div> <font style="font-size: 10pt;"><br>
              </font> </div>
            <div>
              <div style="text-align: center; font-size: 10pt;">[Signature Page to Unit Purchase Agreement]</div>
              <div style="text-align: center;"> <font style="font-size: 10pt;"><br>
                </font> </div>
            </div>
            <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div class="BRPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" id="z5e9b08f1b4584f87bcce962692fb3b67" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="3" rowspan="1" style="vertical-align: top;">
                    <div>SELLER:</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td colspan="3" rowspan="1" style="vertical-align: top;">
                    <div>MAVELY SELLER LLC</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">&#160;</td>
                  <td colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td style="width: 23%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>/s/ Ryan Napierski</div>
                  </td>
                  <td style="width: 22.5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Name:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>Ryan Napierski</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
                  <td style="width: 5%; vertical-align: top;">
                    <div>Title:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>President</div>
                  </td>
                </tr>

            </table>
            <div style="text-align: center; color: #000000; font-weight: bold;"><font style="font-size: 10pt;"><br>
              </font> </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal;">
              <div style="font-size: 10pt;">[Signature Page to Unit Purchase Agreement]</div>
            </div>
            <div style="text-align: center; color: #000000; font-weight: bold;"><font style="font-size: 10pt;"><br>
              </font> </div>
          </div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Exhibit A</div>
          <div style="font-size: 10pt;">&#160;&#160; </div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;"><a name="z_Ref184009418"></a>Restrictive Covenant Agreement</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;"><a name="z_Ref61675905"></a>Exhibit B</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;"><a name="z_Ref184009419"></a>Net Working Capital and Accounting Principles</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Exhibit C</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;">Intellectual Property Assignment Agreement</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Exhibit D</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;"><a name="z_Ref184009421"></a>Form of Transition Services Agreement</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Exhibit E</div>
          <div style="font-size: 10pt;">&#160;&#160; </div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;">Form of Officer&#8217;s Certificate</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Exhibit F</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;">Form of Intercompany Agreement Termination Letter</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
          </div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-size: 10pt;">Exhibit G</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div style="text-align: center; font-weight: bold; font-size: 10pt;">Form of Termination of Employee Covenants Agreement</div>
          <div style="font-size: 10pt;">&#160;</div>
          <div><font style="font-size: 10pt;"><br>
            </font> </div>
          <div>
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ef20041017_ex99-1.htm
<DESCRIPTION>PRESS RELEASE DATED JANUARY 3, 2025
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-size: 10pt;"> </font>
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.1</font><font style="font-size: 10pt;"><br>
    </font> </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: right; font-size: 10pt;"><font style="font-weight: bold;"> <br>
    </font></div>

  <div style="text-align: left;"><img src="image00001.jpg">
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR IMMEDIATE RELEASE</div>
    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Nu Skin Enterprises Announces Strategic Transaction of Mavely for $250 Million</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">PROVO, Utah &#8212; Jan. 3, 2025 &#8212;</font><font style="font-size: 10pt;"> Nu Skin
        Enterprises Inc. (NYSE: NUS) today announced that its Rhyz Inc. subsidiary completed a strategic transaction with Later, a portfolio company of Summit Partners. As part of the transaction, Rhyz sold its Mavely affiliate marketing technology
        platform to Later in exchange for approximately $250 million in the form of cash and a minority equity stake in the combined Later/Mavely business. Approximately $33 million of such consideration will be paid to other equity holders in the Mavely
        business. In connection with the transaction, Mavely is expected to continue to provide certain technology and social commerce capabilities to support Nu Skin&#8217;s affiliate marketing business.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Together, we believe Later and Mavely will provide enhanced capabilities to our company as we pursue our broader beauty, wellness and lifestyle ecosystem vision,
      while the transaction generates additional capital and resources for us to increase innovation in our core Nu Skin business and investment in our Rhyz companies,&#8221; said Ryan Napierski, Nu Skin president and CEO. &#8220;This underscores the value of Rhyz to
      incubate and scale meaningful businesses with synergistic value across the enterprise.&#8221;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This transaction generated an approximate five-times return on the company&#8217;s cumulative investment in Mavely since it was acquired in 2021. Proceeds from the
      transaction are expected to be used to pay down debt and fund additional innovation. The company also plans to use its strengthened balance sheet to buy back stock under its existing stock repurchase program, providing value to its shareholders.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Evercore Group LLC acted as exclusive financial advisor and Simpson Thacher &amp; Bartlett LLP acted as legal counsel to Nu Skin Enterprises.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Nu Skin Enterprises and Rhyz</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. <u><font style="font-family: 'Times New Roman';">Nu Skin</font></u>
      is an integrated beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by 40 years of scientific research, the company&#8217;s products help people look, feel and live their
      best with brands including Nu Skin&#174; personal care, Pharmanex&#174; nutrition and ageLOC&#174; anti-aging, which includes an award-winning line of beauty device systems. Formed in 2018, <u><font style="font-family: 'Times New Roman';">Rhyz</font></u><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 255);"><u>&#160;</u></font>is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Important Information Regarding Forward-Looking Statements:</font><font style="font-size: 10pt;"> This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the
        company's current expectations and beliefs. All statements other than statements of historical fact are &#8220;forward-looking statements&#8221; for purposes of federal and state securities laws and include, but are not limited to, statements regarding the
        consideration to be retained by the company and its subsidiaries relating to the transaction, statements of management&#8217;s expectations regarding achievement of the company&#8217;s vision, the future performance and capabilities of the combined
        Later/Mavely business, the benefits of the continuing commercial services arrangement with Mavely, and planned uses of cash. In some cases, you can identify these statements by forward-looking words such as "will," &#8220;plan,&#8221; &#8220;believe,&#8221; "achieve,"
        &#8220;expect,&#8221; and &#8220;anticipate,&#8221; the negative of these words and other similar words.</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially
      from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:</div>
    <table cellspacing="0" cellpadding="0" id="z7960dbe87619469da488c47c023a0cde" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">the net proceeds to be retained by the company and its subsidiaries in connection with the closing of the transaction are subject to adjustments as set forth in the Unit
              Purchase Agreement in relation thereto, including post-closing determination of working capital and other elements of the purchase price, which may reduce the amount of consideration to be retained by the company and its subsidiaries;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z4a3f8b68b2b64060a3fc5bee84205eb1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">risk that the Mavely and Later businesses may encounter difficulties integrating their businesses or achieving the synergies that are anticipated from the transaction,
              or risks associated with not providing services to the company as currently anticipated;</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z649ae0b5065a471db334144ca020f447" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">any failure of current or planned initiatives or products to generate interest among the company&#8217;s sales force and customers and generate sponsoring and selling
              activities on a sustained basis;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z6524040d0c754b17b74622ad5890b606" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">risk that direct selling laws and regulations in any of the company&#8217;s markets, including the United States and Mainland China, may be modified, interpreted or enforced
              in a manner that results in negative changes to the company&#8217;s business model or negatively impacts its revenue, sales force or business, including through the interruption of sales activities, loss of licenses, increased scrutiny of sales
              force actions, imposition of fines, or any other adverse actions or events;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z09355defc73840a2b0c233bd67549c23" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">economic conditions and events globally;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z825f255961d044beb8b8da689aee29f8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">competitive pressures in the company&#8217;s markets;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z038c3c11647f45aea3cdf13b7504afd3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">risk that epidemics, including COVID-19 and related disruptions, or other crises could negatively impact our business;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z6995e1b78be143b0bed0acc203d7f324" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">adverse publicity related to the company&#8217;s business, products, industry or any legal actions or complaints by the company&#8217;s sales force or others;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z0a893bae246944c898be255e2e73bbe0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">political, legal, tax and regulatory uncertainties, including trade policies, associated with operating in Mainland China and other international markets;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zc249af90ed284f1682588626d5a5eafb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">uncertainty regarding meeting restrictions and other government scrutiny in Mainland China, as well as negative media and consumer sentiment in Mainland China on our
              business operations and results;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z58a9acef03f843fa8d221513827788dd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">risk of foreign-currency fluctuations and the currency translation impact on the company&#8217;s business associated with these fluctuations;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zfe0a087e3bb44b179be28db29c2272ec" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">uncertainties regarding the future financial performance of the businesses the company has acquired;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z743783d22e534fa68f422012b10ce8ee" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support planned initiatives or launch strategies, and increased
              risk of inventory write-offs if the company over-forecasts demand for a product or changes its planned initiatives or launch strategies;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zd47fc0531b054936882c9095d67fb8d7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">regulatory risks associated with the company&#8217;s products, which could require the company to modify its claims or inhibit its ability to import or continue selling a
              product in a market if the product is determined to be a medical device or if the company is unable to register the product in a timely manner under applicable regulatory requirements; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z1a9f7ec2e7504105b094cb5ea17c090b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; font-size: 10pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman'; font-style: italic;">the company&#8217;s future tax-planning initiatives, any prospective or retrospective increases in duties or tariffs on the company&#8217;s products imported into the company&#8217;s
              markets outside of the United States, and any adverse results of tax audits or unfavorable changes to tax laws in the company&#8217;s various markets.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">The company&#8217;s forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents
      filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company&#8217;s beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking
      statements contained in this release to reflect any change except as required by law.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"># # #</div>
    <div style="text-align: left; color: #363636; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONTACTS:</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(54, 54, 54);">Media</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">: </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">media@nuskin.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">,
        (801) 345-6397</font></div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Investors: </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">investorrelations@nuskin.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, (801</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(54, 54, 54);">) 345-3577</font></div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ef20041017_ex99-2.htm
<DESCRIPTION>UNAUDITED PRO FORMA FINANCIAL INFORMATION
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 24.12.1.5274
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 99.2</font><font style="font-size: 10pt;"><br>
    </font></div>
  <div style="text-align: left;"><font style="font-weight: bold; font-size: 10pt;"> </font><font style="font-size: 10pt;"><br>
    </font>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SELECTED UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On January 2, 2025, Nu Skin Enterprises, Inc. (&#8220;<font style="font-family: 'Times New Roman';"><u>Nu Skin</u></font>&#8221; &#8220;<font style="font-family: 'Times New Roman';"><u>we</u></font>&#8221;
      or the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), through our consolidated subsidiary Mavely Seller LLC (&#8220;<u>Seller</u>&#8221;), entered into a Unit Purchase Agreement, dated as of January 2, 2025 (the &#8220;<u>Purchase Agreement</u>&#8221;),

      by and among Seller, Mavely LLC (&#8220;<u>Mavely</u>&#8221;), Clout.io Holdings, Inc. (&#8220;<u>Purchaser</u>&#8221;) and Mavrck LLC, and disposed of all of our equity interests in Mavely. As a result of the disposal, as of January 2, 2025, Mavely and its subsidiaries
      will no longer be included in our consolidated financial statements.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The following unaudited pro forma condensed consolidated balance sheet as of September 30, 2024 assumes that the sale occurred on September 30, 2024. The following
      unaudited pro forma condensed consolidated statements of operations of the Company for the nine month period ended September 30, 2024 and for the year ended December 31, 2023 are presented as if the disposal had occurred as of January 1, 2023.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The unaudited pro forma condensed consolidated financial statements are presented based on information currently available, are intended for informational purposes only,
      and do not purport to represent what the Company&#8217;s financial position and results of operations actually would have been had the sale occurred on the dates indicated, or to project the Company&#8217;s financial performance for any future period.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The unaudited pro forma condensed consolidated financial statements and the accompanying notes should be read in conjunction with the unaudited condensed consolidated
      financial statements and accompanying notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Form 10-Q for the quarterly period ended September 30, 2024. The unaudited pro forma
      condensed consolidated financial statements and the accompanying notes should also be read in conjunction with the audited consolidated financial statements and accompanying notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and
      Results of Operations&#8221; included in the Company&#8217;s Form 10-K for the fiscal year ended December 31, 2023.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Historical columns in the Unaudited Pro Forma Condensed Consolidated Balance Sheet and the Unaudited Pro Forma Condensed Consolidated Statements of Operations
      reflect the Company&#8217;s historical financial statements for the periods presented and do not reflect any adjustments related to the disposal.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The information in the Transactions Accounting Adjustments column in the Unaudited Pro Forma Condensed Consolidated Statements of Operations for the nine months ended
      September 30, 2024 was derived from the unaudited information supporting the unaudited financial statements included in the Company&#8217;s Form 10-Q for the quarterly period ended September 30, 2024. The information in the Transactions Accounting
      Adjustments column in the Unaudited Pro Forma Condensed Consolidated Statements of Operations for the year ended December 31, 2023 was derived from the information supporting the audited financial statement included in the Company&#8217;s Form 10-K for the
      fiscal year ended December 31, 2023.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageNumberArea" style="text-align: right;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of September 30, 2024</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z30a2a736361c465a9783cb3a4ae67d92" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 62%; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(In thousands)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Historical </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(as reported)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Transaction</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Accounting Adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 2%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Pro Forma</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 62%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">ASSETS</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 2%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 62%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Current assets:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" style="vertical-align: top; font-size: 10pt; width: 2%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Cash and cash equivalents</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">227,751</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">197,800<br>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(b)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">425,551</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Current investments</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">10,077</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">10,077</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Accounts receivable, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">68,812</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(14,834</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">53,978</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Inventories, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">247,789</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">247,789</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Prepaid expenses and other</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">98,942</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(296</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">98,646</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total current assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">653,371</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">182,670</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">836,041</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Property and equipment, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">410,673</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(1,185</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">409,488</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Operating lease right-of-use assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">85,550</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">85,550</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Goodwill</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">99,885</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(12,602</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">87,283</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Other intangible assets, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">85,266</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(8,431</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">76,835</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Other assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">248,150</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">10,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(c)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">258,150</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">1,582,895</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">170,452</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">1,753,347</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-weight: bold;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Current liabilities:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Accounts payable</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">32,736</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(230</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">32,506</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Accrued expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">246,615</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(11,903</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(a)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">234,712</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Current portion of long-term debt</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">60,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">60,000</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total current liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">339,351</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(12,133</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">327,218</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Operating lease liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">68,351</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">68,351</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Long-term debt</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">373,470</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">373,470</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Other liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">94,848</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">94,848</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">876,020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(12,133</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">863,887</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman';">Stockholders&#8217; equity:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Class A common stock</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">91</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">91</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Additional paid-in capital</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">624,665</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">624,665</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Treasury stock, at cost</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(1,563,878</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(1,563,878</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Accumulated other comprehensive loss</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">(105,040</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">(105,040</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; font-family: 'Times New Roman';">Retained earnings</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">1,751,037</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">182,585</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(d)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">1,933,622</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total stockholders&#8217; equity</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">706,875</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">182,585</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="1" style="vertical-align: top; width: 2%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="font-family: 'Times New Roman';">889,460</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 62%; padding-bottom: 4px; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman';">Total liabilities and stockholders&#8217; equity</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">1,582,895</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">170,452</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" style="vertical-align: top; width: 2%; padding-bottom: 4px; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">1,753,347</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageNumberArea" style="text-align: right;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNAUDITED PRO FORMA CONDENSED CONSOLIDATED INCOME STATEMENT</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Nine Months Ended September 30, 2024</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="zdcaf930a88e8452788e09954fc6a3934" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(In thousands, except for per share data)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Historical</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(as reported)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Transaction</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Accounting</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Pro Forma</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Revenue</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,286,532</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(37,368</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,249,164</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cost of sales</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">383,828</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(583</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">383,245</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Gross profit</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">902,704</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(36,785</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">865,919</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating expenses:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Selling expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">486,617</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(26,676</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">459,941</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">General and administrative expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">358,107</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(9,112</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">348,995</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Restructuring and impairment expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">156,484</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">156,484</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total operating expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,001,208</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(35,788</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">965,420</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating income (loss)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(98,504</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(997</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(99,501</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Interest expense</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">20,545</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">20,545</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Other income, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,800</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,822</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Income (loss) before provision for income taxes</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(117,249</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(975</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(118,224</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Provision (benefit) for income taxes</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(6,760</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(244</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(7,004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net income (loss)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(110,489</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(731</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">(111,220</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 4px; font-size: 10pt; width: 1%;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net income (loss) per share:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Basic</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(2.23</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;"><br>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(2.24</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Diluted</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(2.23</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;"><br>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(2.24</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Weighted-average common shares outstanding:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Basic</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">49,645</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">49,645</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Diluted</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">49,645</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">49,645</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageNumberArea" style="text-align: right;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNAUDITED PRO FORMA CONDENSED CONSOLIDATED INCOME STATEMENT</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended December 31, 2023</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z2dc0f65d54d44076849a155cfb27c271" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%; text-align: left;">
            <div style="font-family: 'Times New Roman'; font-weight: bold;">(In thousands, except for per share data)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Historical</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(as reported)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Transaction</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Accounting</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Pro Forma</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Revenue</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,969,131</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(24,654</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,944,477</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cost of sales</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">611,850</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">611,850</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Gross profit</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,357,281</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(24,654</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,332,627</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating expenses:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt; text-align: right;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Selling expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">742,365</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(22,088</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">720,277</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">General and administrative expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">546,858</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(10,302</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(e)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">536,556</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Restructuring and impairment expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">19,790</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">19,790</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Total operating expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,309,013</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">(32,390</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">1,276,623</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Operating income</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">48,268</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">7,736</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; background-color: rgb(204, 238, 255); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">56,004</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Interest Expense</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">25,560</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">&#8212;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">25,560</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Other expense, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">3,870</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">182,583</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">(e,g</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">)</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">186,453</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Income before provision for income taxes</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">26,578</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">190,319</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">216,897</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 59%;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Provision (benefit) for income taxes</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">17,983</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">47,580</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">(f)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; width: 9%;">
            <div style="font-family: 'Times New Roman';">65,563</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; padding-bottom: 4px; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net income</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">8,595</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">142,739</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">151,334</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Net income per share:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Basic</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">0.17</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;"><br>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">3.04</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Diluted</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">0.17</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;"><br>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">$</div>
          </td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">3.04</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Weighted-average common shares outstanding:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Basic</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">49,711</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">49,711</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 59%; font-size: 10pt;">
            <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Diluted</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">49,860</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 2%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">49,860</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pro Forma Adjustments and Assumptions</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Separation transaction accounting adjustments:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za01805c3e1d44217afedb0cfada409be">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Reflects the adjustments to eliminate the assets and liabilities attributable to the Mavely business.</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeb92111a8edc4f63b156700a0abce09c">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Reflects net cash proceeds from the transaction, less certain purchase price adjustments and estimated transaction costs.</div>
          </td>
        </tr>

    </table>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0ff293f7afe844acb2f82807d53ea6d5">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Reflects approximately one million shares of ownership interest in Purchaser.</div>
          </td>
        </tr>

    </table>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z65c306c2e2d042e2b9013dae0806135c">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Reflects the effect on total stockholders&#8217; equity of the adjustments described in notes (a) - (c) above.</div>
          </td>
        </tr>

    </table>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze73cb545f08944b99ab916db59c4d38e">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Reflects the adjustments to eliminate the historical operating results of Mavely.</div>
          </td>
        </tr>

    </table>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8e5d7bc7ea4b4d8a805bd81b58fad288">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
          <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Reflects the provision (benefit) for income taxes for the adjustments made to income before provision for income taxes at a statutory tax rate of 25%.</div>
          </td>
        </tr>

    </table>
    <br>
    <div style="font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" id="zcea5d6dffe274a9c90ad0a2f134355df" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">Reflects the estimated $182.6 million gain arising from the transaction. No adjustments have been made to the sale proceeds to give effect to any potential post-closing adjustments
                under the terms of the Purchase Agreement.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>nus-20250102.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.12.1.5274 Broadridge-->
<xs:schema targetNamespace="http://nuskin.com/20250102" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nus="http://nuskin.com/20250102" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="nus-20250102_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="nus-20250102_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://nuskin.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>nus-20250102_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.12.1.5274 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>nus-20250102_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.12.1.5274 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://nuskin.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="nus-20250102.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://nuskin.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  S .D# 2(  A$! Q$!_\0
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M%^/7C?4?A_X$_MK1X;::Z^U1P;;E2R;6#9. 0<\>M'[._P#R1CPO_P!>Q_\
M0VKEOVPO^20'_L(0_P GH ]=\,WTNJ>'-+O[@*LUU:QSN$Z LH)Q[<UI5A>
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M2@!_[.__ "1CPO\ ]>Q_]#:N6_;"_P"20'_L(0_R>NI_9W_Y(QX7_P"O8_\
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M\1Z=XL\+VVLZ-,)K.ZBW+ZH>ZL.S \$5XA^QE_R+OBK_ +"?_L@H ^BJ***
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*D]?SJ[110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm46011760515488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NU SKIN ENTERPRISES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001021561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0565309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">75 West Center Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Provo<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NUS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M+^6NODGA<@LE7R4&5MD_Q0W\:["R"NTM1!K6IQ'7?%IB:%53H+BK?XVVD-K
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  @,"-:F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M " P(UJN)FN04@0  )40   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  @,"-:GZ ;\+$"  #B#   #0
M            @ &5#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( " P(UJ7
MBKL<P    !,"   +              "  7$/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( " P(UH<.&7J/P$  #P"   /              "  5H0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  @,"-:)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  @,"-:99!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20041017_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nuskin.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20041017_8k.htm">ef20041017_8k.htm</File>
    <File>nus-20250102.xsd</File>
    <File>nus-20250102_lab.xml</File>
    <File>nus-20250102_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20041017_8k.htm": {
   "nsprefix": "nus",
   "nsuri": "http://nuskin.com/20250102",
   "dts": {
    "inline": {
     "local": [
      "ef20041017_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "nus-20250102.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "nus-20250102_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nus-20250102_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://nuskin.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250102to20250102",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20041017_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250102to20250102",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20041017_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nuskin.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001140361-25-000113-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-000113-xbrl.zip
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M:XO\J6-9-IE10:YIE#][NLXZS.X'Q@#-,Q7+K&S_R'=&=M_QPX$U=!T'@_]
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M*^D5? WQA-W.-+$(IF@%LP%N.88L0F> 0P.S.0:7<#%(:<7"'TYQ*^GLJ12
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M=")YD6U-X#+"<*X'Y6DH;72)CAP+ \'<T4P]"KSU9$*:K ML@:MS]1E?JQ#
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M<>V$KX\N24YUSM\L4^$3>83.P-)_3Y;^4>Z;#+0A39+A5#MSNX=;KDI,N2:
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M44]4">W'$:,'D3X?84X[!^@-[)#U'FF9[=("'F@0:HS'BVQK!U8>BT="'H2
MPLO(*P/HX2*7^.>@FP9-CRAR%SY>TS>.T>U$"9<V'74Z@4!*!Z<H3& ZHBH0
MG5?10'^HNK:[;[+]FAL'6F>AE\"KS^YN?R2%XXV:H1/!1;4*G88(7'W$WS-C
M.$J75]*V:N5JBU"9Y@$?:>'H)>HWV<1*$0W:Z$ ED4#@17_:??DP"_2$)5(&
M^R#EJD&[*-/UZ.'T0HF\WJ#X@=((#DX?3Y+P:/]$WAV]MM-T)9?U23SM0M2A
M*C%L^'@KNHHK>#\)I7=80'3R)M*>M74F[G.EO93X4U0X88-*D(VN75ZJU^_
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M;2#[[G8S[)H(WVX?;@OJ)V$PGXX?>ET/C=12+&OVF#58.C9XTW$\>NN;F&;
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M"4IASD"AVST TWEC?[,SR]*J3ARN6],/%]@T:9I2O*DE^_%S4=X9)_P:FS=
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M4-+<I6,L<[M+*TSS@CQ'W ](GXF13&,?>]@WI^&6:/24-/U>-O,;$;"V;2N
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MW^0OP UR\C#=''T!.4!<<78Y&DV! H>9T*[3RK+)69[_SKBLZQQ !(K2H>I
MJL2(3FA7XUT :L-7L+YTZ[IP,:7*OIJB7*HJ(F+LNU)'E]),E;!7$A[B'/X2
MM"<\(;'HI)>C[W]E'JLJ_I>@I"I4.3O R:<69>@2LT&O Q?G5?5,RY0DN3/2
M5IN2A#1#'6^ =D0$+9?]#ULQ08MIL]7U(%79#6_D];RA1Q=K\=@;IM)SKO1+
MYDKWGG.EZV56[VYU=];-KO[/Z3_;\#(.,?.#^5=^F_;HYE\B]^UDYC,+/#TG
M:-UY!G:^.,\ ]GF ##?DEQ8VM[34ALAJ;%RA>FI^D"8Z1I&FH]![F ."$@I$
M3-D@5PS =6/C\.#V7W9(1,]CAW5:CF=LW7W]Y6%&+K^J&,FYF$&LO;%B(GR-
M.+K*@JZ(5#+!L9&-7GE$E(SJU 5G2WV%O[/HLYT"=6="P,9P3:Y*XQ&Y[B'\
M,(_0J.VY=\()C="NV\V0G9M;O<+;*.]6ET@ICAE0Z9Y=DW/*GY7G5\W/0X)R
MF#U-IK/U"PS!2?[H79EY!+R-H$U=#K%T#/E@72F9N1>=#4 QYD/C,@+'+#CH
MPC=-!_+\0^?$(7-5;YCV9VXF6-U$?@\8+R)EW^89D"<&Y6X?;(-B_+OYMM<_
M*=:-. 9X?7AC8@%A;C+K-<+!B?SK_I1R0OZ66AK.N4,P?IV99'$M3M84FLZC
M_*)Z;0SG49Q!+P*SFDDC.)M-_3H=G9^D$%B_-B4GZEI$Z%^_U.Z&\(M)2&PO
MH@;%!FE_YJ3&2X06P-4L<0H+S0K^B"^HX-F_;EUNL4'6L:S=8!91%PSZE)X_
M?L%:*?PIL2HDD5&ZWV+9%/R1]"RKR;NR&A+A$H0RU4#Y[RV6"S/R-NIO!6"M
M%LX8IG G\X+9OQ4-*D8E7*,%_!#4CP+*(<OJ34L&%?2UQ"[I0,%*\:DAMU"1
M5O"VZ9??D$Z9=E_VY!@)ZO(/5D8-LR<I,!Z?LW_%C"(8"2K$ZGE,;1WKX )2
M)@7H=1UGOX1E(71V"RJEN=MS:L?R8@"P3U28QC@>Y342R(^K//4J$9$PF".R
M8#.7MI4:<B77^>?.Q@%3)6.PCQ\,QS)\+AU5^U@]>WH#AP?9E5E8PZ:S&PFC
M25'FF8LTH16FGO0M>+CDT4T)SOM1#F^!5=%:&88]2$3DU$:F6=]EX5"*TLOX
M>/N<N&W$('FXXQO!UL9Z+]O-3=R.A<_*^ILKF#;>%5A5FK6=[]:CP/;C[:;;
MZ]RU2US^!7IS]8)[6R>+1<:XSFIXI#_>/CAZF+FK]B2E\_JQ^5^ZGM2!M%[6
M":O)58)D8T8N.HORH+34UI)2)DJ5FBY-/G%W4W);%Q1'>)'ZF?'XS)'!SIY#
MP2C1WX37/W+J=5)17^60M;E@<N;22.P<D)S&0OM$F3,$!))#Q(/@Y< F9;>R
M.)BP&L._L!ZEKI%+/H.%1 1Y#2P='&?J9]#53A'08YLS9.B;%OF?4R@"'DZ9
MIKIT^&GS9&/0C&H$VW#XCO\-_=,JS:C4HFW OM:3)VIL6WHO>XHK/C+O-P^_
M0L_;T?6Y!K10^Y]6D-2L]-HD&!Y2.^;(1\TJC-&&#?+6-B\F&+1EXG403?!>
M-*V#^H]X:6B;OI(J484&Y@H/HBH'?U=(I]2:>W7&>&[I3L',&3H#(K::$L#<
M9@87&_81EP40='@[E^##@_M*%HCY9CX99EP%#?9X[9T"Y1W EZ)'9Y.,#VK\
M93[$]]E,'=M&/%.-?YT<Y/YS#G+-M/U:]JI8K7\:,R:!O!!8%[2W2JDW@;GP
M1O-,T'Y >M9B@,7J1H^"MP8R@;J@LD@(+%8.R%)W@DM64THG?'_VX?47/3$K
M>O(M7GR(F6KK]@,!+*9O:>^=DUIR/0$3@J,&/XE^LKPF#(8"#55S8H_=9^N&
MJ3X^JK<)5F?9_C]<66>13&4E[39"Y(YZ6I#W31W[BHQA;+M*P?F?S'35G(>
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MG6&,AMA'U^W8]U<X]CXB+^9.FU7"_.7G5 )?X!DC"T^B@ICT>PVV(X.4&1?
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MW?KSJR<7J2VX^<"'CV<?.V=##1\,XN4?JNR%*#TX0A_03EFW):R^7I1;5U
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MB-#GK[N2Q/,1+7(EZ;Z[ GSM_D"9L/-Z:QTH;#2$2@^3_8,]<P9VS#H;]RN
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MDJ13)1U.[]'\M%U)-MOW3WBY0692,8)-YLRW#_7?)LMOVY$\>_XY<#0+RIV
MN$X#7T*JXZE1E]LS-/N-%\BV0[PI5FQ'-^&(HU?_$<^N?SF)U'BG<MPUZQZU
M#L'V%/@(;R4LW:'U/NVH58M R@R6#$!Q20ZX750VNL)("2AE[TG;#2"21RG
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M%>=8?UB++??:,XC<=-.HF@@4O!7L.:]\)*5_D+EWEB@#::(N[!6"#MV%,,V
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MN]M7#^T.6N%6C'LMY0:T!YNW'U!BYWZPB4>>]-2U)G4HM75QD<H^,8\::GL
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M9H#=@FH)^ N=YN)"_& $B<$(U,LN;((B0S"B"_YLE\/38C4J@APE@@VR)]A
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M-XCSBU0)AT56SN7B^+G.7>VBNK'72Z@;@VW*<J?B;(>J 0O<":D@;.IVM6Y
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MGC=K.H!NQ'AJ0(O[9KU8&\AYYRB2]'07U%S_O#0 8=/A-$.Y>- J3JQIX<7
M=N%^-8RG0L0CJ:HQH.4QV(M<',4B7Y(0$)RG9N P8"M=G^?/7%>#-K0H6Z<V
M3 I6HB-T.2 $$D.7 +3\L)C5"00V.0JHOL>A0F&(;5*/<N5^(GN=^G>^)+I
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MQOJM_J#3ZX4_@PJ*7J<BHT8[W/IQ=GCS330,4UN11X4S<A>\D<PG"$J4:8Y
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ME@R-G=(J-6?IN*9A[8]V[,(0OX(Y)+XVL:+J+"5B.]FH 3?6Q9>/?^FLN[W
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M$&_$KN>];;)!CT3:5[N%PHBA9&PI:G[J JNN:,KY29B!/1Y?G9HA"X4D)J=
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MIY?0W^C,_P/[\0;.I_MO^U_FO^6__OGS1399X7]\7LRFZC_^/U!+ P04
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M3K,W53PMYDW!?;& N>51^TS)S;5T,P2?:X %4*G7N 4GLBQH;<0"\H4^81K
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MN^HV_*6,F/-%&D&F4==13 /^4I%F[X6 VQZ@ K56@7JVXACP<U2R)*%7[IT
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MZ(NN4FL:\D6766:K'+] EG?"N _Z"M.$Q!^RV/_ Y5!=#?ZF".D+H*(&<Y^
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M02'_J\.OI]/:?7(S4"V4#PA/]]9E->CORZ-] +G/9? ?Y?D2\]9N<,+MGK#
MP3NCJ<3]_&')IEWRTE[::5A;PK'8(/]QOHG(%_D/[4__ U!+ 0(4 Q0    (
M " P(UJJ -%]N2$  +3O   1              "  0    !E9C(P,#0Q,#$W
M7SAK+FAT;5!+ 0(4 Q0    ( " P(UKE?^L49U,! (U:"  4
M  "  >@A  !E9C(P,#0Q,#$W7V5X,BTQ+FAT;5!+ 0(4 Q0    ( " P(UJS
MK+;GL!(  (E=   5              "  8%U 0!E9C(P,#0Q,#$W7V5X.3DM
M,2YH=&U02P$"% ,4    "  @,"-:TK5:0?@F   )=P0 %0
M@ %DB $ 968R,# T,3 Q-U]E>#DY+3(N:'1M4$L! A0#%     @ (# C6C(V
M_"-/ P  IP\  !               ( !CZ\! &YU<RTR,#(U,#$P,BYX<V10
M2P$"% ,4    "  @,"-:\:R8DGP(   Q5@  %               @ $,LP$
M;G5S+3(P,C4P,3 R7VQA8BYX;6Q02P$"% ,4    "  @,"-:;NG;Q=P%  #M
M/@  %               @ &ZNP$ ;G5S+3(P,C4P,3 R7W!R92YX;6Q02P4&
2      < !P#) 0  R,$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ef20041017_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nus-20250102.xsd" xlink:type="simple"/>
    <context id="c20250102to20250102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001021561</identifier>
        </entity>
        <period>
            <startDate>2025-01-02</startDate>
            <endDate>2025-01-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250102to20250102"
      id="Fact_1810df1c96af46559905d5f3515db7b4">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250102to20250102"
      id="Fact_0caa692cb4c747929457a618dd3a8c95">0001021561</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20250102to20250102"
      id="Fact_0b8fd64ba47449c597a6e69b0675b569">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250102to20250102"
      id="Fact_a549a580a03c4c44b1e87338fdeb46fd">2025-01-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250102to20250102"
      id="Fact_c254e99801e243e18dc6a8cda7836358">NU SKIN ENTERPRISES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250102to20250102"
      id="Fact_307f90c0bf7845f3b0a9e35176d24278">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250102to20250102"
      id="Fact_c89dcc002a864412a6d4556c2e737653">001-12421</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250102to20250102"
      id="Fact_14e4e15c041a469babea233ccbc53803">87-0565309</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250102to20250102"
      id="Fact_88064ad6030843579a84c6eef6872943">75 West Center Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20250102to20250102"
      id="Fact_d68ae28ecd4647718cdbaf2f91723395">Provo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250102to20250102"
      id="Fact_f5265a4e9aeb4cb6ba45069d1f4d9a48">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250102to20250102"
      id="Fact_76da7dcacbec4f3a87be86ab724d0e68">84601</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250102to20250102"
      id="Fact_8f9a3838b7784264ac3efeb94c87a220">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250102to20250102"
      id="Fact_62c7500726464b7c955767bcb83b96b4">345-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250102to20250102"
      id="Fact_0fe86df9f77140e6b4ac3c8d21430bc6">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250102to20250102"
      id="Fact_f1e93f8f1cf847ebb655233a4b0adbbd">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250102to20250102"
      id="Fact_f33c44402eee4649990f03900f3a2f0e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250102to20250102"
      id="Fact_6455ccda734a45ff9c4ceb9c4fecd99e">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250102to20250102"
      id="Fact_b321ec4a195549c585e954889de768d8">Class A Common Stock, $.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250102to20250102"
      id="Fact_9c29162cf7084223a8724086eb0bf17c">NUS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20250102to20250102"
      id="Fact_0680ae7b05714700ab048a1bb872eae9">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250102to20250102"
      id="Fact_2d4db45d7e554cf987899529f050f1fa">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
